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ABSTRACT

Androgens, testosterone (T) and 5a-dihydrotestosterone (DHT), have profound
modulatory roles in the mammalian central nervous system by specifically binding to
androgen receptors (ARs) in target cells. The studies contained in this dissertation
were designed to characterize AR expression in the hippocampus, a central structure
of the limbic system, and to determine if this area is a neural target for androgen's
actions. In the first series of experiments, AR and AR messenger ribonucleic acid
(mRNA) levels in the adult male rat hippocampus were found to compare closely to
levels found in the hypothalamus, and AR mRNA expression was primarily
concentrated in the CAl pyramidal cell region of the hippocampus. Hippocampal AR
and AR mRNA expression were uniquely autoregulated following the removal of
circulating androgen in adult male rats, and in old male rats with reduced circulating
levels of T. Next, the effect of selective AR activation on the constitutive expression
of the glucocorticoid receptor (GR) and mineralocorticoid receptor (MR) genes in the
hippocampus were investigated. As compared to castrated control rats, DHT
treatment of castrates decreased GR mRNA levels, but not MR mRNA levels, in the
CAl region of the hippocampus. Transcriptional cross-talk or interactions between
AR and GR may mediate some aspects of androgen action on hippocampus-mediated
behaviors. The final study in this dissertation investigated the influence of androgens
iv

on the pattern and magnitude of inducible cellular immediate early gene (cIEG)
expression in the rat hippocampus following exposure to a novel open field; a
paradigm which stimulates the hippocampus. The induction of hippocampal c-jun,

jun-Band zij268 mRNA were not affected by androgen status, however, DHT
treatment attenuated, and castration increased, novelty-induced c-fos mRNA
expression in the CAI region. These data suggest that AR activation changes the
active properties of hippocampal neurons to incoming signals.
In summary, these studies have begun to define the sensitivity of the adult
male rat hippocampus to androgens and provide a foundation for further investigation
of androgen's roles in hippocampal function and hippocampally-mediated behaviors.

"
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CHAPTER I
INTRODUCTION

Androgens have a wide range of biological effects in peripheral and central
tissues that are exerted primarily through the activation of androgen receptors (AR)
within target cells. For the most part, studies in the brain have concentrated on
androgen action in hypothalamic regions, where testosterone (T) and
dihydrotestosterone (DHT) have clear roles controlling aspects of reproductive
behavior (Feder, 1984) and hormonal feedback mechanisms (Messi et al., 1988). In
recent years, the cloning of AR as well as the development of techniques that provide
greater anatomical resolution have led the way to the discovery of abundant AR
expression in many areas of the adult mammalian brain. Some of these areas include
the amygdala, cortex, striatum and hippocampus (Sar and Stumpf, 1974; Handa et al.,
1987a; McLachlan et al., 1991; Burgess and Handa, 1993a; Osada et al., 1993).
This widespread localization of AR in the central nervous system (CNS) suggests a
much broader physiological importance for androgens than initially anticipated.
Furthermore, since AR acts as a ligand-activated transcription factor, thereby
increasing or decreasing the transcription of many target genes within a cell, the
potential activational effects of androgens in neural tissue are many.
In mammals, gender differences exist not only in the levels of circulating
androgen and sex behavior, but also in several non-reproductive behaviors. These
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include aggressive tendencies, spatial ability, verbal ability, activity level, and certain
cognitive functions. Because adult males produce much higher levels of the gonadal
hormone, T, whereas the main circulating hormone in females is estrogen, it has been
suggested that these gonadal hormones act in the brain to sexually differentiate
behavior throughout life. However, currently there is little information regarding
where in the brain or through what mechanism gonadal hormones exert these
physiological effects.
Additional evidence implicating androgens as modulators of neural function
comes from studies examining human subjects who abuse anabolic-androgenic
steroids. Anabolic-androgenic steroids are synthetic variants of the endogenous male
hormones, T and DHT. These steroids promote both androgenic (male sexual
characteristics) and anabolic (muscle building) effects by specifically binding to
intracellular ARs in target tissues. The use of supraphysiologic doses of anabolicanabolic steroids to enhance athletic performance and physical appearance has become
a serious social problem in recent years. In addition to the many peripheral side
effects of these drugs, psychiatric evaluations of anabolic steroid abusers have
revealed a wide range of adverse emotional and behavioral problems that are closely
linked to steroid use or withdrawal (Katz and Pope, 1990; Uzych, 1992). The
psychological ramifications of high level androgen use also suggest that some limbic
areas of the brain may be sensitive to increasing levels of AR activation. Despite
these many reports, little is known about the biological and cellular mechanisms of
action of androgens, especially in neural tissues.
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The hippocampus, a central structure of the limbic system, has been implicated
in influencing a variety of behaviors including learning and memory formation (Teyler
and DiScenna, 1985; Whishaw, 1987; Zola-Morgan and Squire, 1990; Eichenbaum
and Otto, 1992), emotion (Derryberry and Tucker, 1992), spatial mapping (O'Keefe
and Nadel, 1974; Olten, 1977; Olten et al., 1979; Nadel and McDonald, 1980;
Sutherland et al., 1982; Bouffard and Jarrard, 1988; Best and Thompson, 1989), and
cognition (O'Keefe and Dostrosvsky, 1971). Relatively high levels of AR expression
have been detected in the mammalian hippocampal formation (Sar and Stumpf, 1973;
McLachlan et al., 1991; Burgess and Handa, 1993a; Kerr et al., 1995), however,
their physiological significance is unknown. Recently, androgenic compounds have
been shown to influence hippocampus-mediated learning behavior (Flood et al., 1992)
and neuronal plasticity of hippocampal pyramidal cells (Pouliot et al., 1995) in
rodents. Although cellular mechanisms were not investigated in these studies, the
authors suggested that such long-lasting neuronal events may result from AR-mediated
modulation of cellular immediate early gene (cIEG) expression or alterations in
membrane receptor-meidated actions.

Based on these observations, it was hypothesized that the adult
hippocampus is a neural target for androgens. Furthermore, androgens act
through the AR to change the basal and active properties of hippocampal
pyramidal cells. Thus, either higher than normal levels of circulating androgen or
the complete removal of circulating androgen by gonadectomy (GDX) may alter
transcriptional activity in these neurons which may lead to changes in neuronal
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plasticity or behavior.
The first series of experiments performed for this dissertation characterized
AR and AR messenger ribonucleic acid (mRNA) expression in the adult male rat
hippocampus using a multidisciplinary approach. AR and AR mRNA levels were
quantitated in the hippocampus and compared to levels in other brain and peripheral
tissues known to be sensitive to androgens. Saturation analysis of 3H-DHT binding in
various brain tissues was performed to determine receptor affinity and compare AR
binding characteristics in the cortex, hypothalamus and hippocampus. In addition, the
ability of hippocampal AR to regulate its own expression following the removal of
circulating androgen in adult male rats and in old male rats who have reduced
circulating levels of T was determined.
The second study in this dissertation was designed to investigate the effect of
selective AR activation on the expression of the highly and constitutively expressed
mineralocorticoid receptor (MR) and glucocorticoid receptor (GR) genes in
hippocampal pyramidal and granule cell layers. Both MR and GR are members of
the steroid hormone receptor/transcription factor family and are known to mediate
many important physiological effects in the hippocampus. Transcriptional cross-talk
or interaction between AR and these co-localized, structurally related steroid hormone
receptors may mediate some aspects of androgen's actions on hippocampal-mediated
behaviors.
The third study in this dissertation investigated the influence of androgens on
the pattern and magnitude of inducible cIEG expression in the rat hippocampus
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following novel open field exposure, which stimulates the hippocampus. The
induction of cIEGs serves as a marker for cellular activation. Thus, androgen
modulation of cIEG induction following a stimulus would suggest that AR activation
changes the active properties of hippocampal neurons to incoming signals.
Together, these studies have begun to define the sensitivity of the adult male
rat hippocampus to androgens and provide the foundation for further investigation into
androgen's roles in hippocampal physiology and hippocampal-mediated behaviors.

CHAPTER II
REVIEW OF RELATED LITERATURE

Mechanisms of Androgen Action

The HllJothalamic-Pituitacy-Testicular Axis
Androgens have many biological effects on accessory sexual organs, a broad
range of effects on metabolic processes, as well as important organizational and
activational effects on behavior and cognition. In males, the secretion of androgens
from the testes is under tight control by the brain via the hypothalamic-pituitarytesticular (HPT) axis. The closed feedback neuroendocrine loop of this axis consist of
several anatomical structures including the central nervous system, the anterior
pituitary gland, the testes, and the target organs where androgens ultimately exert
their biological effects. As depicted in figure 1, the hypothalamus is under positive
and negative influences by neurotransmitters from higher brain centers including the
cortex and limbic system, as well as auditory, visual and olfactory centers. These
signals coordinate the pulsatile release of gonadotropin releasing hormone (GnRH)
from the medial basal hypothalamus into the hypophyseal-portal blood system
(Belcheltz et al., 1978). GnRH, in tum, regulates the pulsatile secretion of two
anterior pituitary gonadotropic hormones, follicle stimulating hormone (FSH) and
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luteinizing hormone (LH) (Clayton, 1987). Following secretion, these hormones act
directly on the testes to stimulate the production of sex steroids that function locally to
promote spermatogenesis or are released into the circulation where they act on many
peripheral and central tissues.
The principal hormone of the testes, T, is a C19 steroid with a hydroxyl group
at the 17 position. As shown in figure 2, T is synthesized from cholesterol in Leydig
cells and, in humans, is also formed from androstenedione secreted from the adrenal
cortex. In adult males, more than 95 % of circulating T is of testicular origin and has
a normal production rate of approximately 6-7 mg per day (Coffey, 1988). Females
secrete very small amounts of T, probably originating from the ovary and adrenal
gland (Botella-Llusia et al., 1980; Higuchi and Espey, 1989). T circulates bound to
albumin ( - 33 %) and sex hormone binding globulin (SHBG, - 65 %) as well as in a
free form ( - 2 %). T bound to albumin or in its free form are generally available for
end target action, whereas the fraction bound to SHBG is less functionally active
(Winters, 1990). In contrast, circulating T in rodents is primarily found in its free
form.
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Figure 1. Schematic representation of the hypothalamic-pituitary-testicular (HPT)
Axis. ( +), stimulatory signals; (-), inhibitory signals; DA, dopamine; 5HT, 5hydroxytriptamine; NE, norepinephrine; GABA, -y-aminobutyric acid; GnRH,
gonadotropin releasing hormone; LH, luteinizing hormone; FSH, follicle stimulating
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Within target cells, T has several fates. It can directly bind to AR to exert its
biological action, or it may be reduced by the intracellular enzyme, 5a-reductase, into
DHT which specifically binds to the AR with higher affinity than T (Wilbert et al.,
1983). Thus, DHT formation is a way of locally amplifying the action of Tin target
tissues. DHT is found in the circulation of adult men in levels about one tenth those
of T (30 to 80 ng/dl). Alternatively, in some cells where the enzyme aromatase is
present, T can be converted into 17.6-estradiol (see figure 2). This locally produced
estrogen can then interact with estrogen receptors (ER) if present in the cell.
To complete the HPT axis and tightly regulate its own production, Tacts at
the level of the pituitary (Sheckter et al., 1989), hypothalamus (Messi et al., 1988),
and possibly higher brain centers such as the hippocampus to inhibit further
production and release of GnRH and LH (figure 1). Although T negatively regulates
LH secretion, it has little effect on plasma FSH. This differential secretion led to the
search for inhibin, a glycoprotein produced by the testes that negatively regulates FSH
secretion at the level of the anterior pituitary gland (Abeyawardene and Plant, 1989).

Intracellular Actions of Androgens: The Androgen Receptor
The magnitude of T action in target cells is determined by various factors
including: the amount of diffusion of free hormone into the cells, the extent of
metabolic conversions within the cells, the number of receptor proteins available for
interaction with the steroids, and finally, receptor action at the transcriptional level.
The transcriptional actions of androgens (T and DHT) in both peripheral and central
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tissues have been linked in part to their ability to specifically bind and activate AR.
The AR is a member of a superfamily of nuclear transcription factors which also
includes other steroid hormone receptors such as the GR, MR, ER, thyroid hormone,
and progesterone receptor (PR) (Evans, 1988). This structurally related superfamily
also includes receptors for vitamin D, retinoic acid, as well as the newly described
orphan receptors which share amino acid sequence homology of steroid hormone
receptors but for which no known ligands have been found (Ribeiro et al., 1995). All
of these receptors when bound by ligand influence gene transcription via direct
interactions with deoxyribonucleic acid (DNA) (Godowski and Picard, 1989). Protein
chemistry (Wrange and Gustafsson, 1978; Carlstedt-Duke et al., 1988) and
complementary DNA (cDNA) cloning studies (Hollenberg et al., 1985; Kumar et al.,
1986; Rusconi and Yamamoto, 1987; Lubahn et al., 1988) have confirmed that each
member of the steroid hormone receptor superfamily is structurally organized into at
least three specific domains: a highly variable N-terminal region thought to be
involved in transcriptional activation, a short and well-conserved cysteine-rich central
domain responsible for DNA binding, and a high homology C-terminal end necessary
for binding with a specific steroid hormone (Evans, 1988). The domain structure of
AR will be discussed in more detail later in this review (see pp 36-42).
Despite the diversity of androgen target tissues, the basic sequence of events
leading to androgen's effects on gene transcription are thought to be consistent from
tissue to tissue. AR follows the traditional model of steroid action (O'Malley and
Tsai, 1992; Tsai and O'Malley, 1994) as diagrammed in figure 3. This pathway
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involves the passive diffusion of T into cells where it either binds directly to AR or is
first enzymatically converted into DHT. Once T or DHT binds to the AR, the
protein undergoes a conformational change and chaperone proteins, such as the 90
kDa heat shock protein (HSP90), dissociate from the receptor (Marivoet et al., 1992).
This transformation process exposes dimerization motifs and a zinc-finger DNA
binding domain within the AR molecule. As a result, AR has the propensity for
homodimerization with a second activated AR and it is this homodimer that has a high
affinity for DNA (Forman and Samuels, 1990a; Truss and Beato, 1993; Wong et al.,
1993). Specifically, the activated AR complex binds to specific DNA sequences,
termed hormone response elements (HREs), which flank target genes (Beato, 1989).
Once anchored to the HRE, the complex is capable of modulating transcriptional
activity either in a positive or negative fashion (Rundlett et al., 1990). The activated
DNA-bound receptor does not act alone to regulate transcription of a target gene, but
rather secures a complex arrangement of specific stabilizing proteins, transcription
factors and ribonucleic acid (RNA) polymerases which act together to ultimately
increase or suppress the transcription process (Rundlett et al. , 1990; Adler et al. ,
1993; Kupfer et al., 1993). These events occur as quickly as 5 minutes after steroid
injection into an animal, but measurable changes in steady state mRNA levels may
take between 15 min and several hours (Spelsberg et al., 1989).
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Figure 3. Schematic representation of the molecular pathway for androgen
action in target cells. T, testosterone; DHT, dihydrotestosterone; AR, androgen
receptor; HRE, hormone response element; hsp90, heat shock protein.
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Non-Genomic Actions of Androgens
It has become apparent in recent years that not all actions of sex hormones

involve "slow" gene transcription regulation. Rapid effects of steroid hormones and
steroid precursor molecules on electrophysiological and neurochemical parameters
have been reported (reviewed by McEwen, 1991). Although unique membrane
receptors for steroid hormones have yet to be found, it is has been shown that some
steroids allostericly interact with the )'-aminobutyric acidA (GABAA) ligand-gated ion
channel receptor and modulate its activity (Majewski, 1992). The most potent
naturally occurring steroids with allosteric GABAA -agonistic features are
tetrahydroprogesterone, tetrahydrodeoxycorticosterone, and the T precursor,
androsterone (Majewski et al., 1986; Lambert

el

al., 1987; Turner et al., 1989). In

contrast, some steroid molecules behave as noncompetitive antagonists at this
receptor. Pregnenolone sulfate and the sulfate derivative of the T precursor,
dehydroepiandrosterone (DHEA) belong to this latter category (Majewski and
Schwartz, 1987; Mienville and Vicini, 1989; Majewski et al., 1990). Interestingly,
these latter compounds have been found to be synthesized de novo locally within the
brain at concentrations much greater than those in plasma (LaCroix et al., 1987).
Thus, these neuroactive steroid metabolites and precursors have been termed
"neurosteroids" (Baulieu and Robel, 1990).
Most recently, two anabolic-androgenic steroids, stanozolol and 17amethyltestosterone, were found to modulate benzodiazepine binding to the GABAA
receptor in the male and female rodent brain (Masonis and McCarthy, 1995). This
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was the first report of direct membrane-bound receptor effects of androgens that are
also known activators of intracellular ARs. The authors speculate that these
membrane-bound receptor effects may account for some of the psychotropic responses
following high doses of anabolic steroids. These findings certainly leave the door
open for possible rapid membrane-bound receptor effects of T and DHT, however, to
date, such reports are few (Teyler et al. , 1980).

Localization of Androgen Receptors

AR expression has been detected in a wide range of tissues by various methods
including in vivo autoradiography with radioactive T or DHT, in vitro binding assays,
in situ hybridization, polymerase chain reaction (PCR), and immunocytochemistry. In

peripheral tissues, AR expression has been found in accessory male sex glands (e.g.
ventral prostate (VP), seminal vesicles, and epididymis; Mangan et al., 1968;
Anderson and Liao, 1968; Sar et al., 1970; Hansson and Tveter, 1971; Husmann et

al., 1990; Prins et al., 1991; Blok et al., 1992a), skeletal muscle (Saartok et al.,
1984), male external genitalia (e.g. penis and testes; Takane et al., 1990; Blok et al.,
1991, 1992a), bone (Colvard et al., 1989), adrenal gland (Osada et al., 1993), uterus
(Giannopoulos, 1973), as well as several other organs (e.g. kidney, lung, and liver;
Roy et al., 1974; Dube and Tremblay, 1974) and glands (e.g. anterior pituitary,
sweat, and sebaceous; Choudhry et al., 1992; Osada et al., 1993). This anatomical
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distribution coincides with the regions known to mediate important peripheral
androgen-dependent functions such as the development and maintenance of the male
genitalia and secondary sex characteristics, hypertrophy of skeletal muscle,
spermatogenesis, mineralization of bone and male-patterned hair growth (or loss)
(Winters, 1990).
Many studies have also localized AR expression to specific areas of the CNS
including the hypothalamus, medial preoptic area, cortex, amygdala, thalamus, bed
nucleus of the stria terminalis, hippocampus, motor nuclei and brain stem (Sar and
Stumpf, 1973, 1974; Barley et al., 1975; Banda et al., 1986, 1987a; Roselli et al.,
1989; Simerly et al., 1990; Sarrieau et al., 1990; Clancy et al., 1992, 1994; Burgess
and Handa, 1993a; Osada et al., 1993). Several studies have confirmed that the
distribution of AR mRNA in the brain and peripheral tissues match the distribution of
the AR protein (Simerly et al., 1990; Quarmby et al., 1990; Takane et al., 1991;
Blok et al., 1992a; Menard and Harlan, 1993). Most studies have focused on the
areas of the brain involved in reproductive behaviors or endocrine feedback
mechanisms. The reports of AR expression in extrahypothalamic regions such as the
hippocampus and cortex have been meager. Interestingly, studies have found no
dramatic sexual differences in AR mRNA distribution or AR binding levels in the
adult rat brain (Simerly et al., 1990; Handa et al., 1986). Together, these findings
suggest an important role of androgens in CNS function. An overview of androgen
action in the brain will be covered in the following section.
As methods to detect AR have become more sensitive, it has become harder to
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find tissues that fail to express AR at some level. However, a few tissues, including
the spleen, are considered to be AR negative (Takada et al., 1990; Osada et al.,
1993). Thus, it appears that sensitivity to androgens may be a function of the
changing AR level in cells and the hormonal milieu, than strictly the presence or
absence of AR expression.

Physiological Actions of Androgens in the CNS: Organizational Versus Activational
Effects

Such widespread localization of AR in the brain suggests that androgens
influence the action of most neurons (Mooradian et al., 1987). Typically, the
physiologic effects of gonadal steroids have been divided into those that are
organizational, which occur during fetal development and the early neonatal period,
and those that are activational, which occur later in life (Pheonix et al., 1959, Young

et al., 1964). The former effects are considered relatively permanent changes in the
size or connectivity of neural pathways, metabolism or steroid responsiveness of
neurons and result in the development of sexually dimorphic brain structures and sextyped behavior (Arnold and Breedlove, 1985). For example, in rodents, the amount
and timing of gonadal steroid release in the perinatal period determines whether the
male copulatory behavior, mounting, or the female behavior, lordosis, will manifest
in adulthood (Sodersten, 1978). A possible correlate for this behavioral change
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comes from studies demonstrating that androgen exposure in the late fetal or early
neonatal period in the male leads to the enlargement of a sexually dimorphic preopticanterior hypothalamic nucleus (Gorski et al., 1978). Additionally, castration of male
fetuses or neonatal male rats results in a decrease in size of this nucleus and
corresponding changes in sexual behavior (Raisman and Field, 1973; Arnold and
Gorski, 1984). In humans, LeVay (1991) reported a sex difference in one of several
interstitial nuclei of the anterior hypothalamus, termed INAH-3. His finding that
INAH-3 was larger in healthy heterosexual men compared to healthy females or
homosexual men with acquired immunodeficiency syndrome (AIDS) suggested that
homosexual men may have brain organizational development closer to that of women
than men. Some researchers have argued that these findings in homosexual men may
have resulted from AIDS-related pathology, so studies are currently underway in
homosexual men who have died from other causes. Several other studies have
reported significant structural differences in male and female brain anatomy that may
be the result of hormonal influences in early development and may account for some
of the sexually dimorphic behaviors discussed below (Swaab and Fliers, 1985;
Holloway and de Lascoste, 1986; Allen and Gorski, 1986, 1987; Allen et al., 1989).
Although the relative contribution of androgen binding to AR or the necessity of
aromatization to estrogen and thus, ER action, to brain organizational processes is
still a matter of debate (Feder, 1984; Breedlove, 1992), it appears that AR activation
plays some part in the hard wiring of neuronal circuits during development (Goldfoot
and van der Werff ten Bosch, 1975; Baum eJ af., 1982; Meaney and McEwen, 1986).
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Studies examining the activational effects of androgens on neural systems
throughout puberty and adulthood have lagged behind the studies pinpointing
hormonal influences during development. This is partially due to the ambiguity of
measurable endpoints such as "motivation", "emotion", "spatial ability" and
"learning" in animal models and also partially due to the difficulty in removing
external environmental influences that may compensate for the effects of steroids.
Additionally, some of the discrete functions of androgens cannot be assigned to one
particular brain region, which makes studying the relationship between androgen
action and behavior more difficult.
Hormonal effects in adulthood are termed "activational" because they activate
neural pathways which are already present and presumably, relatively static in nature.
In general, activational effects are considered transient and fluctuate in accordance
with the level of circulating hormone. For example, in the rodent, the expression of
male sexual behavior is partially dependent on the appropriate circulating levels of
androgens, as castration of the adult male rat eliminates or reduces the frequency of
male sexual behavior, and the administration of T can reinstate the sexual response to
the appropriate sensory cues (Mitchell and Stewart, 1989; Baum, 1992). The link
between circulating androgen levels and sex behavior in humans is more tenuous.
Although castration has shown to reduce libido, this varies dramatically among
individuals (Carter, 1992). Studies of sexual behavior in normal men is difficult as
well. Certainly, sexual behavior is under the control of powerful external influences,
such as partner preference and sexual partner availability. In every day life, these
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influences may overcome individual variations in circulating hormone levels to control
sexual behavior patterns.
Like sexual behavior, the effect of androgens on aggression, appears to have
organizational and activational components (Swerdloff et al., 1992). Male laboratory
animals typically exhibit more aggressive behaviors than females (see review by
Beatty, 1984). This sex difference is controlled by the presence or absence of T
during certain critical developmental periods, as well as during puberty and
adulthood. Edwards (1968) showed that male mice were relatively nonaggressive if
castrated during early life and given androgen replacement therapy in adulthood.

He

also showed that genetically female mice would become as hostile as male mice if
given T during fetal development and into adulthood. The development of aggression
in male mice corresponds to the increases in circulating Tat the time of puberty
(McKinney and Desjardins, 1973; Gandelman, 1973). Adult castration reduces this
behavior, while T administration restores it (Gandelman and vom Saal, 1975).
Female rodents also display aggressive behaviors if given Tin adulthood, however the
administration of very high levels of androgen for prolonged periods was necessary to
consistently elicit the response (Svare et al., 1974; Barkley and Goldman, 1977).
These studies suggest that the female rodent brain architecture is capable of
responding to androgen but is generally less sensitive to the stimulus. Several reports
indicate that both DHT and estrogen are important in stimulating intermale aggression
and infanticide (Finney and Erpino, 1976; Svare, 1979) suggesting that both AR and
ER activation are influential in the process.
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Research examining the involvement of androgens in human aggressive
behavior is somewhat more limited and, at best, correlative in nature. Studying
healthy young males, Persky et al. (1971) showed a positive correlation between
circulating levels of T and measures of dominance, hostility and aggressive behavior.
Another study reported no such correlations (Brown and Davis, 1975). More
recently, reports of violent behaviors associated with the abuse of anabolic-androgenic
steroids (Strauss et al., 1982; Haupt and Rovere, 1984; Lubell, 1989; Telander and
Noden, 1989; Svare, 1990) also suggest some correlation between circulating
androgen level and aggressive behavior in humans. It is still unclear as to the exact
areas of the CNS most involved in the expression of aggressive behavior, however,
the amygdala (Luiten et al., 1985; Meaney and McEwen, 1986), hypothalamus and
hippocampus (Siegal and Edinger, 1983) have been implicated.
Other behaviors that have been found to be modified by androgen action in the
CNS include activity level (Broida and Svare, 1984), food intake (Bell and Zucker,
1971), sensation and perception (Pietras and Moulton, 1974), mood (Pope and Katz,
1988), and learning (Beatty and Beatty, 1970; Chambers, 1976; Flood et al., 1992).
As with aggressive behavior, the brain areas most associated with these functions have
not been well defined. Despite this, such widespread effects of androgens on many
defined behaviors implicate a physiological role for AR in higher brain centers such
as the cortex and hippocampus.
The effects of sex steroids exclusively on hippocampal mediated behaviors and
physiology are discussed below.
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Hippocampal Structure and Function: Effects of Gonadal Hormones

Anatomy of the Hippocampus
The hippocampus is a centrally-located component of the limbic system and
has been implicated in wide variety of behaviors. In the rodent, the hippocampus is a
cashew-shaped structure situated along the curvature of the lateral ventricle (figure 4).
Early neuroanatomists thought that the hippocampus resembled a seahorse, which is
how it got its name (hippocampus is Greek for seahorse).
The cellular organization of the hippocampus is relatively simple in
comparison to other brain regions which makes it uniquely suited for
electrophysiologic study. The hippocampus proper is composed of three regions: the
subiculum (adjacent to the entorhinal cortex), the Comu Ammonis (CA1-CA3)
pyramidal cell regions, and the dentate gyros (DG) which contains granule cells.
Pyramidal cells are found in a narrow layer, 3-5 cells thick, extending the length of
the horn. The CAI field is composed of densely-packed, medium-sized cells. The
CA2 and CA3 regions contain larger, more loosely packed cells. The cells of the
CA2 region differ from those of the CA3 field; they do not have dendritic spines on
their apical dendrites. The DG contains one layer of very compacted granule cells
stacked 4-10 cells deep (Amaral and Witter, 1989). Although this area has been best
studied in the rodent model, the same basic pattern of organization is found in higher
species.
Studies examining the connectivity of hippocampal neurons have revealed a
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"trisynaptic circuit" with readily identifiable cell populations (reviewed by Amaral and
Witter, 1989). The location, internal circuitry and defined regions of the rat
hippocampus are depicted in figure 4. The main input to the hippocampus comes
through the perforant path from the overlying region of the cortex, called the
entorhinal cortex. Stimulation of the entorhinal inputs (perforant path) results in the
activation of granule cells in the DG. These cells, in turn, activate the pyramidal
cells of the CA3 region through the mossy fiber system. The axons of the CA3
pyramidal cells bifurcate, sending efferent stimuli out through the fimbria to the
fornix as well as sending collateral branches (Schaffer collaterals) which synapse on
the apical dendrites of the CA 1 pyramidal cells. The efferents arising from CA 1
pyramidal cells and exiting to the subiculum provide the major output for the
hippocampal formation and complete the unidirectional open-loop circuit. These
intrinsic connections have been verified electrophysiologically (Swanson et al., 1982).
As currently understood, this loop is important in receiving information and
integrating the outgoing signals from the hippocampus. Therefore, interruption of this
loop at any point might ultimately disrupt or alter function.
The extrinsic projections of the CA 1 field are extensive and include the
subiculum, lateral septa! nucleus, olfactory bulb, nucleus accumbens, perirhinal
cortex, prefrontal cortex, amygdala, hypothalamus, and the contralateral hippocampus
(Swanson and Cowan, 1977; Van Groen and Wyss, 1990). In addition, the
projections of the CA 1 field are topographically organized with the septa! third of
CAl projecting to different cortical regions than the temporal third of CAl (Van
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Groen and Wyss, 1990). Interestingly, many of these projections to the neocortex are
reciprocal and enable this structure to ultimately compare and integrate incoming
information with previously stored information (Squire and Zola-Morgan, 1988).
Hippocampal afferents are as widespread as it's efferents. Neurons from every level
of the diencephalon and brainstem project directly to some part of the hippocampus
(Wyss et al., 1979).
After examining the extensive connections of the hippocampus, it is not
surprising that this structure has been implicated in a variety of behavioral functions.
These include emotion (Derryberry and Tucker, 1992), motivation (Jarrard, 1973),
memory and learning (Teyler and DiScenna, 1985; Whishaw, 1987; Zola-Morgan and
Squire, 1990; Eichenbaum and Otto, 1992), spatial mapping (O'Keefe and Nadel,
1974; Olten, 1977; Olten et al., 1979; Nadel and McDonald, 1980; Sutherland et al.,
1982; Bouffard and Jarrard, 1988; Best and Thompson, 1989), and cognition
(O'Keefe and Dostrosvsky, 1971). The hippocampus has also been implicated as an
important target for neuronal hormonal feedback regulation (reviewed by Jacobson
and Sapolsky, 1991; Morano et al., 1994).
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Figure 4. The hippocampus in the rat brain. The top illustration shows the general
position of the hippocampus in the rat brain. A coronal section of one half of the
hippocampus is enlarged to depict the cell body fields and trisynaptic circuit. The
perforant pathway (pp) arrives from the overlying cortex and perforates the dentate
gyrus (DG). The mossy fibers of the DG synapse on CA3 pyramidal cells which
send Schaffer collaterals (Sch) that either exit through the fimbria (fim) or synapse
onto the apical dendrites of CAl pyramidal cells. Efferents from CAl neurons exit to
the subiculum (Sub) to complete the circuit.
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SYxual Dimorphisms in Hippocampal Structure: Organizational Androgens
As earlier described for certain hypothalamic nuclei, many sex differences in
the mammalian CNS are developmentally influenced by androgens. There is a
growing body of literature demonstrating a relationship between gonadal hormones
and gender differences in spatial ability (Beatty, 1984; Gaulin and Fitzgerald, 1986;
Roof, 1993; Luine, 1994). Unfortunately, there are few studies describing the
possible anatomical substrates through which gonadal hormones may produce this
effect. The hippocampus is a likely candidate due to its proposed involvement in
spatial navigation (O'Keefe and Nadel, 1974; Olten, 1977; Olten et al., 1979; Nadel
and McDonald, 1980; Sutherland et al., 1982, 1983; Bouffard and Jarrard, 1988;
Best and Thompson, 1989) as well as its sensitivity to hormones during development
(Pfaff, 1966; O'Keefe and Handa, 1990). Studies have found that the levels of
several neurotransmitters, and their receptors, in the hippocampal formation are
sexually dimorphic (reviewed by Loy, 1986) and could contribute to sex differences
in behavior later in life. Several other studies have demonstrated morphological
differences in the hippocampi of male and female rodents. Unfortunately, the
measurements used by the various investigators are somewhat convoluted and, thus,
the data are difficult to interpret. Wilmer and Wilmer (1985) showed that, in certain
strains of mice, females had fewer granule cells than males. Yanai (1979) did not
observe this dimorphism in rats. Juraska and colleagues have made extensive size
measurements of hippocampal granule neuron dendritic arbors that are believed to
reflect the number of synapses (reviewed by Juraslca, 1991). Subtle differences
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between similarly treated, postpubertal male and female littermates were observed,
but more interestingly, the change in the size of dendritic tree branching was in
opposite directions following environmental enrichment of male and female rats
(Juraska et al., 1985). Castration of male rats at birth resulted in female-like
dendritic branching patterns of granule cells and suggested that T, acting either during
early life or at puberty alters dendritic tree plasticity (Juraska et al., 1988). Recently,
Roof (1993) also reported a sexual dimorphism in the DG of pre-pubescent rats. In
this study, the granule cell layer of male and T-treated (at postnatal days 3 and 5)
females was 8-9% greater in width and length and was asymmetrical as compared to
untreated females. Additionally, the size of the DG correlated with performance on a
spatial task (Morris water maze). Overall, males with the larger DG layer performed
better. These anatomical and behavioral differences were still present in adult rats
similarly treated soon after birth (Roof and Havens, 1992). Since little to no AR or
ER expression have been found in the DG of the adult rat hippocampus (Stumpf and
Sar, 1978; Loy et al., 1988; Maggi et al., 1989; Simerly et al., 1990), it is not clear
how the effects on granule cells manifest. Most speculate that they are a function of
transsynaptic influences, however, there is little information on the distribution of AR
and ER expression in the hippocampus during development.
Strangely, few studies have examined other cell body regions of the
hippocampus for sexual dimorphisms. Meyer et al. (1978) demonstrated that prepuberal castration of male rats resulted in an altered number of synaptic spines on
CAI pyramidal cells, but not on granule cells of the DG. Since hippocampal AR and
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ER are highly expressed in the CAI region (Simerly et al., 1990; Maggi et al.,
1989), Meyer's findings could be attributed to a more direct effect of androgen or
estrogen on hippocampal dendritic morphology.
Whether such differences in hippocampal structure occur in humans and play a
part in the well documented sex differences in spatial abilities and verbal skills
(Jarvik, 1975; Kimura, 1992) has yet to be elucidated and will be difficult to ascertain
because of the inability to manipulate the hormonal milieu in the human fetus. Some
clues have come from female fetuses exposed to high levels of adrenal androgens due
to congenital adrenal hyperplasia and those unknowingly exposed to the synthetic
estrogen, diethylstilbestrol. Later in life, these girls exhibited "masculinized"
behavior patterns such as superior spatial skills and lower verbal I. Q. scores (Hines
and Shipley, 1984; Resnick et al., 1986; Nass and Baker, 1991). Although far from
conclusive, these data do implicate gonadal hormones in the hard-wiring of higher
neuronal systems, of which, the hippocampus is a likely candidate.

Hippocampal Neuronal Plasticity
No one has established conclusively how the brain forms new memories or
generates such complex outcomes as emotion or cognition. However, it is known that
neurons, especially those in the hippocampus, can change their pattern of dendritic
synaptic connections and/or electrophysiological responses following a learning
experience (Doyere et al., 1993; Lisman and Harris, 1993) or damage (Onodera et
al., 1990; Levisohn and Isacson, 1991). These changes are referred to collectively as
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neuronal plasticity. The role gonadal hormones play in neuronal plasticity in areas of
the brain not associated with reproduction are just beginning to be explored.
The actions of estrogen, the primary circulating gonadal hormone in females,
have been studied within the rat hippocampal formation to a greater extent than
androgen. Striking examples of estrogen action in the adult rat hippocampus were
demonstrated by Woolley and McEwen (1992, 1993) and Gould et al. (1990). These
investigators found that estrogen increased the dendritic spine density of CA 1 neurons
and that these changes fluctuated in accordance to the 4-5 day menstrual cycle of the
adult female rat. In addition, the removal of circulating estrogen by ovariectomy
resulted in dramatic decreases in dendritic spine density. These effects were specific
for CAl pyramidal cells, as ovariectomy or steroid replacement did not affect spine
density in CA3 pyramidal cells or granule cells of the DG. Similar changes in spine
density in response to estrogen have been described in ventromedial hypothalamic
neurons (Frankfurt et al., 1990); an area where estrogen likely acts to control some
aspects of reproductive behavior and hormone secretion. Since changes in the number
or size of hippocampal dendritic spines appears to be correlated with changes in the
synapses that they receive, as well as with altered neuronal electrophysiology (Chang
and Greenough, 1984), and possibly the modification of behavior or learning
(Purpura, 1974; DeVoogd et al., 1985; Popov and Bocharova, 1992), these studies
provide an exciting anatomical correlate to fluctuating behavior patterns and sexually
dimorphic behavior in adulthood. Interestingly, women did not perform as well on
certain spatial tasks during the preovulatory estrogen surge as compared to other times
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of the menstrual cycle characterized by lower estradiol levels (Komenich et al., 1978;
Hampson and Kimura, 1988, 1992; Hampson, 1990). Although the morphological
alterations in hippocampal neurons in response to estrogen have only been
demonstrated in a female rat model, these data provide a strong basis for establishing
the relationship between circulating gonadal hormones and behavior.
In addition to the modulation of dendritic spine density, estrogens have been
found to rapidly (within 20 minutes) alter CAI cell neuronal excitability in response
to the stimulation of glutaminergic Schaffer collaterals (Teyler et al., 1980; Wong and
Moss, 1992). Additionally, two days following subcutaneous estrogen injections, both
glutamate and GABA receptor binding were upregulated in this area (Schumacher et

al., 1989; Weiland, 1992). These effects may contribute to estrogens known part in
the lowering of the threshold for seizures originating in the hippocampus (Terasawa
and Timiras, 1968). There is also a considerable amount of evidence to suggest that
estrogen enhances mood in women (Ditkoff et al., 1991; Palinkas and Barrett-Conner,
1992; Sherwin, 1994). Although the mechanisms underlying this effect have not been
investigated, areas in the limbic system, including the hippocampus, are likely targets
for estrogen action. Taken together, these studies further indicate that estrogen has
long term activational effects on hippocampal physiology.
Studies examining androgen effects on hippocampal plasticity have not been as
plentiful as those performed with estrogen, even though it appears that the
hippocampus contains a higher concentration of AR mRNA than ER mRNA (Simerly

et al., 1990). Flood and Roberts (1988) demonstrated that a single subcutaneous
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injection of the largely adrenal-derived, androgenic precursor steroid, DHEA (see
figure 2), as well as its sulfated derivative, DHEAS, strikingly improved T-maze
footshock active avoidance training (F AAT) in middle-aged and old mice. The same
group later showed that immediate post-training intracerebroventricular administration
of various androgenic compounds including pregnenolone, DHEA, androstenedione, T
and DHT all improved retention for FAAT (Flood et al., 1992). The authors have
speculated that the memory-enhancing effects of steroids lasting long after fast neural
events have ceased may have been through their modulation of the rate of
transcription of cIEGs. In contrast, Goudsmit et al. (1990) found that T
administration did not reverse age-related spatial memory deficits in rats and may
actually impair retention in middle-aged rats. Clark et al. (1995) also did not observe
any improvements or impairments in the acquisition or retention of the Morris water
maze when male rats were given high levels of anabolic-androgenic steroids for 12
weeks. These conflicting data are difficult to resolve since there is very little
consistency in the length and mode of androgen administration, as well as in the
behavioral "learning" tasks employed.
The underlying cellular mechanisms of androgen action on hippocampal
physiology are just beginning to be explored. For example, Kus et al. (1995) have
found that treatment of castrated adult male rats with the AR-selective androgen,
dihydrotestosterone propionate (DHTP), decreased the binding of the N-methyl-Daspartate (NMDA) receptor antagonist, [3H]MK-801, in CAl pyramidal cells.
NMDA receptors are known to mediate the actions of glutamate, the major excitatory
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neurotransmitter in the hippocampus and, in particular, the Schaffer collaterals
synapsing on CAl pyramidal cells. Although far from being well understood, these
data suggest that in vivo AR activation can alter normal adult hippocampal physiology
and may affect learning.
The most direct evidence for androgenic effects on hippocampal neurons has
been demonstrated using an in vitro hippocampal slice preparation. Gonadal steroids
have been shown to increase neuronal excitability in the female rodent hippocampal
CAl pyramidal cells (Teyler et al., 1980). However, in this study no consistent
effects were found in males. In conjunction with studies being performed in our
laboratory, Pouliot et al. (1995) demonstrated that DHTP prevents NMDA's
excitotoxic electrophysiologic effects in CAl pyramidal cells. These events are likely
AR mediated since the effects were only observed after several hours of androgen
treatment. These findings are consistent with the NMDA receptor binding studies of
Kus et al. (1995) and may be an important underlying mechanism for behavior since
it has been shown that the activation of hippocampal glutamate receptors mediate
processes involved in the synaptic plasticity associated with learning and memory
(Morris et al., 1986; Tonkiss et al., 1988) epileptogenesis (Gilbert, 1988) and
schizophrenia (Collinge and Curtis, 1991).
The effects of androgens on hippocampal physiology are also seen following
damage. When the hippocampus is deafferented, the surviving neurons rapidly form
new branches and new connections to compensate for the loss. This process is called
sprouting and is considered another form of neuronal plasticity. Since learning is also
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believed to utilize this type of plasticity, it is a convenient model to employ when
examining the role of gonadal hormones in cognition. As had been found with
dendritic branching in the undamaged rat hippocampus, estrogen was found to be
critical for maintaining the sprouting response to differentiation in females (Morse et

al., 1992; Scheff et al., 1988a). Androgens did not appear to act similarly in males.
Neither castration nor adrenalectomy alone had any effect on the sprouting response
(Scheff et al., 1988b; Scheff and Dekosky, 1989). However, if males were both
castrated and adrenalectomized, sprouting was decreased. In this instance, it appears
that the hormones secreted from the gonads and adrenal gland serve complementary
functions which maintain sprouting. The interaction of gonadal and adrenal derived
hormones should likely be taken into greater consideration when examining effects in
the hippocampus since this area is rich in several types of steroid receptors (Van
Eekelen et al., 1988; Simerly et al., 1990; Kerr el al., 1995a).
Few studies have examined the direct effects of androgens on human adult
hippocampal function probably due to the fact that men do not show large natural
fluctuations in circulating T levels over a set period of time (unlike women whose
estrogen levels fluctuate throughout the menstrual cycle). Thus, correlating androgen
levels and behavior is much harder in men. In spite of these limitations, Hampson
and Kimura (1988) found that spatial reasoning in men varied in relation to small
Yearly fluctuations of their circulating T levels. Additionally, studies in men have
demonstrated a positive correlation between circulating T levels and spatial ability,
cheerfulness, and some mood traits (Adler et al., 1986; Hubert, 1990). A negative
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correlation between T and DHT levels and verbal ability (O'Carroll et al., 1985;
Christianse and Krussman, 1987) and anxiety (Altschuler et al., 1990) in men has
also been reported. Interestingly, women having above average plasma levels of free
T scored lower on a visual memory task; this task is typically performed better by
women than men (Phillips and Sherwin, 1991). These data fit well with a comparison
of spatial ability, mathematical reasoning, and perceptual speed in both men and
women revealing that women with higher than normal T levels, and men with lower
than average T levels, performed best on tests which are hippocampally mediated
(Shute et al., 1983; Gouchie and Kimura, 1991; Kimura, 1992). These data suggest
that an undefined "optimum" level of Tis required for superior cognitive function and
that either too little or too much is detrimental to performance. In support of these
studies, T supplementation to older men, who naturally have up to a 40% decline in
free circulating T levels (Davidson et al., 1983; Vermeulen, 1991), has proved
beneficial for spatial cognition, but was not effective in the improvement of verbal or
visual memory, motor speed, cognitive flexibility, or mood (Janowski et al., 1994).
This latter study also implies that the hippocampus remains sensitive to androgens
during aging.
Many of the behavioral studies mentioned in this section suggest subtle
activational effects of androgen on hippocampal function throughout life, however,
few actually pinpoint the exact location of the androgenic effect and do not fully
elucidate the cellular mechanisms involved. Further studies are needed to elucidate
the processes involved in androgen modulation of hippocampal synaptic events and

35
neuronal plasticity. The use of molecular tools to study the transcriptional effects of
steroid receptors and their interactions with various second messenger systems and
other intracellular pathways should allow progress in this complex area of study.

Structure of the Androgen Receptor

Although both the human and rat androgen receptors have been studied using
biochemical methods for many years, the androgen receptor has been cloned only
recently (Chang et al., 1988; Lubahn et al., 1988; Tan et al., 1988; Trapman et al.,
1988; Brinkmann et al., 1989; Faber el al., 1989; Tilly et al., 1989; Gaspar et al.,
1990; He et al., 1990). DNA sequence analysis confirmed that the androgen receptor
has the same functional domain structure as other steroid hormone receptors
(discussed in detail below) and both the rat and human androgen receptors share
complete amino acid sequence identity in their DNA-binding and steroid-binding
domains (Tan et al., 1988). The rat androgen receptor, has a cDNA sequence 4191
base pairs in length, and encoding for 902 amino acids which results in a protein of
approximately 98 kilodalton molecular weight (Tan et al., 1988). The complete
androgen receptor gene encompasses at least 90 lcilobases of DNA in the q 11-12
region of the X chromosome (Lubahn et al., 1988; Brinkmann et al., 1989) and
includes eight exons and seven intervening introns (Jarme and Shan, 1991).
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Domain Structure of the AR
As with the other members of the steroid hormone receptor superfamily, the
AR can be divided into four distinct functional regions. Starting from the N-terminal
the regions are as follows: the transactivation domain, the DNA-binding region, the
hinge region and the ligand binding sequence (reviewed by Godowski and Picard,
1989 and Jfume et al., 1993). This characteristic domain organization of AR is
depicted in figure 5. Although the AR gene and protein may appear modular in
nature, each part works in concert with the others such that disruption of one activity
can severely cripple the normal action of AR. A brief description of each of the
functional domains follows.

The Transactivation Domain
The transactivation domain, also termed the A/B region or hypervariable
domain, is the least understood region as its function has not been delineated in great
detail for any of the intracellular receptors. This domain has the least conserved
amino acid sequence among the superfamily of intracellular receptors. The
hypervariability renders this area the most immunogenic part of the protein and it is
likely to play a role in the specificity of receptor action. Data from studies examining
the two distinct PR forms that differ solely in the length of their A/B domain suggest
that this area optimizes the transactivation process of the receptor as well as
determines target gene specificity (Tora et al., 1988; Kastner et al., 1990). The
entire coding sequence for the 559 amino acid-long ARN-terminal domain, along
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with a 1-Kb-long 5'-untranslated sequence (Tilley et al., 1990a) was found to be
present in the large first exon of the AR gene (Faber et al., 1989; Kuiper et al.,
1989). Interestingly, the N-terminal domains of AR, MR, GR and PR make up
approximately half the size of each of the receptors. This is exceptionally large as
compared to other nuclear receptors and coincides with the observation that AR, MR,
GR and PR all share the same HRE sequence on DNA (Forman and Samuels, 1990b;
Freedman and Luisi, 1993). Several studies have demonstrated that particular
stretches of the transactivational region of the AR are critical for cell- and receptorspecific regulation of target genes presumably by interacting with components of core
transcriptional machinery, coactivators, or other transactivators (Simental et al., 1991;
Adler et al., 1992; Palvimo et al., 1993; Kupfer eJ al., 1993; Jenster et al., 1995).
This may help to explain the large size of this region and how four receptors that
have the potential to bind to the same HRE can elicit different effects through the use
of their divergent N-terminal domains. It has also become apparent from the analysis
of AR deletion mutants and AR!GR chimeras that sequences within the long
transactivation domain also have specific roles in stabilizing the AR by slowing the
rate of ligand dissociation and preventing AR degradation (Zhou et al. , 1995), in
modulating nuclear import of the receptor complex (Simental et al., 1991; Wilson et

al., 1991; Zhou et al., 1994a) and AR dimerization (Wong et al., 1993).
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Figure 5. Schematic representation of the domain structure of the androgen
receptor. Amino acid length is based on the human receptor sequence published by
Lubahn et al. (1988).
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.QNA Bindin~ Domain
All steroid receptors, including the AR, recognize specific DNA sequences
with a well-conserved functional domain encompassing 66-68 amino acid residues
termed the DNA binding domain (DBD). This cysteine-rich region folds into two
motifs that are variations of "zinc fingers" found in other nucleic acid binding
proteins (Miller et al., 1985). Each finger is comprised of two pairs of cysteine
residues that coordinate in a tetrahedral fashion around a single zinc atom (Freedman

et al., 1988). The N-terminal zinc finger is largely responsible for DNA recognition,
whereas the second finger appears to modulate the dimerization of the two receptor
molecules during its association with DNA (Green et al., 1988; Danielsen et al.,
1989; Umesono and Evans, 1989; Luisi el al., 1991). The AR DBD displays
tremendous amino acid homology with that of the MR, GR and PR. As a result, all
four receptors recognize the same 15 basepair palindromic-like nucleic acid sequence
flanking target genes. This sequence (5'-GGTACANNNTGTTCT-3') was first
described as the consensus glucocorticoid response element (GRE) (Beato, 1989;
Roche et al., 1992; Zilliacus el al., 1995), but now has been more generally termed
an HRE. Research is currently underway to determine how four receptors with
obviously different functions can distinguish a common HRE upstream of target genes
(Adler et al., 1993; Robins et al., 1994). This distinction would be especially critical
in areas like the hippocampus where AR, MR and GR are all highly expressed and
are likely co-localized within certain neurons (Kerr et al., 1995b). As discussed
above, findings indicate that the divergent N-terminal domain likely makes protein-
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protein interactions that specifies transcriptional regulation to some degree. It has
also become apparent that HRE orientation within the enhancer region of target genes
affects hormone receptor stringency (Adler el al., 1993). Additionally, it can not be
ruled out that some overlap of target gene expression may occur in cells containing
more than one of these receptors.

The Hinge Region
Next to the DBD, a variable hinge region exists (region D) in the AR protein.
This area may allow the AR protein to bend or alter its conformation and has also
been shown to contain part of a nuclear targeting signal (Zhou el al., 1994a).
Although not yet well studied specifically for the AR, the analysis of the action of the
highly homologous GR has demonstrated that the hinge region also affects the affinity
of the receptor for DNA (Rusconi and Yamamoto, 1987).

Steroid Binding Domain
The C-terminal region of the AR spans about 250 amino acid residues (653910) and is primarily involved in ligand binding. This region, termed the steroid
binding domain (SBD), forms a hydrophobic pocket that exhibits high affinity for
androgens. Surprisingly, the SBD of AR displays a 50-55 % homology with similar
domains in GR and PR (Trapman et al. , 198 8; Hollenberg

el

al. , 1985; Mishari

el

al., 1987). This homology may account for a few reports of promiscuous binding of
androgens, progestins and glucocorticoids with more than one receptor type (Mayer
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and Rosen, 1975; Janne and Bardin, 1984a, 1984b; Ahima and Harlan, 1992;
Kemppainen et al., 1992). In addition to hormone binding, a 54 amino acid stretch
of AR's SBD is required for the interaction of the large docking heat shock protein,
HSP90 (Marivoet et al., 1992).

AR

Messen~er

Ribonucleic Acid

The exact size and number of the androgen receptor mRNA isoforms have
been controversial and vary depending on the species and tissue analyzed. A major
form, approximately 11 kb in length, has consistently been reported in peripheral
tissues including prostate, skeletal muscle, liver, kidney, seminal vesicle, epididymis,
anterior pituitary gland and coagulating gland (Tan et al., 1988; Trapman et al.,
1988; McLachlan et al., 1991; Burgess and Banda, 1993a). In addition to this, a
novel 9.3 kb transcript has been detected in rat neural tissues (McLachlan et al.,
1991; Burgess and Banda, 1993a). The smaller form was prominent in the cortex,
cerebellum, and brain stem; while in the hippocampus and hypothalamus, both the
larger and smaller transcripts were expressed to a similar degree. It is thought that
the two mRNA species differ in part in the length of their 5'-untranslated region (5'UTR), but complete sequence analysis is still necessary. The significance of the
smaller form found predominantly in the CNS is not known. The 5 '-UTR of the
human AR mRNA, that spans about 1100 bp, has been shown to play an essential role
in the induction of AR translation (Mizokami and Chang, 1994). This 5'-UTR is one
of the longest reported 5'-UTR in mammalian systems (Trapman et al., 1988).
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Whether both transcripts found in the rat CNS encode for fully functional androgen
receptor proteins and are regulated or translated similarly are questions remaining to
be answered. Although some earlier studies suggested a two receptor system for the
binding of T and DHT (Sheridan, 1981, 1991), it appears unlikely that two unique
ARs are translated from each of the mRNA transcripts as virtually all well-controlled
biochemical studies have found a single androgen binding site in both peripheral
tissues and the brain (Wilson and French, 1976; Tilley et al., 1990b).

The AR Protein: Steroid Binding. Receptor Recycling and Metabolism
The AR is a large phosphoprotein that is found within peripheral target cells in
relatively low abundance (2000-6000 receptors/cell and less than 100 femtomoles
DHT binding sites per milligram protein) as compared to most membrane-bound
receptors (Fang and Liao, 1971). In brain tissue, AR concentration is generally an
entire order of magnitude less than that found in peripheral reproducive tissues. A
striking feature of AR is its extreme !ability and rapid degradation (t 112 = 1-1.5 h) in
the absence of agonist ligand binding (Kemppainen et al. , 1992; Zhou et al. , 1995).
In the presence of androgen, AR is degraded at a

~omewhat

slower rate (t112 = 6 h).

In comparison, ligand-free GR degrades with a half-time of 4-6 h, about 5-fold slower
than AR, and in the presence of dexamethasone, degradation can be slowed to 16 h
(Zhou et al., 1995). This instability has made AR exceptionally difficult to study in

vitro and potent proteolytic inhibitors were required to stabilize AR in its intact 100120 kDa form (Wilson and French, 1979). As a result, studies on AR binding
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properties, metabolism and recycling still lag behind those exploring the other steroid
hormone receptors.
The study of AR binding kinetics of T and DHT, as well as of antiandrogens
such as hydroxyflutamide, have been followed with great interest with hopes of
elucidating how these hormones sometimes exert differential physiological effects. It
has been well established that DHT is 2.5 to 10 times more potent in bioassays and,
in broken cell preparations, DHT binds to the AR with a several-fold higher affinity
than T (approximately 0.25 - 2 nM versus 0.4 - 5 nM) (Wilbert et al., 1983; Winters,
1990). Wilson and French (1976) demonstrated that despite relative affinity constants
that are nearly equivalent, T binds and dissociates from AR about three times faster
than DHT. Presently, it is unclear how altered binding kinetics translate to
differences in transcriptional activity; however, the authors speculated that AR nuclear
retention time may be longer with DHT binding. Interestingly, at ten-fold higher
concentrations than DHT, T was able to overcome this rapid dissociation rate by
simple mass action (Grino et al., 1990). This finding suggests that when localized T
concentrations are undiluted (i.e. paracrine actions of T within testes) it can be as
physiologically potent as DHT. AR degradation was also differentially affected by T
and DHT binding (Kemppainen et al., 1992; Zhou et al., 1995). These observations
suggest that DHT initiates a slightly different conformational change in the receptor
complex that promotes its stabilization, and possibly, its transcriptional efficiency.
Interestingly, antagonists of the AR, which compete with agonists for AR binding, but
do not permit the receptor to assume a transcriptionally active form, initiated distinct
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conformations of the AR complex as detected by proteolytic digestion (Wong et al.,
1993; Kallio et al., 1994; Kuil and Mulder, 1994). Additionally, AR antagonists
including hydroxyflutamide and cyproterone acetate were not able to stabilize AR and
prevented agonist-induced stabilization even at a 100-fold molar excess (Kemppainen

et al., 1992). Thus, it appears that a precise conformation is required for maximal
receptor stabilization and the induction of transcriptional activation. DHT appears to
be the ligand most likely to generate this conformation.
In the last ten years controversy has abounded in endocrinology over whether
steroid receptors are found exclusively in the cytoplasm in the unoccupied form and
translocate to the nucleus only following ligand binding. This had been the original
hypothesis following discoveries using in vitro binding techniques on broken cell
preparations and high speed centrifugation to separate cell fractions (Jensen et al.,
1968). The recent development of specific antibodies for each of the hormone
receptors has spawned most of this controversy; as it is now possible to clearly
identify the intracellular localization of steroid hormone receptor labelling both in the
presence and absence of circulating hormone, without disrupting membrane integrity.
Using such histological studies, several groups determined that both bound and
unbound ER, PR and GR were primarily confined to the nucleus (King and Greene,
1984; Welshons et al., 1984, 1985; Gase et al., 1989). Since this initial observation,
several reports have described cytoplasmic staining of unbound ER (Fox et al. , 1991;
Blaustein et al., 1992), PR (Blaustein et al., 1992) and GR (Ahima and Harlan,
1991), adding further confusion. Some of the discrepancies may be the result of non-
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specific antibodies, or it has been proposed that some of these antibodies may not
reliably recognize both the bound and unbound conformational states of the receptors.
The recent characterization of AR immunohistochemical localization in transfected

cos cells indicate that in the absence of androgens,

AR immunoreactivity (ARIR) is

located predominately in the cytoplas. The addition of androgen shifts ARIR to the
nucleus (Simental et al., 1991; J enster el al. , 1993). This latter finding has also been
observed in vivo in the male hamster brain (Wood and Newman, 1993). Taken
together, these data indicate that androgen is one factor that regulates the partitioning
of the AR to the nucleus, however, it can not be ruled out that the equilibrium of AR
intracellular distribution can vary with cell or tissue type (Husmann et al., 1990).
The physiologic significance of AR intracellular partitioning is not known, however,
it could potentially affect the ease by which AR "sees" its ligand within the cell.
Regardless of the cytoplasmic or nuclear localization of unbound AR, hormone
binding serves to anchor the AR receptor complex in nuclei.
Earlier studies examining skeletal muscle suggested that physiological levels of
T were sufficient to fully occupy and transform all available AR (Wilson, 1988). In
contrast, studies done in neural tissue have demonstrated that only a fraction (3050%) of total AR in the cell are transformed to the nuclear, DNA-bound form under
physiological conditions (Handa et al., 1987a; Roselli et al., 1989). These
observations suggest that circulating androgen levels are an important component
regulating the magnitude of androgen action in the CNS and suggests that very high
levels of circulating androgen can transform a greater proportion of neural cytosolic
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AR and possibly elicit a greater transcriptional response.

Regulation of Androgen Receptor Gene Expression

As discussed earlier, a functional AR gene is essential for normal male
development. However, the distribution, timing and magnitude of AR expression
during development and throughout adulthood are also important determinants of
androgen sensitivity. Thus, it has become imperative to analyze how the AR gene is
regulated in concert with androgen regulation of target genes. The 5' flanking
regions of the rat, mouse and human AR gene have been cloned (Baarends et al. ,
1990; Tilley et al., 1990a; Faber et al., 199la,b; Kumar et al., 1992; Song et al.,
1993; Mizokami et al., 1994), allowing for the detailed examination of molecular
mechanisms controlling AR gene expression. In this section, current understanding of
the AR gene promotor region as well as various endocrine and non-endocrine factors
that act to regulate the AR gene are reviewed.

The AR Gene Promoter
The major site of transcription initiation is approximately 1.1 kb upstream of
the initiation codon in the human AR mRNA (Tilley et al., 1990a; Mizokami et al.,
1994) and this appears to be similar for the rat AR gene (Song et al., 1990).
Sequence analysis of rat, human and mouse AR promoter regions have confirmed that

47
all three lack typical "TATA" or "CAAT" sequence motifs, but instead, each of the
promoter regions lies in a GC-rich region and contains a putative SPl binding site that
is characteristic of a "housekeeping" promoter (Baarends et al., 1990; Tilley et al. ,
1990; Faber et al., 1991a,b; Kumar et al., 1992; Song et al., 1993; Mizokami et al.,
1994).
The complete sequence analysis of 2656 bp of the rat AR upstream region has
revealed consensus DNA-binding sequences for numerous known transcription factors
(Song et al., 1993). Several half-palindrome sites for AR/PR/GR (TGTTCT) and one
half-site for the ER (AGGTCA) were detected. Although steroid receptors could
potentially bind to these half-sites and confer steroidal regulation of AR expression,
their true physiological significance has not been investigated. Also identified were
the potential binding sites for the transcription factors SPl, C/EBP, Pu.1, Zeste (a
Drosophila homeobox protein), zij268 (a zinc finger motif cIEG protein), PEA3 (an

enhancer protein), NFKB and for the Fos/Jun heterodimer. The presence of these
binding regions strongly suggests that multiple factors, including AR itself, have the
potential to modulate AR expression. Further delineation of the regulatory regions of
the AR gene will prove to be beneficial in the understanding of the interplay of
various transcription factors in the tissue-specific expression and regulation of the AR
gene.
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Autologous Regulation of AR Expression
Several studies have examined the regulation of AR synthesis in response to
hormonal manipulation in both neural and non-neural tissues. In the majority of
peripheral tissues studied, AR expression (as measured by steady state mRNA levels)
was increased by short term castration (l-4 days) and decreased by androgen
treatment (Tan et al., 1988; Shan et al., 1990; Talcane et a., 1990; Quarmby et al.,
1990; Blok et al., 1991, 1992a; Abdelgadir et al., 1993). AR is not autoregulated in
in peripheral tissues in testicular feminized rats; a genetically engineered animal strain
where the AR gene is mutated so that the resulting AR protein is unable to bind
androgen (Quarmby et al., 1990). Similarly, AR was not regulated in skin fibroblasts
from patients with androgen insensitivity syndrome (Kaufman et al., 1981). This
syndrome also involves a genetic mutation of the AR gene that renders the AR protein
unable to bind ligand. The absence of AR autoregulation in individuals who do not
have functional AR, but normal levels of circulating androgen, supports a receptormediated process. In the human prostate carcinoma cell line LNCaP, nuclear run-on
analysis demonstrated that androgen treatments prompted a 75 % reduction in AR
transcription initiation (Blok et al., 1992b; Wolf et al. , 1993 ). In accordance with
these findings, recent studies by Prins and Woodham (1995) have shown castrationinduced increases in AR mRNA levels in rat VP, however, this regulation was lobe
specific and was shortlived in some areas. In addition, nuclear run-on assays
demonstrated that these increases were due to an increase in the rate of AR
transcription. Thus, in most peripheral tissues, it appears that the AR gene is
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autologously regulated, at least on an acute basis, such that the activated androgen
receptor-hormone complex primarily acts on the genome to prevent the transcription
of new AR mRNA. The binding of activated AR complexes to the half-site HREs
found in the AR promoter region (Song et al., 1993) could potentially mediate this
response. Conversely, positive regulation of AR and AR mRNA levels by androgens
have been reported in isolated smooth-muscle cells from the rat penis (Gonzci.lezCadavid et al., 1993) and in human genital skin fibroblasts (Gad et al., 1988)
suggesting that particular cell types may be genetically programmed to respond
differently to androgen at certain developmental stages. Additional! y, the
aromatization of T to estradiol also appears to affect AR mRNA levels and could
account for this tissue-specific regulatory pattern (Lin et al., 1993).
Immmunoblot analysis of corresponding AR protein changes in the rat VP and
several cell lines under similar experimental conditions that had caused several-fold
increases in AR mRNA revealed that androgen withdrawal by castration elicited
modest or no increases in immunoreactive receptor protein content (Shan et al., 1990;
Wolf et al., 1993). Additionally, Krongrad et ai. (1991) have shown that androgenmediated down-regulation of AR mRNA is associated with a transient up-regulation of
AR protein in the human prostate cancer cell line, LNCaP. These data support the
recent finding that androgens stabilize the AR protein (Zhou et al., 1995).
Ultimately, AR concentrations are likely controlled through multiple mechanisms
including the rate of transcription, mRNA stability, mRNA translational efficiency,
and the turnover rate of the protein.
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Studies of autologous AR regulation in brain tissue have been sparse and much
more difficult to interpret. Using northern blot analysis, Quarmby et al. (1990)
demonstrated a three-fold increase in AR mRNA in whole rat brain four days after
castration as compared to the intact animal. The administration of T propionate one
day before sacrifice prevented this increase. Consistent with these data, Burgess and
Randa (1993a) demonstrated significant increases in hypothalamic-preoptic area AR
mRNA content four days after castration when measured by ribonuclease (RNase)
protection assay. This effect was reversed by DHT treatment one day prior to
sacrifice. In contrast, McLachlan et al. (1991) did not observe any changes in the
amount of either the 9. 3 or 11 kb AR mRNA forms in rat cortex one and three days
following castration, however, their densitometric analysis of northern blots may not
have been sensitive enough to detect small changes. Using a more sensitive RNase
protection assay, Abdelgabir et al. (1993) reported no effects of 2, 4 or 7 day
treatment with T, DRT or estrogen on AR mRNA levels in the rat hypothalamus,
preoptic area, cortex, hippocampus or amygdala. Unfortunately, these data must be
interpreted cautiously as they are based on one or two animals per group. In contrast,
Randa et al. (1995) have demonstrated acute increases in AR mRNA in the medial
preoptic area of the hypothalamus following castration. However, after two month
castration, these increases in AR mRNA Levels were dramatically reduced or absent.
These effects of castration were reversed by DHT and estrogen. Conversely, rats
treated with 14 daily injections of high-dose anabolic-androgenic steroids showed
increases in AR immunoreactivity in most AR-positive brain regions, including the
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CAl region of the hippocampus (Menard and Harlan, 1993). Whether the androgen
treatment truly upregulated AR numbers or simply translocated more AR to the bound
conformational state of the receptor that could have been preferentially recognized by
their antibody was not determined.
The inconsistent findings in brain tissue suggest that a unique, tissue-specific
AR regulatory process may be occurring in the CNS as compared to most non-neural
reproductive tissues. Taken together, it appears doubtful that circulating androgen
levels are the sole determinant of AR mRNA levels in neural tissue. Other factors
such as the length of androgen treatment, the mode of steroid administration, and the
presence of tissue-specific regulatory proteins may play important roles in determining
neural AR mRNA expression. Whether changes in brain AR mRNA translate into
similar changes in the receptor protein have not been determined and may be
complicated by the fact that two AR mRNA transcripts are found in neural tissue. A
much clearer understanding of AR regulation in the brain is necessary to predict the
responsiveness of neural tissue to androgens.

AR Regulation by Other Factors
Recently, it has become apparent that the AR gene is influenced by several
other regulatory signals, including peptide hormones, growth factors,
neurotransmitters and other steroid hormone receptors. Additional data suggest that
the AR gene is regulated by membrane associated second messengers commonly
stimulated by neurotransmitters or peptide hormones. For example, FSH, a hormone
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whose actions are mediated via cyclic 3' ,5'-adenosine monophosphate (cAMP) and
activates the protein kinase A pathway, or the addition of cAMP analogs alone,
increased both AR protein and AR mRNA in Sertoli cells (Verhoeven and Cailleau
1988; Blok et al., 1989, 1992b, 1992c). Additionally, cAMP stimulated a mouse AR

5 '-chloramphenicol acetyltransferase construct in mouse and rat pituitary cell lines
(Lindzey et al., 1993). Similarly, epidermal growth factor, which activates the
protein kinase C second messenger pathway, decreased AR mRNA levels in LNCaP
cells (Mizokami et al., 1992). Some of these effects could potentially be mediated
directly via the calcium (Ca2 +)/cAMP-response-element-binding protein (CREB), the
activating transcription factor, AP2 (lmagawa el al., 1987; Montminy et al., 1990),
or indirectly via induction of other transcription factors such as the activator protein
(APl) components, Fos and Jun. The localization of several of these transcription
factor binding sites within the 5' promoter regions of the human, rat and mouse AR
genes support such mechanisms (Baarends et al., 1990; Tilley el al., 1990a; Faber et

al., 1991a,b; Kumar et al., 1992; Song et al., 1993; Mizokami et al., 1994).
Additionally, cellular Ca2+ levels may also play a part in AR expression. The
progressive lowering of Ca2+ concentrations significantly decreased AR protein levels
in rat Leydig cell culture (Nakhla et al., 1989), and incubation of LNCaP cells with
the Ca2 + ionophore, A23187, or the intracellular endoplasmic reticulum Ca2 +
adenosine triphosphatase inhibitor, thapsigargin, down-regulated AR mRNA and AR
protein levels in a time- and dose-dependent manner (Gong et al., 1995).
Several studies have suggested that the e:xpressiDn of one steroid hormone
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receptor may interfere with or alter the transcriptional activity of another steroid
hormone receptor expressed in the same cell line (Meyer et al., 1989; Bansal and
Latchman, 1990; Kumar et al., 1994). In particular, the overexpression of ER
significantly inhibited AR transcriptional activity with the addition of androgen and
estrogen to the cell culture (Kumar et al., 1994). The authors proposed that high
levels of DNA-bound ER may compete for some unknown factor also necessary for
transcriptional activation to occur through AR. Whether such an interaction could
result in decreased transcription of the AR gene has yet to be determined. Estrogeninduced down-regulation of the AR in the adult rat VP has been demonstrated in vivo
(Rennie et al., 1988; Prins, 1992), however, estrogen induced !!12regulation of AR has
been repeatedly demonstrated in other tissues (Handa eJ al., 1987a, 1987b, 1995;
Handa and Rodriguez, 1991). In some circumstances, estrogen may directly regulate
AR expression through the estrogen response element half-site found in the promoter
region of the rat AR gene (Song eJ al., 1993). Although no studies have looked at
alternate factors regulating AR in neural tissue, interactions between AR and other
ligand-activated transcriptions factors or second messenger pathways could be
particularly important in brain areas like the hippocampus that express high levels of
certain membrane receptors and multiple types of intracellular steroid receptors.
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Androgen-Regulated Gene Networks

It is now widely accepted that steroid receptors initiate their diverse biological

responses through selective regulation of cell-specific gene networks (Yamamoto,
1985; Meisfield, 1989). In order to understand the function and mechanism of action
of androgens, androgen-responsive genes from a variety of cell types need to be
identified. However, despite androgen's many physiological effects in peripheral and
central tissues and the estimation that almost every tissue or organ possesses an
androgen-regulated gene (Mooradian et al., 1987), surprisingly few androgenregulated genes have been characterized.
In the periphery, the rat prostate gland has served as an important target tissue
for the study of androgen dependent gene expression. Natural growth and
maintenance of the rat VP is dependent upon androgen, and castration initiates
epithelial cell apoptosis (Isaacs, 1984; Kyprianou and Isaacs, 1988; Rennie et al.,
1988). The study of androgen action in this tissue is clinically relevant for the
potential improvements in the diagnosis and treatment of prostate cancer -- the second
leading cause of cancer-related death in American men (Coffey, 1993). Several
prostate-specific androgen-regulated genes have been characterized, including prostatic
steroid binding protein (the principle secretory protein of the rat VP) (Page and
Parker, 1982; Allison et al., 1989), probasin (a single-polypeptide protein that may be
a ligand carrier) (Spence et al., 1989; Rennie et al., 1993), human glandular
kallikrein-1 (a serine protease) (Morris, 1989; Murtha et al., 1993), and prostate
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specific antigen (a serine protease that is an important marker for prostate cancer)
(Lilja, 1985; Riegman et al., 1991). All these genes appear to be regulated by AR
complexes through HRE sequences present in their promoter regions (Riegman et al. ,
1991; Murtha et al., 1993; Rennie et al., 1993).
The expression of a more ubiquitous glycoprotein, termed sulfated
glycoprotein 2 (SGP-2), has also been demonstrated to be under the control of
androgen in variety of tissues (Bettuzzi et al., 1989). In the rat VP, SGP-2 mRNA
levels increased 16-fold 4 days after castration (Bettuzzi et al., 1989) and also
increased in association with programmed cell death (Buttyan et al., 1989).
Subtraction hybridization analysis determined that the transcription of this gene
accounts for the majority (92 %) of castration-induced mRNAs in the rat VP (Briehl et

al., 1990) and suggests that the androgen gene network in this tissue is relatively
small. SGP-2 is also the major glycoprotein secreted by Sertoli cells (Collard and
Griswold, 1987) and, at least in male reproductive tissues, appears to have a role in
sperm function. Interestingly, SGP-2 was also found to be produced in the rat brain
(Bettuzzi et al., 1989; Day et al., 1990), and the homologous human RNA species
was increased in the hippocampus during Alzheimer's disease (May et al., 1990).
SGP-2 was first shown to increase in the rat hippocampus following entorhinal cortex
lesions suggesting a role for this protein in either the cell death process or in the
regenerative phase involving synaptogenesis or axonal reorganization. More recently,
Day et al. (1990, 1993) demonstrated that 3 weeks after castration, there was
increased SGP-2 expression [along with glial fibrillary acidic protein (GFAP)]
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specifically in astrocytes within the molecular layer of the rat hippocampus. Since no
studies have detected AR expression in this area of the hippocampus, the mechanism
of androgens' actions in astrocytes is unclear; but the authors speculated that
androgen-mediated changes in pyramidal cell neural activity could account for the
results. Androgens have also been found to upregulate the expression of two major
neuronal cytoskeletal elements, /3-tubulin and ,6-actin, in androgen-sensitive spinal
motomeurons (Matsumoto et al., 1992, 1993). As androgens appear to play a role in
hippocampal synaptic reorganization and sprouting (Morse et al., 1988; Scheff et al.,
1988) as well as promote axonal regeneration and synaptic input in other CNS loci
(Matsumoto et al., 1988; Jones, 1993), androgen-regulated SGP-2, GFAP and
cytoskeletal protein expression may prove t"°·be important markers for such processes.
Few other studies have examined androgen regulated genes in the brain,
however, androgens have been shown to positively regulate GnRH mRNA (Park et
al., 1988) and aromatase cytochrome P450 mRNA levels (Abdelgadir et al., 1994) in

the rat hypothalamus, as well as negatively regulate D-2 dopamine receptor content in
the rat striatum (Watanabe et al., 1989) and NMDA receptor levels in the
hippocampus (Kus et al., 1995). The continued identification of androgen-regulated
genes will provide additional clues to the cell-specific events initiated by AR and will
help to elucidate androgen's ultimate function in target tissues.
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Hiwocampal Glucocorticoid Receptors: Action. Location. and Regulation

Glucocorticoids are adrenal steroid hormones typically secreted in response to
stress (Munck et al., 1984). This secretion is controlled by the brain via the
hypothalamic-pituitary-adrenal (HPA) ax.is. This axis is a closed-loop endocrine
system in which the end product, the adrenal glucocorticoids, feedback onto various
brain regions including the hippocampus, hypothalamus and pituitary to inhibit the
release of adrenocorticotropin hormone (ACTH) from the anterior pituitary gland.
In the rat, corticosterone (CORT) is the major circulating glucocorticoid
hormone. It's effects on the body are widespread and, for the most part, are
beneficial. CORT is a potent anti-inflammatory agent and also acts to mobilize
energy stores and maintain osmotic balance in time of need (Baxter and Forsham,
1972; Axelrod and Reisine, 1984; Munck et al., 1984). In the central nervous
system, CORT has been found to induce changes in the Levels of several
neurotransmitter receptors (Jhanwar-Uniyal and Leibowitz, 1986; Martire et al.,
1989; Clark and Cotman, 1992) and in the regulation of second messenger pathways
(Harrelson and McEwen, 1987). These changes may be the mechanism by which
CORT influences certain aspects of behavior including mood, attention, learning and
adaptation (reviewed by McEwen et al., 1986).
The actions of CORT are mediated in the brain and periphery through its
binding to specific intracellular receptors (McEwen et al. , 1986). Radioligand
binding studies have demonstrated that CORT acts through two types of receptors (De
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J(loet et al., 1975; Reul and De Kloet, 1985). The first, termed the Type I receptor,
or MR, has a very high affinity for CORT

(~ =

0.5nM) as well as aldosterone (1't

== 1.5 - 2.0nM) and dexamethasone (Kd = 0.8 - 2.6nM). The second receptor,
termed the Type II, or GR, is distinguishable by its much lower affinity for CORT
(Kd = 2.5 - 5.0nM) and aldosterone (~

>

25nM), yet much higher affinity than the

Type I receptor for the synthetic glucocorticoid RU 28362. MR, having a high
affinity and low capacity for endogenous glucocorticoids, is thought to be occupied at
low basal levels of CORT and thus mediate the effects of glucocorticoids on ongoing
neural activity. In contrast, GR is thought to occupied only after increases in CORT
occur, such as following stress.
More recently, MR and GR have been distinguished by their molecular
characteristics (Arriza et al., 1987; Hollenberg el al., 1987; Patel et al., 1989). Both
receptors are members of the superfamily of steroid hormone receptors (along with
AR), which when bound to ligand, are able to act as transcription factors as discussed
earlier in this review. The rat MR and GR share considerable amino acid sequence
homology which likely contributes to some of the overlap in ligand binding and
transcriptional activity between them, yet both are products of distinct MR and GR
genes.
In addition to their structural and binding characteristics, GR and MR differ in
their neuroanatomical distribution (Fuxe et al., 1985; Reul and De Kloet, 1985; Van
Eekelen et al., 1987; Sarrieau et al., 1988). MR is predominantly localized in
septum and hippocampus. In contrast, the distribution of GRs over the brain is much
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more widespread. GR is found in brain regions including the hippocampus, septum,
paraventricular nucleus, supraoptic nucleus, and the medial amygdala. Recent in situ
hybridization analysis has revealed distinct patterns of expression of GR and MR
mRNA within the various regions of the rat hippocampus (Van Eekelen et al., 1988).
MR mRNA was demonstrated in all pyramidal cell fields (CAl-4) of the hippocampal
formation and the granule cells of the DG. In contrast, GR mRNA was mainly
restricted to CAl and CA2 pyramidal cells and the DG. GR-like immunoreactivity
mapping has demonstrated similar hippocampal distribution of the GR protein in male
and female intact rats (Ahima et al., 1992). These high levels of corticosteroid
receptors expressed in the hippocampus are thought to mediate glucocorticoid effects
on neuronal proliferation and differentiation, neuronal death, membrane potential, and
neuroendocrine feedback mechanisms (McEwen et al., 1986). Interestingly, the
distribution of MR, GR and AR mRNA in the hippocampus overlap, with especially
high levels of all three receptors in almost all pyramidal cells of CA 1. Such cellular
overlap in expression may suggest some interactive function or cooperativity of AR
and GR in hippocampally-mediated behaviors.
Corticosteroids are known to modulate the expression of their own receptors as
evidenced by numerous in vitro studies demonstrating GR autoregulation in several
different types of cell culture systems (Cidlowski and Cidlowski, 1981; Svec and
Rudis, 1981; Mcintyre and Samuels, 1985; Berkovitz et al., 1988). More recently,
the in vivo regulation of GR by glucocorticoids has been characterized in the
hippocampus. In most cases, adrenalectomy (ADX) caused an increased level of GR
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mRNA in the hippocampus within one day (Reul et al., 1989; Sheppard et al., 1990).
These increases were returned to intact levels by dexamethasone administration
(Sheppard et al., 1990). Using in situ hybridization, anatomical specificity of this
regulation has been demonstrated. Eight days following ADX, elevated levels of GR
and MR mRNA are found in the CAl-2 subfields of the hippocampus (Herman et al.,
1989). In contrast, a similar treatment has been found to decrease GR-like
immunoreactivity in these areas (Ahima et al. , 1992). The exact reasons for such
discrepancies between protein and mRNA levels is unclear, however, several studies
have found a role of glucocorticoids in modulating the stability of the receptor protein
(Mcintyre and Samuels, 1985; Dong et al., 198 8; Hoeck et al. , 1989). Autologous
regulation of GR also appears to be exerted at the level of GR mRNA synthesis (see
review by Burnstein and Cidlowski, 1992). Several experiments have found that the
GR cDNA contains intragenic signals that activated GR complexes can bind to and
subsequently act by repressing transcription initiation or blocking elongation
(Burnstein et al., 1990, 1991; Okret et al., 1986). The exact nature of these
intragenic sequences has not been investigated.
The actions of other steroid hormones on hippoca.mpal GR regulation have
been investigated recently. Estrogen, the prominent circulating sex steroid in
females, has been found to alter the regulation of CORT receptor mRNAs in the
female hippocampus (Burgess and Ha.nda, 1993b). In this study, estrogen treatment
resulted in a loss of the GR's ability to down-regulate its mRNA.
Sex differences have recently been observed in the regulation of the
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intracellular location of hippocampal GR-like immunoreactivity of ADX rats by
CORT and progesterone (Ahima et al., 1992). In this study, estradiol treatment of
ADX male or female rats did not significantly alter staining intensities in any area of
the hippocampusas compared to the untreated ADX male or female rats. Similarly,
recent evidence has demonstrated upregulation of rat GR immunoreactivity in the
pyramidal cell layer of CAl and granular layer of the DG of the rat hippocampus
after a one week treatment with anabolic-androgenic steroids (Ahima and Harlan,
1992). These data suggest a link between AR activation and GR regulation in the
areas of the hippocampus which contain high levels of both of these receptors. It is
not known if these anabolic steroids are transactivating ARs which in turn alter the
transcriptional rate of the GR gene or are acting through some other mechanism in
hippocampal cells. It is possible, however, that the behavioral changes observed
during anabolic-androgenic steroid abuse may be mediated in part through its effects
on GR regulation and resulting changes in hormonal feedback mechanisms.

Cellular Immediate Early Genes

Despite accumulating molecular data on steroid hormone-receptor complex
action on individual HREs, the steps leading from hormonal signals to the modulation
of neuronal activity remain poorly defined. New avenues to approach such questions
have resulted from the observation that neuronal stimulation rapidly activates the
transcription of several cIEGs. Most of the cIEGs encode for proteins which act as
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transcription factors and regulate, in a hierarchial fashion, the transcription of target
genes that determine the overall behavior or phenotype of the cell (reviewed by
Morgan and Curran, 1991). In essence, cIEG protein products are the "third
messengers" of the stimulus-transcription coupling cascade that produce the long-term
or "hard-wired" changes in neurons (reviewed by Morgan and Curran, 1989).
In general, clEGs share several characteristics. First, they are expressed in
very low or undetectable amounts in quiescent ceJls, but are rapidly transcribed within
minutes of cellular activation. Second, their transcriptional activation is short-lived
and does not require new protein synthesis, however protein synthesis is necessary to
shut-off the transcriptional process. Last, cIEG mRNAs and proteins have short halflives (minutes to a few hours), and thus, are characteristic of an early signalling
system that triggers further regulation of gene expression (Sheng and Greenberg,
1990).

cIEG Forms and Mechanisms of Induction
To date, the best studied cIEG is c-fos, but others, including several c-fos
family members ifosB and Fos related antigen, fra), several jun family members (cjun, junB, junD), zij268 (also known as NGFT-A, krox24, TTS-8 and Erg-1), c-myc,

and c-Ha-ras are also expressed in neuronal tissue and are currently being examined.
The c-fos gene encodes a nuclear protein, Fos, that has an apparent molecular weight
of 62 kDa and is subject to extensive post-translational modifications (Schilling et al.,
1991). Using a leucine-zipper motif and surrounding basic regions, the Fos and Jun

63
family member proteins bind to DNA regulatory regions either as homodimers (JunJun dimers) or heterodimers (Fos-Jun dimers) to form the transcription factor known
as AP-1 (reviewed by Curran and Franza Jr., 1988; Cohen and Curran, 1989). In
this case, additional regulation of gene transcription occurs depending on the relative
amounts of Fos and Jun expressed in the cell after stimulation (Chiu et al., 1989;
Schutte et al., 1989; Diamond et al., 1990).
The three known Jun proteins (Jun, JunB and JunD) differ from each other in
their transactivation properties, binding affinities, and cellular function (Chiu et al.,
1989; Ryseck and Bravo, 1991). c-jun andjunB are considered classical cIEGs in
that they are rapidly and transiently expressed in cells following various stimuli
(reviewed by Sheng and Greenberg, 1990). In contrast, junD is constitutively
expressed in considerable amounts in many tissues and exhibits delayed and prolonged
induction following certain stimuli (Gass et al., 1992; Demmer et al., 1993;
Herdegen et al., 1995). Functionally, Jun has been linked to the promotion of cell
growth, whereas JunB and JunD act to inhibit cell proliferation (Schlingensiepen et

al., 1994). The zij268 gene, which encodes for a lone-acting, zinc-finger-containing
transcription factor, was initially found to be rapidly induced in mammalian neurons
following seizures (Saffen et al., 1988), although, it was also found to be
constitutively expressed in some areas of the brain (Schlingensiepen et al., 1991;
Hughes et al., 1992; Herdegen et al., 1995).
The expression of c-fos was initially studied in PC 12 pheochromocytoma cells
and was found to be induced by neurotrophic factors (Greenberg et al., 1985), agents
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that activate classical neurotransmitter receptors (Greenberg et al., 1986),
depolarizing conditions (Morgan and Curran, 1986), and a variety of agents that
provoke Ca2+ influx through voltage-gated channels (Morgan and Curran, 1986).
These findings prompted researchers to look for inducible c-fos (as well as its closely
related cIEGs) in the nervous system. Although a precise function for Fos and other
cIEG proteins has yet to be established, they have been implicated in diverse
processes such as neuronal differentiation, proliferation, cell death, and signal
transduction (Muller et al., 1985, Schlingensiepen el al., 1994).

cIEG Expression in Neural Tissue
Recently, many studies have examined cIEG induction in neuronal tissue of
intact animals. In summary, cIEG expression, as measured by immunocytochemistry
or mRNA content in neuronal tissue, has been shown to increase by pharmacological
(Morgan et al., 1987, Sonnenberg et al., 1989), electrical (Dragunow and Robertson,
1987), surgical (White and Gall, 1987), and physiological stimuli (Bullitt, 1990,
Senba et al., 1994). Related findings have been comprehensively reviewed by
Morgan and Curran (1989, 1991).
Although it may appear that the cJEG induction is a non-specific, ubiquitous
phenomenon in response to cellular activation, in fact, the pattern of cIEG expression
in the brain, and the specificity in which cIEGs are induced, are very dependent on
the given stimulus. For example, sexual behavior increased Fos immunoreactivity
selectively in the male rat medial preoptic area of the hypothalamus and nucleus
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accumbens (Robertson et al., 1991). Coincidentally, neurotransmitter release in both
of these areas have been implicated in the control of male sexual behavior (Mas et

al., 1990; Warner et al., 1991). Taken together, the examination of these gene
products serve as a useful tool for mapping specific neuronal populations which are
activated following a stimulus (Sagar et al., 1988) and distinct combinations of cIEGs
could confer specificity in the cellular response to different stimuli.
The study of cIEG expression in the hippocampus following physiological
stimuli has been particularly useful in identifying specific roles for these protein
products. One popular model of neuronal plasticity in the mammalian CNS is longterm potentiation {LTP). LTP is a lasting enhancement of synaptic efficacy in
hippocampal neurons following brief high-frequency perforant pathway stimulation
(Bliss and Gardner-Medwin, 1973). LTP has been shown to persist from days to
months in the absence of any further stimulation which makes it an attractive model to
study the mechanisms responsible for long-term memory (Teyler and Discenna,
1984). Such a prolonged time course of LTP decay has led researchers to implicate
transcriptional changes in the maintenance of this phenomenon; cIEGs being among
the first genes to be examined. Several clEGs have been found to be induced in DG
granule cells following LTP induction (Abraham eJ al. , 1991; Richardson et al.,
1992). In these studies, the most consistently induced cIEG, zij268, correlated best
with LTP persistence (Richardson et al., 1992; Williams et al., 1995). Members of
the c:fos and c-jun gene families were also induced in the hippocampus under these
conditions, but did not correlate with LTP induction or stabilization (Demmer et al.,
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l993). The induction of LTP, as well as the corresponding cIEG induction, both
appeared to be dependent on hippocampal NMDA receptor activation (Demmer et al.,
1993). Interestingly, zij268 was also basally expressed in CAl pyramidal cells
(Hughes et al., 1992) and this basal expression in CAl neurons was largely NMDAreceptor mediated (Worley et al., 1991). zij'268 expression may be involved with new
learning, inasmuch as destruction of CAl neurons (Kubo et al., 1993) and NMDA
antagonists injected into the hippocampus (Ohino et al., 1992) impaired learning.
Consistent with these findings linking cIEGs induction with the learning process,
brightness discrimination training, learning a bar-pressing task, as well as two-way
active-avoidance behavioral training elevated cIEG mRNA levels, namely c-fos, c-jun
and zif268 mRNA, in the rodent hippocampus (Tischmeyer et al., 1990; Nikolaev et
al., 1992; Heurteaux et al., 1993).
In addition to learning and memory, other forms of hippocampal plasticity
have been correlated with cIEG induction. Distinct induction patterns for c-fos, c-jun,
junB and NGFI-B were demonstrated in each cell body region of the rat hippocampus

following transient forebrain ischemia, which may relate to the delayed neuronal death
of CAl neurons following anoxia as compared to other hippocampal cell body regions
(Neumann-Haefelin et al., 1994). Fos protein expression also immediately preceded
the appearance of ribosomes and structural remodeling of dendritic spines of partially
deafferented dentate granule cells (Chen and Hillman, 1992). In primary rat
hippocampal cultures, the selective inhibition of c-jun expression using antisense
oligonucleotides prevented neuronal cell death and promoted neuronal survival
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suggesting a role of Jun in programmed cell death in this brain area (Schlingensiepen

et al., 1994). Additionally, several studies have demonstrated that the induction of cfos mRNA and protein in the hippocampus is prominent in the CAl pyramidal cell
layer following exposure to a novel environment (Banda et al., 1993; Papa et al.,
1995). Thus, c-fos mRNA induction may be a good marker for CAI pyramidal cell
activity.

Interaction of cIEGs and Steroid Hormone Receptors
Although the majority of evidence to date relates cIEG induction through
neural excitation via membrane receptors for glutamate (Sonnenberg et al., 1989;
Lerea and McNamara, 1993; Wan et al., 1994; Papa et al., 1995), adrenergic
compounds (Gubits et al., 1989), opiates (Chang and Harlan, 1990) or acetylcholine
(Greenberg et al., 1986), the possibility of direct and/or indirect hormonal modulation
of cIEGs is now emerging (see reviews by Landers and Spelsberg, 1992; Schuchard

et al., 1993; Hyder et al., 1994). Estrogen treatment has been shown to cause a
rapid and transient increase in c-fos mRNA in the uterus (Loose-Mitchell et al., 1988)
and hypothalamus (Insel, 1990) of ovariectomized rodents. This very rapid induction
appears to be a direct effect of the transformed estrogen receptor complex acting on
estrogen response elements that flank the cfos gene (Weisz and Rosales, 1990; Hyder

et al., 1991a, 1991b). To date, response elements for the androgen receptor have not
been identified upstream of cIEG genes, however, studies in prostate and prostatic
cell lines have demonstrated androgen-induced changes in several cIEGs including c-
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myc and cjos (Quarmby et al., 1987; Buttyan et al., 1988; Rennie et al., 1989; Wolf
et al., 1992). One recent study found no effects of androgen treatment on matinginduced Fos immunoreactivity in hypothalamic brain regions of castrated male rats
(Baum and Wersinger, 1993). Whether androgens can affect cIEG induction in other
cell types or brain areas is not presently known. Potentiation of cjos and c-jun
mRNA content in the hippocampus (Li et al., 1992) and hypothalamus (Jacobson et

al., 1990) have been demonstrated following ADX; an effect the authors attribute to
the removal of circulating glucocorticoid hormone. It is likely safe to assume that a
mechanism of androgen modulation of cIEG expression is available in the CNS,
especially in areas of the hippocampus where there is an anatomical overlap of AR
synthesizing cells with those cells where cIEGs are induced following various
physiologic stimuli. Androgen modulation of cIEG expression would implicate
androgens in the long term alteration of hippocampal function and would suggest that
the hormonal status of the animal affects the active response of hippocampal cells to
incoming information.

Clinical Implications

The study of androgen action in the hippocampus has the potential to impact
several areas of clinical medicine. There is growing concern over the health risks and
psychological problems associated with the long term abuse of anabolic-androgenic
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steroids. Few studies on how high-doses of androgen affect brain tissue have been
performed. Essentially, anabolic-androgenic steroids are synthetic derivatives of T
and DHT which act through the AR to elicit many of their effects. When taken in
high doses and combined with rigorous training and a high protein diet, anabolic
steroids can produce large increases in muscle mass in a relatively short period of
time (Haupt and Rovere, 1984). Such results have led to a dramatic surge in anabolic
steroid abuse by professional, college, high school and recreational athletes in order
to enhance their performance or body appearance. Currently, both males and females
use anabolic steroids and it is estimated that there are at least one million users in the
United States alone (Marshall, 1988). Typically, steroid abusers take multiple forms
of hormone at once and thus provide circulating androgen 10-200 times physiological
levels (Narducci et al., 1990). Common peripheral side effects of such steroid abuse
include testicular atrophy, virilization (females), increased risk of heart disease, acne,
and hepatotoxicity (Narducci et al. , 1990). In addition, recent clinical evidence
suggests various psychotropic effects of high dose anabolic steroids. These include
violent behavior, hyperactivity, psychoses, hallucinations, depression, suicide
ideation, antisocial behavior, and panic disorders (Lubell, 1989; Katz and Pope, 1990;
Uzych, 1992). These psychological changes appear to be the result of chronically
high levels of androgen reaching the brain, however, the underlying mechanisms are
unknown. Limbic areas of the brain that control aggression and emotion, including
the amygdala and hippocampus, are likely targets for androgen action. Although the
clear answer to these problems is the prevention of anabolic-androgenic steroid abuse,
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an understanding of the cellular actions of long term, high dose androgens in brain
tissue may aide in the treatment of those individuals who still choose to illegally use
these drugs.
The increasing number of studies touting the beneficial androgenic effects on
hippocampal plasticity, memory and overall well-being throughout adulthood have
recently prompted studies examining T supplementation in older men. Typically,
circulating androgen levels decline with age in both men (Davidson et al., 1983;
Vermeulen, 1991; Vermeulen and Kaufman, 1995) and women (Zumoff et al., 1995).
Whether T replacement to levels found in younger :individuals can improve certain
memory skills, mood and libido are just beginning to be explored (Goudsmit et al.,
1990; Janowski et al., 1994; Tenover, 1994). Currently, not much information exists
on androgen sensitivity in brain or peripheral tissues during the aging process
(Goudsmit et al., 1988; 1990b). Such research would certainly shed light on the
validity and safety of such treatments in older men and women.

Summary

The increasing number of reports of psychological side effects of anabolicandrogenic steroid abuse, as well as the possible beneficial effects of physiological
levels of androgens on neuronal plasticity, have prompted a heightened research
interest into the intracellular mechanisms of androgens in brain tissue. The presence
of relatively high levels of androgen receptors and their mRNAs in the CAI
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pyramidal cells of the hippocampus suggests that this area is a major neural target for
androgens. Subsequently, changes in androgen sensitivity in hippocampal pyramidal
neurons, which form a major output of the hippocampus to limbic and cortical areas,
may underlie some of the behavioral effects of anabolic-androgenic steroids. The
quantification and regulation of AR and its mRNA in the hippocampus following
various androgen treatments were determined to begin to examine the responsiveness
of the hippocampus to circulating androgen. The action of the AR at the
transcriptional level is also not well understood. Changes in the expression of various
constitutively expressed or inducible genes are possible mechanisms that could alter
the way in which hippocampal pyramidal cells respond to incoming signals.
Therefore, a multidisciplinary approach was used to characterize the hippocampal AR,
its regulation and its effects on constitutive and inducible gene expression following
androgen removal and replacement. Together, these studies have begun to define the
sensitivity of the adult hippocampus to androgens and serve as a basis for further
investigation of activational androgenic effects on hippocampally-mediated behaviors,
such as cognition, memory formation and spatial ability.

CHAPTER III
DISTRIBUTION AND HORMONAL REGULATION OF
ANDROGEN RECEPTOR (AR) AND AR MESSENGER RNA
IN THE RAT HIPPOCAMPUS

Abstract

The action of androgens in both peripheral and central tissues are linked in
part to their ability to specifically bind and activate ARs. ARs have been well studied
in the rat hypothalamus and peripheral reproductive tissues, where they are directly
involved in endocrine feedback mechanisms and reproduction. Previous studies have
revealed relatively high levels of AR and AR mRNA in the rat hippocampus;
however, the action of androgen in this brain region remains unclear. To begin to
address this issue, a multidisciplinary approach was used to quantitate hippocampal
AR and AR mRNA levels and to investigate AR autoregulation following various
hormonal manipulations. In vitro binding assays revealed a single, saturable, high
affinity binding site for androgen in hippocampal cytosols. Western immunoblot
analysis of hippocampal, hypothalamic, cortical and ventral prostate cytosol
preparations using an AR specific antibody showed a primary signal at approximately
110-140 kilodaltons suggesting a single AR species in both brain and peripheral
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tissues. The expression of AR mRN A in the intact adult male rat hypothalamus and
hippocampus was quantified using a RNase protection assay. Comparable levels of
AR mRNA were found in the hippocampus and hypothalamus. In addition, in situ
hybridization analysis revealed a unique distribution of AR mRNA in the
hippocampus. AR mRNA was found predominately in the CAl pyramidal cells which
form the major signal output of the hippocampal trisynaptic circuit. RNase protection
assay demonstrated a significant decrease in AR mRNA content in the hippocampus of
animals killed four days following castration, or in intact rats after four daily
injections of the AR antagonist, flutamide (15 mg/animal), as compared to mRNA
levels in intact controls (P<0.01). In contrast, a 35% increase (P<0.05) in the
hippocampal AR mRNA content was found in old (22 month-old) male rats as
compared to young (5 month-old) male rats. In both cases, [3H]-DHT binding to the
cytosolic preparation did not parallel the changes observed in the AR mRNA content.
In summary, these data demonstrated that hippocampal cells containing AR can
respond to circulating androgen to alter AR gene expression. Furthermore, AR
mRNA autoregulation was be both age and tissue specific and did not directly follow
the regulatory patterns previously described for other steroid hormone receptors found
in the hippocampus.
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Introduction

T and its Sa-reduced metabolite, DHT, are the major circulating androgenic
hormones in males. Androgen action is linked in part to its ability to specifically bind
and activate ARs. In neural tissue, AR are distributed in a pattern consistent with
androgenic effects on the regulation of gonadotropin secretion and reproductive
behaviors (Sar and Stumpf, 1973; Lieberburg et al., 1977; Randa et al., 1986;
Roselli, 1991).
Studies revealing relatively high levels of AR and its mRNA in
extrahypothalamic brain areas such as the cortex, lateral septum and the hippocampus
of the rat (Sar and Stumpf, 1974, 1977; Randa et al., 1987a; Roselli et al., 1989;
Simerly et al., 1990; McLachlan et al., 1991; Zhou et al., 1994b) present the
possibility that androgen action in the brain is not limited to the expression of some
reproductive behaviors and endocrine feedback mechanisms. Recently, androgenic
compounds have been shown to influence some hippocampal-mediated learning and
memory tasks in rats (Roofs and Havens, 1992; Flood et al., 1992) as well as
modulate NMDA receptor levels (Kus et al., 1995) and NMDA receptor-mediated
electrophysiological properties (Pouliot et al., 1995) in hippocampal pyramidal cells.
In humans, sex-related differences in certain memory skills as well as other cognitive
functions (Kimura, 1992) implicate gonadal hormones as important organizational
modulators of hippocampal physiology. Fluctuations in gonadal hormone levels
during the normal monthly cycle in women or the seasonal cycle in men (Hampson
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and Kimura, 1992) as well as T supplementation in older men (Janowsky et al., 1994)
have been shown to significantly alter cognitive ability. These studies suggest an
active role of gonadal hormones on hippocampal function throughout life; however,
their mechanism of action is not understood.
In aging male rats, a gradual decline in circulating levels of T has consistently
been reported (Ghanadian et al., 1975; Bethea and Walker, 1979; Kaler and Neaves,
1981). Androgen-mediated behaviors decline similarly with age in the male rat;
however, restoration of circulating T levels equivalent to the young male will not
fully restore behavior, suggesting that age-related deficits in behavior are probably
due to changes in androgen responsiveness in certain brain areas (Chambers and
Phoenix, 1984; Goudsmit et al., 1990; Chambers et al., 1991). Studies examining
other steroid hormone receptors have shown significant decreases in hippocampal GR
and MR density in aged rats (Sapolsky et al., 1983; Van Eekelen et al., 1991). How
the aging process and its associated decline in circulating androgen levels affects AR
expression in the hippocampus has not been explored.
Based on these data, it was hypothesized that the hippocampus is a major
neural target for androgens. In the studies reported here, a multidisiplinary approach
was used to characterize, quantify and localize AR and AR mRNA in the rat
hippocampus. Furthermore, the responsiveness of the hippocampal AR and AR
mRNA expression to removal of circulating androgen by castration as well as to
naturally occurring deficits in circulating androgens such as those found in the aging
male rat were examined.

.........

~----------
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Materials and Methods

,Animals and Tissue
Young (3- to 5-month-old) and old (22- to 24-month-old) male Fischer 344
rats (Harlan Inc, Indianapolis, IN) were maintained on a 12-h light, 12-h dark cycle
(lights on at 0700 h) and given free access to food and water. Bilateral GDX was
performed under ether anesthesia and all animals were sacrificed by decapitation.
Brain dissections of the hypothalamus, hippocampus and cortex were performed as
previously described by Randa et al. (1986).

Experiment 1: Characterization. Quantification and Localization of AR and AR
mRNA in the Hiwocampus of Youn& Male Rats
To confirm the presence of AR in the rat neural tissues hippocampal AR were
characterized using in vitro binding of [3H]-DHT to hippocampal, cortical and
hypothalamic cytosols obtained from rats castrated 24 h before death. Prior castration
was necessary to ensure that all available AR were free of ligand and unbound to
DNA. In addition, western immunoblot analysis was performed on cytosolic protein
extracts from intact rat hippocampus, hypothalamus and cortex to determine the
approximate size of the AR protein found in these neural tissues. To determine
whether the location of the expression of AR mRNA in neural tissue mimicked that of
its protein, total RNA isolated from the cortex, hypothalamus, and hippocampus of
intact young rats was assayed by RNase protection assay. The distribution of AR
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mRNA in the hippocampus of the intact rat was further analyzed using in situ
hybridization.

Experiment 2: Regulation of Hippocampal AR and AR mRNA
In this experiment the regulation of AR and AR mRNA after androgen
removal or AR antagonism was examined. Young animals were left intact,
gonadectomized for 4 days, or subcutaneously injected daily with 15 mg of the AR
antagonist, flutamide (30 mg/ml; dissolved in sesame oil), for 4 days. Total RNA
was isolated from each hippocampus and assayed for steady state levels of AR mRNA
using the RNase protection assay. In vitro binding of [3H]DHT to hippocampal
cytosols from animals gonadectomized for 12 h, 24 h, or 4 days was used to
determine whether changes in AR protein levels mimic the changes in mRNA levels
under similar conditions. To estimate total receptor numbers in intact rats, castration
12 h prior to sacrifice was performed to ensure that all AR were free of ligand and
not bound to DNA and, thus, could be obtained in the cytosolic fraction.

Experiment 3: Hippocampal AR Levels in Aged Rats
To investigate the effect of naturally occurring reductions in T on hippocampal
AR and mRNA content, I compared steady state levels of AR and AR mRNA in the
hippocampus of young vs. old intact rats. In vitro binding and RNase protection
assay were used for the quantification of AR and AR mRNA levels, respectively.
Saturation analysis of [3H]DHT binding were also performed to analyze possible age-
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related changes in AR binding affinity.

In vitro Binding Assay
Tissue was analyzed for concentration of cytosolic AR as previously described
(Handa et al., 1986). Briefly, brains were rapidly removed from the skull and placed
on crushed ice for dissection. Each brain region was homogenized in 600 µl of
TEGMD buffer (10 mM Tris, 1.5 mM EDTA, 10% glycerol, 25 mM molybdate, 1
mM dithiothreitol; pH 7.4); for saturation analysis, six hippocampi were pooled and
homogenized in 1. 5 ml of TEGMD buffer. The homogenate was centrifuged at
100,000 x g for 15 min in a TFT 80.4 rotor in a Sorval OTD55B ultracentrifuge
(Sorval, Norwalk, CT) at 4°C to obtain a pure cytosolic fraction. For single point
assay, 100 µl of the cytosolic fraction was incubated with 2 nM of [3H]DHT
(l,2,4,5,6,7-3H(N)-5a-Androstan-17fi-ol-3-one, 110-150 Ci/mmol, New England
Nuclear (NEN) Research Products, Boston, MA) for 20-24 hat 0-4°C for
determination of total AR binding (total incubation, 150 µl). A 400 nM concentration
(200-fold excess) of radioinert AR specific agonist, methyltrienolone (Rl881, NEN
Research Products), was incubated in parallel tubes with [3H]DHT to determine
nonspecific binding. For saturation curves, purified cytosolic fractions were aliquoted
(100 µl) into 1.5 ml conical tubes containing [3H]DHT (0.05 nM to 2 nM). A
parallel set of incubation tubes containing an additional 200-fold excess of unlabelled
R1881 were used to determine nonspecific binding. Following the overnight
incubation at 4°C, all samples were passed through Sephadex LH-20 columns to
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separate bound from free ligand. Six hundred microliters of eluate containing bound
radioactivity were collected. Four milliliters of UltimaGold scintillation fluid
(Packard, Downers Grove, IL) was added to the eluate, and the radioactivity was
counted in a Packard 1900 LA liquid scintillation counter at 37% efficiency. Specific
binding was calculated by subtracting nonspecific binding from total binding. Ten
microliters of the remaining cytosol was used for measurement of protein levels by
the method of Lowry et al. (1951). All receptor data are expressed as femtomoles
(fmol) per mg protein. Scatchard transformations were generated by computer using
The LIGAND program (version 3.0, Elsevier North Holland, Amsterdam, The
Netherlands).

RNA Isolation
Dissected brain regions were homogenized separately in 4 M guanidinium
isothiocyanate (Boehringer Mannheim, Indianapolis, IN) buffer containing 50 mM
sodium citrate, pH 7.0, 0.5% sarkosyl and 0.1 M fi-mercaptoethanol. Total RNA
was isolated as previously described by Chirgwin et al. (1979), by pelleting through a
5.7 M CsCl cushion for 14-16 hat 147,000 x g at 15<>C. The resuspended RNA
pellet was phenol-chloroform-isoamyl alcohol (24:24: 1) extracted, and the aqueous
phase was then further purified by ethanol precipitation. The resultant pellets were
washed with 70% ethanol, resuspended in diethylpyrocarbonate-treated H 20 and
stored at -70<>C until used for the RNase protection assay. RNA content was
determined by UV absorbance at 260 nm.
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RNase Protection Assay

In vitro solution hybridization of AR mRNA was performed as previously
described by Burgess and Handa (1993a). To generate antisense radiolabelled RNA
probes, a 141 basepair fragment of the rat AR2 cDNA (Tan et al., 1988) was
subcloned into a pGEM 3Z plasmid vector (Promega), as depicted in figure 6A. A
radiolabelled antisense RNA probe was transcribed following linearization of these
vectors with EcoRl and transcription with SP6 DNA-dependent RNA polymerase in
the presence of a- 32P-labeled CTP (800 Ci/mmol; Amersham, Arlington Heights, IL).
This procedure and subsequent RNase protection assay are outlined in figure 6B.
The resulting antisense probe had a specific activity of more than 109 cpm/µg.
Aliquots of the transcribed RNAs were analyzed on denaturing 5% acrylamide, 7.5 M
urea gels to confirm their integrity. Only 32P-1abeled cRNA transcripts that were
more than 90% full length were used in subsequent assays. Sense strand RNAs were
transcribed from the same construct, using the T7 polymerase, following linearization
with Pst I. Dilutions of in vitro synthesized sense strand RNA ( > 99 % full length)
were used to generate the standard curves performed in each assay.
Either 10 µg sample RNA or dilutions of in vitro transcribed sense strand
RNA [50, 25, 12.5, 5 and 2.5 attomoles(amol)] were hybridized in solution to a
molar excess (100,000 cpm) of 32P-labeled antisense RNA (total incubation volume,
30 µl). The standard curves generated were linear, with correlation coefficients
consistently greater than 0.99. Ten micrograms of transfer RNA were used as a
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negative control. Following hybridization overnight and digestion of unprotected
fragments with RNases A and Tl (40 µg/ml and 2 µg/ml, respectively), the protected
fragments were phenol-chloroform-isoamyl (24:24: 1) extracted, ethanol precipitated
and resuspended in 10 JLl formamide load buffer (80% formamide, 10 mM EDTA, 1
mg/ml Bromophenol blue, 1 mg/ml xylene cyanole). Resuspended fragments were
electrophoresed through 5 % acrylamide-7. 5 M urea gels at 300 V. Gels were fixed
in 7% acetic acid and dried. Radioactivity in the gels was counted directly by a
Betascope 6000 analyzer (Betagen, Waltham, MA). Values are expressed as fmol
protected probe per mg input RNA. Each sample was run in duplicate in each assay,
and the resulting values were averaged to obtain a final value for each animal.
Autoradiograms were obtained by exposing the dried gels to Hyperfilm (Amersham,
Lake Forest, IL) at -7<J'C for 4-7 days. Validation of the assay and a typical standard
curve (cpm in the protected band vs. amol of sense stand added) are shown in figures
7A and 7B.
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Figure 6. (A) Schematic representation of the AR2S cDNA construct prepared by
subcloning a 141 nucleotide fragment of the rat AR cDNA, corresponding to the 5'translated region. (B) The RNase protection assay process. The plasmid is
linearized with EcoRl and in vitro transcribed with SP6 RNA polymerase to produce
a uniformly labelled antisense cRNA transcript of 170 bases. This probe hybridizes
to AR mRNA and following digestion of all single stranded RNA and purification, the
resulting 141 nucleotide protected fragment was left.
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In Situ Hybridization

Jn situ hybridization was performed using the in vitro transcribed AR cRNA
probe as described above, but labeled with [35S]UTP (800 Ci/mMol, Amersham,
Arlington Heights, IL). Completeness of transcription was determined by 5 %
acrylamide-7.5 M urea gel electrophoresis. The specific activity of the probes
averaged 1 x 109 cpm/ µg. Only probes greater than 90% full length were used for in

situ hybridization.
Whole brains were rapidly removed from skull and immersed in cold
isopentane (-30°C). Brains were stored frozen at -80()C until sectioned. Brains were
sectioned at 16 µmin a Leitz 1600 cryostat and mounted onto Superfrost plus slides
(Fisher Scientific, Pittsburgh, PA). In situ hybridization using the 35S-labelled cRNA
probe was performed according to the method previously described by Handa et al.
(1993). Approximately 85 µl of a 20 x 106 cpm!ml hybridization solution (50%
formamide, 20% dextran sulfate, 1.2 M NaCl, 20 mM Tris, 0.04% Denharts
solution, 2 mM EDTA, 0.02% salmon sperm DNA, 0.1% yeast RNA, 0.1 % sodium
thiosulfate, 100 mM dithiothreitol (DTT), 0.1 % sodium dodecyl sulfate (SDS)) were
added to each slide, coverslipped and allowed to hybridize in a humidified incubator
for 16 h at 65°C. Slides were rinsed in 2 x saline sodium citrate (SSC) and
nonhybridized RNA was digested with RNase A (20 µg!ml: 37()C for 30 min). Slides
were washed to a final stringency of 0.1 x SSC at 60'C. Autoradiograms were
obtained by exposing slides to X-ray film (Hyperfilm B-max, Amersham, Arlington
Heights, IL) for 21 days. Following film exposure, slides were dipped in nuclear
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tract emulsion (Kodak NTB-3) and exposed for 35 days before development and
cresyl violet staining. These sections were examined under bright- and darkfield
illumination using a Zeiss Axioplan microscope (Zeiss, New York, NY). Resulting
images were digitized from photographic slides. Composite figures were made using
Adobe Photoshop software.

Western Immunoblot Analysis
Freshly dissected tissues were homogenized in 300 - 600 µI of Tris-EDTA
buffer, pH 7.4, supplemented with 0.2 mg/ml Aprotinin, 1 mM DTT and 0.1 % SDS.
Cytosolic extracts were made by centrifuging at 100,000 x g for 30 min in an TFT
80.4 rotor in a Sorval OTD55B ultracentrifuge at 4°C. Protein levels in the cytosol
were determined by the method of Lowry et al. (1951). After boiling for 5 min, 50
µg of the denatured cytosolic extracts were electrophoresed on 1.5 mm SDS-

polyacrylamide gels consisting of a 5% stacking gel and an 8% resolving gel. Protein
was electrophoretically transferred to polyvinylidene difluoride membrane
(Polyscreen™, NEN Research Products, Boston, MA) at room temperature for 1 hat
200 amps in a buffer containing 0.048 M Tris, 0.039 M glycine, 0.037% SDS and
20% methanol. Membranes were incubated overnight at room temperature in
blocking buffer (5% Carnation nonfat dry milk in 1 X TBS, 0.05% Tween-20, and
0.02% sodium azide) and then incubated for 1 h with purified PG-21 antisera (1
µg/ml). This is a rabbit antiserum raised against a synthetic peptide corresponding to
the first 21 amino acids of the rat and human AR (generously supplied by Dr. Gail
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Prins, University of Illinois College of Medicine). A preabsorption control consisting
of 1 µg/ml PG-21 and a 10-fold molar excess of the antigenic peptide AR21 (0.2
µg/ml) was incubated on corresponding membranes to demonstrate specificity. All
membranes were incubated at room temperature in biotinylated goat antibody to rabbit
IgG (2 µg/ml) in 5% dry milk and 0.05% Tween-20 (TBST) for 1 h. After each
incubation, membranes were washed with TBST (2 X 15 min) at room temperature.
Immunoreactive bands were visualized using Renaissance™ western blot
chemiluminescence reagent (NEN Research Products, Boston, MA; 0.125 ml/cm2
membrane for 2 min) and exposed to autoradiographic film (ReflectionTM, DuPont,
Boston, MA) for 5 - 10 min.

Statistical Analysis
All data were analyzed by a one-way analysis of variance followed by the
Student-Newman-Keuls multiple comparisons test. P <0.05 was considered
significant.
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Results

Characterization. Quantification and Localization of AR and AR mRNA in the Rat
Hippocampus
To determine whether the binding characteristics of AR in the hippocampus
were similar to that previously reported in other neural tissues, such as the
hypothalamus, we examined the in vitro binding of [3H]DHT to hippocampal, cortical
and hypothalamic cytosols obtained from young male rats castrated one day prior to
sacrifice. Scatchard analysis of [3H]DHT binding to AR in each of the three cytosols
(figure 8) demonstrated a saturable, high affinity binding site which was best fit by a
single site model and had an apparent Kc1 of 0. 2 nM. The highest concentration of
AR binding was found in the hypothalamus with an approximate binding capacity
(Bmax) of 4.5 fmol/mg protein, followed closely by hippocampal binding with an
approximate Bmax of 3.9 fmol/mg protein. Cortical tissue had the lowest AR
concentration of the three tissues with a Bmax of approximately 1.4 fmol/mg protein.
Western immunoblots were performed to characterize and compare rat AR
immunostaining in neural and peripheral tissues believed to express relatively high
levels of AR. A prominent specific AR protein approximately 110-140 kilodalton
(kDa) in size was detected in ventral prostate, hippocampus, hypothalamus, cortex
and pituitary gland using the PG-21 antibody (figure 9, lanes 1-5, respectively). This
corresponds well to the known molecular weight of the rat AR. In ventral prostate
and hypothalamus, smaller immunoreactive bands approximately 45-85 kDa in size
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were visible and are thought to be a cleavage products of AR (figure 9, lanes 1 and
3). All bands were completely competed by excess antigenic AR21 peptide (figure 9,
lanes 6 and 7, ventral prostate and hippocampus shown). Quantification of the
resulting autoradiograph bands would not be meaningful due to potential differences in
degradation or cleavage rates of AR in the tissues studied. Efforts to minimize
degradation through the addition of molybdate, multiple protease inhibitors, and
increased SDS concentrations were unsuccessful in eliminating all of the degradation
products. The extreme labile nature of AR protein, especially in the absense of
ligand, has been reported by others (Kemppainen et al., 1992; Zhou et al., 1995).
Additionally, studies in rat peripheral tissues have detected multiple bands upon AR
immunoblot analysis and these authors cited region-specific degradation as the
probable cause of multiple smaller bands (Shan et al., 1990; Prins et al., 1991). The
addition of excess ligand, as well as the believed relative stability of the steroid
binding region of the AR protein, makes AR binding analysis more suitable for the
measurement of AR concentrations in neural and peripheral tissues.
Quantification of AR mRNA levels in neural tissue using the RNase protection
assay paralleled our findings of AR binding levels. Similar steady state levels of AR
mRNA were found in young male hypothalamus and hippocampus with values of 557

± 56 and 539 ± 54 amol/mg input RNA,

respectively. AR mRNA levels in the

cortex were significantly lower than in both hippocampus and hypothalamus (310 ±
32 amol/mg input RNA, P<0.01).
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Figure 8. Scatchard analysis of specific [3H]DHT binding in rat brain. Cytosolic
preparations were analyzed from the hypothalamus(•), hippocampus (0), and cortex
(•)of young male rats castrated 24 hours prior to sacrifice. Tissues from 6 rats
were pooled to obtain cytosolic preparations. Cytosols were incubated with 0.05
nM - 2 nM [3H]DHT with and without a 200-fold excess of unlabelled Rl881 to
obtain saturation isotherms. Scatchard transformations and dissociation constants (~
were generated by computer using the LIGAND program. A~ value of 0.22 nM
were obtained for all three tissues studied. Reprinted, by permission, from J.E. Kerr,
R.J. Allore, S. G. Beck, R.J. Randa. Distribution and hormonal regulation of
androgen receptor (AR) and AR messenger RNA in the rat hippocampus.
Endocrinology, 136(8):3213-3221, 1995. ~The Endocrine Society.
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Figure 9. Western immunoblot analysis of AR using the PG-21 antisera in
cytosolic preparations from young adult male rat ventral prostate (lanes 1 and 6),
hippocampus (lanes 2 and 7), hypothalamus (lane 3), cortex (lane 4) and pituitary
gland (lane 5). Proteins were separated by SDS-polyacrylamide gel electrophoresis
on a 8 % gen and transferred to polyvinylidene difluoride membrane. Strips were
incubated with PG-21 antisera (l~g/ml) in the absence (lanes 1-5) or presence (lanes 6
and 7) of a 10-fold molar excess of the antigenic peptide AR21 • Bands were
visualized using chemiluminescence. The position of the molecular weight markers
(kDa) are shown on the left. The major immunoreactive band is at - 110-140 kDa.
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Further investigation of AR mRNA in the hippocampus demonstrated that it is
not expressed equally in all cellular regions. The examination of emulsion-coated
tissue sections following in situ hybridization revealed that AR mRNA is
predominately expressed in the CA I pyramidal cell region of the intact male rat
hippocampus. For comparison, AR mRNA was expressed in near equivalent levels in
the ventromedial nucleus and arcuate nucleus of the hypothalamus where AR is known
to play a role in hormonal feedback and sexual behavior (figure 10). The
examination of the hippocampus at high magnification revealed that virtually all CAI
neurons expressed AR mRNA (figure llA). Much lower expression of AR mRNA
was detected in the CA3 region (figure llB) and expression was absent in the DG

(figure llC). The level of exposed silver grains over the CAI pyramidal cells is
comparable to levels found over the cells of the ventromedial nucleus of the
hypothalamus (figure llD).
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Figure 10. Localization of AR mRNA in rat brain using in situ hybridization.
Darkfield photomicrographs (magnification = lOOX) illustrating the distribution of
AR mRNA in the hippocampus (A) and the ventromedial nucleus (VMN)/arcuate
nucleus (Arc) of the hypothalamus (B) in the young male rat. AR mRNA expression
is highest in the CA 1 pyramidal cell region of the hippocampus and comparable levels
are found in the VMN/ Arc. Images were digitized from photographic slides and
composite figures were generated using Adobe Photoshop software. 3V, Third
ventricle. Reprinted, by permission, from J.E. Kerr, R.J. Allore, S.G. Beck, R.J.
Handa. Distribution and hormonal regulation of androgen receptor (AR) and AR
messenger RNA in the rat hippocampus. Endocrinology, 136(8):3213-3221, 1995.
(C) The Endocrine Society.
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Figure 11. Localization of AR mRNA in hippocampal and hypothalamic neurons
of young intact male rats. Digitized brightfield photomicrographs (magnification =
lOOOX) show exposed silver grains over tissue following in situ hybridization of 35Slabelled cRNA probe to AR mRNA. Cresyl violet darkly stains cell nuclei, whereas
perikarya are pale to invisible due to RNase treatment of the tissue during in situ
hybridization. Dense labelling is evident over cells of the CAI region of the
hippocampus (A) and ventromedial nucleus of the hypothalamus (D). Little to no
labelling is found over the CA3 pyramidal cell region (B) and dentate gyrus (C) of the
hippocampus. Reprinted, by permission, from J.E. Kerr, R.J. Allore, S.G. Beck,
R.J. Randa. Distribution and hormonal regulation of androgen receptor (AR) and AR
messenger RNA in the rat hippocampus. Endocrinology, 136(8):3213-3221, 1995.
<0 The Endocrine Society.
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Short Term Regulation of Hippocampal AR

=---

As measured by RNase protection assay, animals castrated 4 days previously
and animals injected for 4 days with the androgen receptor antagonist, flutamide, had
decreased hippocampal AR mRNA concentrations as compared to intact animals
(P<0.02, figure 12). Castration l day prior to death did not alter AR mRNA levels
in the hippocampus as compared to that in intact controls. In contrast, [3H]DHT
binding to hippocampal cytosols was increased in 1- and 4-day castrates compared to
that in control animals castrated 12 h prior to sacrifice (P < 0. 05, figure 13).

Age-Related Changes in Hii:wocampal AR Expression
To determine whether hippocampal AR levels are altered in the old rat with
physiologically relevant reductions in circulating androgen, AR mRNA content as
well as AR binding levels and kinetics were examined in young and old intact male
rats. Using the RNase protection assay, hippocampal AR mRNA concentration was
539

± 54 amol

mRNA/mg input RNA in the young animals as compared to 729

±

46 amol mRNA/mg input RNA in the old rats (figure 14). This represents a 35 %
age-related increase (P<0.05). Age-related differences were not found in the cortex
or hypothalamus (figure 14). In contrast, in vitro binding studies revealed no
significant changes between total cytosolic [3H]DHT binding in the hippocampi of
young and old animals (4.4 7

±

0. 25 and 5 .19

± 0. 3 fmol

bound/mg protein,

respectively; figure 15), and no alterations in AR binding affinity (Kd = 0.24 and
0.26 nM, respectively; data not shown) were detected.
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Figure 12. Hippocampal AR mRNA regulation. Effect of castration and AR
blockade on the concentration of AR mRNA in the hippocampus of young male
Fischer 344 rats. Animals were left intact, bilaterally gonadectomized for 4 days (4
day GDX), or injected daily with the AR antagonist, flutamide (15mg/day), for 4 days
(4 day Flutamide). One-way ANOVA revealed a significant effect of treatment
(F=8.0, df =2; P < 0.004). *Indicates significantly different (P < 0.01) from intact
value, as determined by post-hoc analysis. Data are expressed as attomoles of
protected probe (cAR mRNA) per mg input RNA. Each bar represents the mean +
SEM of 6-7 determinants. Reprinted, by permission, from J.E. Kerr, R.J. Allore,
S.G. Beck, R.J. Handa. Distribution and hormonal regulation of androgen receptor
(AR) and AR messenger RNA in the rat hippocampus. Endocrinology, 136(8):32133221, 1995. ©The Endocrine Society.
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Figure 13. [3H]DHT binding to cytosolic preparations of the hippocampus from
young male Fischer 344 rats killed 12 hours (12 h GDX), 1 day (1 day GDX), or
4 days (4 day GDX) after castration. One-way analysis of variance revealed a
significant effect of treatment (F =6.5, df =2; P < 0.01). *, Significantly different
(P < 0.05) from 12 hour castrates, as determined by post-hoc analysis. Each bar
represents the mean ± SEM of 8 determinants. Reprinted, by permission, from J.E.
Kerr, R.J. Allore, S.G. Beck, R.J. Handa. Distribution and hormonal regulation of
androgen receptor (AR) and AR messenger RNA in the rat hippocampus.
Endocrinology, 136(8):3213-3221, 1995. «:)The Endocrine Society.
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98

-

5

c

"(j)
+"'
0
:i...

4

Cl.
0)

E

::::::::
0

E

..._

3

0)

c

-0

c

co 2

~

I
0I
I

Cf)

1

0

Young
Old
Hippocamp us
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Endocrinology, 136(8):3213-3221, 1995. ci The Endocrine Society.
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Discussion

In these studies a multidisciplinary approach was used to characterize and
quantify AR in the rat hippocampus. The presence of high levels of AR and AR
mRNA in the hippocampus was demonstrated by RNase protection assay, in situ
hybridization, western immunoblot and in vitro binding analysis suggesting that this
area is a major neural target for androgen.
The significance of the finding that the majority of AR mRNA is found in the
hippocampal CAl region is unclear. However, as these neurons complete the
unidirectional trisynaptic circuit and provide the major output for the hippocampal
formation to other cortical and limbic structures (Van Groen and Wyss, 1990), the
high density of AR mRNA in practically every cell in this region suggests a role for
androgens in the modulation of hippocampal output. Recent electrophysiologic and
binding studies have found androgen-mediated changes in NMDA sensitivity (Pouliot

et al., 1995) and NMDA receptor number (Kus et al., 1995) in hippocampal CAl
pyramidal cells. This modulation of NMDA receptors may be one mechanism by
which androgens could phenotypicall y alter the response of hippocampal CA 1 neurons
to incoming signals.
The distribution of AR mRNA overlaps the distribution of ER, GR and MR
mRNA in the hippocampus, in that all mRNAs are found in the CAl region (Simerly

et al., 1990; Van Eekelen et al., 1988). Consequently, AR may synergize with these
receptors in regulating hippocampal functions known to be sensitive to adrenal
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hormones (see review, de Kloet et al., 1993a) or estrogen (see review, Becker,
1992). Consistent with this notion, androgen has been shown to inhibit ACTH and
corticosterone responses to stress in a fashion similar to corticosterone (Randa et al.,
1994a).
Western immunoblot analysis was performed to further characterize AR in
central tissues. The specific AR signal observed at approximately 110-140 kDa in rat
central tissues, as well as in the rat VP, corresponds well to the known mol wt of the
rat AR. This mol wt parallels the findings of other published AR western
immunoblots of protein samples obtained from a variety of species or cell lines,
various peripheral tissues and using a multitude of antibodies (Zhou et al., 1994b;
Young et al., 1988; Prins et al., 1991; Wolf et al., 1993). This single band in rat
brain cytosols confirms previous studies (Barley et al. , 1975; Roselli, 1991)
suggesting a single AR despite the presence of two AR mRNA forms in neural
tissues. We believe that the smaller bands ranging from 45-85 kDa that were
observed in ventral prostate and hypothalamus are degradation or cleavage products of
the intact AR protein for two reasons. First, all the bands were completely competed
by excess antigenic AR21 peptide suggesting that these are AR protein fragments and
are not the result of non-specific antibody binding. Secondly, when the prepared
protein samples were left for any length of time, or frozen prior to electrophoresis we
observed a greater proportion of the lower molecular weight bands and a dramatic
decrease of the large 110-140 kDa band. Other studies in rat peripheral tissues have
also detected these degradation products (Zhou et al., 1994b; Prins et al., 1991).
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our finding that AR mRNA levels in the hippocampus were decreased after 4
days of castration or AR antagonism is unusual. Most previous studies examining AR
mRNA regulation in brain (Quarmby et al., 1990; Burgess and Handa, 1993a) and
peripheral tissues (Tan et al., 1988; Quarmby et al., 1990; Takane et al., 1990; Blok

et al., 1991, 1992a) have found that steady state AR mRNA levels increase following
castration; however, discrepancies do exist (McLachlan et al., 1991; GonzcilezCadavid et al., 1993; Abdelgadir et al., 1993). Earlier studies revealed an increase
in AR mRNA in the medial preoptic area of the hypothalamus shortly after castration,
but AR mRNA levels were significantly decreased in the same area in rats castrated 8
weeks prior to sacrifice (Handa et al., 1993b). Burgess and Randa (1993a) reported
apparent increases in hippocampal AR mRNA expression, as measured by Northern
blot analysis, in rats castrated for 7 weeks before death. This latter study, along with
our present findings, suggest a unique biphasic regulatory pattern of AR mRNA that
appears to be both time- and tissue-specific. Unfortunately, the measurement of
steady state levels of AR mRNA gives us little information as to where AR may
confer its transcriptional control. Evidence for steroid receptor modulation at
transcriptional (King, 1992) and post-transcriptional (Nielsen and Shapiro, 1990)
stages have been reported, and changes in AR mRNA synthesis as well as changes in
mRNA stability or turnover in response to androgen removal could account for our
results.
The fact that changes in AR binding do not parallel changes in AR mRNA
levels can be interpreted in several ways. First, due to the nature of the cytosolic in
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vitro binding assay, and the necessity to castrate the control animals 12 h prior to
sacrifice, it is possible that this time frame was not sufficient enough to allow for
previously bound AR to cycle out of the nucleus and be measured in the cytosolic
fraction. This would result in a false low control level and would not compare
correctly to the AR binding levels in the 1- and 4-day castrates. Although no detailed
studies of the rate of AR recycling following androgen removal have been done in
hippocampus, the studies of Krey and McGinnis (1990) in rat hypothalamus suggest
that the time it takes for AR to cycle out of the nucleus following T removal is
relatively rapid (within 4 h) and renders this explanation for our results unlikely.
Alternatively, androgen removal may enhance hippocampal AR protein stability to
alter androgen sensitivity during fluctuations in circulating hormone. A rapid increase
in AR stability 1 day after androgen removal may trigger the down-regulation of AR
mRNA that we observed after 4 days of hormonal depletion. Although this
mechanism could be occurring locally within the hippocampal neurons, recent
evidence points to the enhanced stability of AR by ligand (Kemppainen et al., 1992;
Zhou et al., 1995).
Discrepancies between steroid hormone receptor mRNA and protein levels
following hormone manipulations have been shown in human breast and prostate
tumor cell lines (Krongrad et al., 1991; Wolf et al., 1993). These studies suggest
that neither the measurement of steady state mRNA, nor protein levels alone, can
adequately determine hormonal sensitivity. ln the hippocampus, where AR expression
is predominantly found in the CA 1 pyramidal cell region, it may be necessary to
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measure AR and AR mRNA changes with much greater anatomical acuity using
immunocytochemical and in situ hybridization analysis rather than from extracts of
whole hippocampal homogenates. The possibility of differential regulation of AR in
individual pyramidal cell regions exists. Furthermore, the finding that both the
neural-specific 9.3-kb AR mRNA and the more widely distributed 11-kb AR mRNA
are expressed in approximately equal amounts in the hippocampus (McLachlan et al.,
1991; Burgess and Handa, 1993a) allows for the possible differential regulation of
these forms following hormonal manipulations. A recent study describing the
differential regulation of three variants of the MR mRNA within the hippocampus
after ADX (Kwak et al., 1993) supports this possibility. Presently, methods to
accurately quantitate and localize AR mRNA forms independently have not been
developed, and the use of northern blot hybridization to detect subtle changes in AR
mRNA levels in brain tissue, where expression is relatively low, is difficult.
Complete sequence analysis of the 9. 3-kb transcript, and the generation of probes
directed at detecting this form, would prove useful to elucidate hippocampal AR
regulatory mechanisms.
The physiologic significance of the relatively small changes ( - 35 %) in
hippocampal AR and AR mRNA levels following short-term castration remains to be
elucidated. The changes in AR expression that were observed do not parallel the
reported 2- to 10-fold induction of AR mRNA in rat whole brain and peripheral
tissues following similar treatment (Quarmby et al., 1990). However, these reported
increases are based entirely on film density and do not accurately represent molar
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amounts as does the RNase protection assay. Additionally, few studies have
quantitatively investigated AR and AR mRNA regulatory mechanisms in discrete
brain nuclei that contain relatively low levels of AR as compared to the accessory
sexual organs. In brain areas such as the hippocampus where moment-to-moment
fine-tuning of hormonal feedback may be necessary, small and rapid changes in AR
expression could have great functional significance.
To further investigate the regulatory actions of AR, we used old intact male
rats as a physiologically relevant model of long term deficits in circulating androgen.
The upregulation of hippocampal AR mRNA levels in intact old rats compared to
their young counterparts was an intriguing finding; however, subsequent changes in
AR binding were not detected. Serum T levels in old male Fischer 344 rats are less
than half that in young rats (Chambers et al., 1991; Gruenewald el al., 1992). This
deficit alone could have triggered the autologous up-regulation of AR mRNA that was
observed. Other hormonal changes in aging rats, including increased serum CORT
(Landfield et al., 1978), progesterone, and estrogen (Gruenewald et al., 1992), have
been reported and may be responsible for altered AR mRNA levels in the old
hippocampus. Alternatively, low levels of aromatase, the enzyme responsible for the
intracellular conversion of T to estrogen, have been found in the rat hippocampus
(Abdelgadir et al., 1994). Age-related decreases in aromatase activity have been
shown in the preoptic area of the male rat (Chambers et al., 1991). Although yet
unexplored, alterations in hippocampal aromatase activity leading to changes in the
availability of T to bind to AR, could contribute to altered AR autoregulation and our
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observed increases in AR mRNA. Unfortunately, at present, little is known about the
interactions between the steroid receptors and aromatase activity in hippocampal
neurons.
Despite AR mRNA increases, it appears that AR remains constant in the
hippocampus during long-term deficits in circulating androgen, and that androgen
sensitivity is maintained in this region. These data differ from those of previous
studies that have shown dramatic losses of hippocampal GR and GR mRNA as well as
MR and MR mRNA expression in the aged male rat (McEwen, 1992). These GR and
MR losses appear to be related to cell death and occur mainly in the CA3 pyramidal
cell region (Sapolsky et al., 1990). It is possible that the age-related maintenance of
AR content that was observed may be related to the sparing of CAl neurons. This
sparing of CAl neurons with the concomitant age-related loss of other hippocampal
cells could explain the increases were observed in AR mRNA concentrations, because
data from the RNase protection assay are expressed as AR mRNA per µg of total
hippocampal RNA. Without the use of individual cell counts and techniques with
greater cellular resolution, it is premature to speculate as to whether androgens have a
protective role in the hippocampus with aging. Unfortunately, the extreme density of
CAI neurons in the rat hippocampus makes individual cell counting virtually
impossible in this region. Additionally, the use of thinner slices to try to overcome
the density problem would likely push AR mRNA levels too low to be detected
reliably with in situ hybridization. Regardless, studies using other models have
implicated androgens as important modulators of axon regeneration following injury
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(Jones, 1993) or of hippocampal neuron survival after stress (Mizogushi et al., 1992).
The maintenance of hippocampal AR, and perhaps androgen sensitivity, may prove to
be beneficial in maintaining cognitive ability during the aging process.
In summary, these studies have demonstrated high levels of functional AR in
the hippocampus and argue strongly for a direct transcriptional effect of androgens in
hippocampally mediated behaviors. Consequently, changes in the levels of AR in this
area due to hormonal manipulation or normal aging would have a profound influence
on the expression of these behaviors. The regulation of AR expression in the
hippocampus did not appear to follow the well described regulatory pattern of other
steroid hormone receptors either after short term hormone removal or during the
aging process. These studies point to the importance of maintaining AR numbers
regardless of hormone status and suggest a reliance on the action of androgen in the
hippocampus throughout life.

CHAPTER IV
ANDROGENS MODULATE GLUCOCORTICOID RECEPTOR mRNA, BUT NOT
MINERALOCORTICOID RECEPTOR mRNA LEVELS,
IN THE RAT HIPPOCAMPUS

Abstract

AR, MR and GR are ligand-activated transcription factors that alter gene
expression and have a wide variety of effects in the CNS. High levels of AR, MR
and GR mRNA have been found in the CA 1 pyramidal cell region of the rat
hippocampus and all three of these proteins bind to a similar HRE in DNA suggesting
the possibility of common receptor function or cross-talk between these receptors at
the level of transcription. To begin to investigate this hypothesis, we examined the
regulation of AR, MR and GR mRNA expression in the rat hippocampus following
treatment with androgens in combination with GDX andJor ADX. Three month old
male Sprague-Dawley rats were either castrated for three weeks, castrated and
immediately implanted with two Silastic capsules filled with the non-aromatizable
androgen, DHTP, or left gonadally intact. Four days prior to sacrifice, these animals
were either adrenalectomized or sham operated. GR, MR and AR mRNA were
measured in the hippocampal subfields using in situ hybridization. In the CAl
region, DHTP treatment of castrates decreased GR mRNA levels to 69 percent of
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levels found in gonadally intact rats and prevented the ADX-induced increases in GR
mRNA observed in the gonadally intact and castrated animals. No changes in GR
mRNA were observed in the CA3 region or DG, where AR expression is low or
absent. There was no effect of androgen treatment on MR mRNA levels nor did
GDX or androgen replacement alter the increases in MR mRNA following ADX. AR
mRNA levels in the CA 1 region were unchanged across all treatment groups. In vitro
binding studies revealed almost complete nuclear occupancy of hippocampal AR in
DHTP-treated castrates. No appreciable in vitro binding of DHT to hippocampal MR
or GR

(~

= 1500 nM) was observed which suggests that androgen regulation of GR

mRNA in the hippocampus is occurring through AR binding. These data demonstrate
a functional similarity of androgens and glucocorticoids in the regulation of GR
mRNA levels in an area where AR and GR are colocalized. Androgen-mediated
downregulation of GR expression may prove to be an important event in the adaptive
responses of CA 1 pyramidal cells to hormonal stimuli.

Introduction

Adrenal corticosteroids and gonadally-derived androgenic steroids have
profound effects on stress responses, memory, mood and hormonal homeostasis (Roof
and Havens, 1992; De Kloet et al., 1993a; Dubrovski et al., 1993; Randa et al.,
1994b). These hormones exert their effects by specifically binding to intracellular
receptors, which, following transformation and interaction with HREs of target genes,
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either activate or repress transcription (Beato, 1989). The receptors for these
hormones have been mapped throughout the mammalian CNS. Two types of
corticosteroid receptors have been identified based on affinity and distribution (Reul
and De Kloet, 1985). The type I or MR is characterized by its high affinity for
CORT and is selectively localized in the hippocampal formation and other limbic
regions (Beaumont and Fanestil, 1983). The type II receptor, or GR, has a ten-fold
lower affinity for corticosteroid, but is present in nearly all tissues (Veldhuis et al.,
1982). A single form of AR has been reported in neural tissues including the
hypothalamus, cortex, amygdala and hippocampus (Sar and Stumpf, 1977; Kerr et al.,
1995a).
Although GR, MR and AR are all expressed in the hippocampus, each shows a
unique pattern in relative density across hippocampal subfields (Reul and De Kloet,
1985; Kerr et al., 1995a). Particularly high levels of GR, MR and AR mRNA and
protein have been found in the CAl pyramidal cell region (Van Eekelen et al., 1988;
Kerr et al. , 1995a). These neurons complete the hippocampal trisynaptic circuit and
form the major efferents to cortical and limbic areas of the brain (Van Groen and
Wyss, 1990). The overlapping expression of these three receptors in the CAI area is
interesting because all three presumably bind and activate the same HRE (Chandler et
al., 1983; Beato, 1989). This suggests the possibility of common receptor functions

within cells or cross-talk at the transcriptional level.
Regarding the functional aspects of hippocampal MR, GR, and AR, numerous
studies point to an involvement of MR and GR in glucocorticoid feedback inhibition
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of the HPA axis (Ratka et al., 1989; Jacobson and Sapolsky, 1991). Presently, little
is known about the functional role of AR in the hippocampus; however, androgens
have also been shown to inhibit HPA axis function (Handa et al., 1994a) and to
modulate several hippocampal-mediated behaviors including emotionality (Hubert,
1990), memory formation (Roof and Havens, 1992) and the response to novelty (see
Chapter V and Kerr et al., 1995c).
In many rat tissues, levels of AR, GR and MR are autologously regulated by
their respective ligand. For example, depletion of endogenous glucocorticoids by
ADX elicits an increase in GR and MR (Herman, 1993); whereas prolonged elevation
of circulating glucocorticoids, such as following chronic stress, results in
downregulation of brain corticosteroid receptors (Sapolsky et al., 1984). Similarly, in
peripheral tissues and whole brain, AR expression is increased following GDX and
these increases are reversed by androgen treatment (Quarmby et al., 1990; Blok et

al., 1992a). However, exceptions to these rules have been reported (Sheppard et al.,
1990; Peiffer et al. , 1991; Abdelgadir et al., 1993; Herman, 1993; Kerr et al. ,
1995a) and it appears that the regulation of AR, GR and MR expression differs
depending on the tissue, as well as length of time following treatment and mode of
steroid administration. Several studies have demonstrated heterologous regulation of
brain GR levels by other hormones including insulin (Tornello et al., 1982),
vasopressin (Veldhuis and De Kloet, 1982a), ACTH (Veldhuis and De Kloet, 1982b),
thyroid hormone (Meaney et al., 1987) and estrogen (Ferrini and DeNicola, 1991;
Burgess and Randa, 1993b) which suggest that many factors may ultimately determine
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steroid receptor levels in a given tissue. Compelling evidence for the involvement of
hippocampal adrenal steroid receptors in the treatment of affective disorders (Seckl
and Fink, 1992), hippocampal cell death (Sapolsky et al., 1988) and altered regulation
of the HPA axis (De Kloet et al. , 1991) renders mechanisms that modulate
hippocampal MR and GR concentrations of great clinical relevance.
Recently, studies have demonstrated sex differences in hippocampal 3H-CORT
binding (Turner and Weaver, 1985) and GR mRN A concentrations (Bohn et al.,
1994), as well as androgen-mediated changes in nuclear GR immunoreactivity in
selected regions of the rat hippocampus (Ahima and Harlan, 1992). Collectively,
these data suggest that androgen status may influence adrenocorticoid receptor
expression in the hippocampus. To examine this possibility, we tested the hypothesis
that androgen treatment could alter GR or MR mRNA levels in a fashion similar to
previously described autoregulatory mechanisms. This was accomplished using in situ
hybridization histochemistry to quantitate steroid hormone receptor mRNA levels in
each hippocampal subfield under conditions of selective or combined occupation of
AR, GR and MR. This methodology circumvents the pitfalls of in vitro radioligand
binding studies which require prior ADX or GDX to clear steroids from already
occupied binding sites. These studies also begin to explore possible mechanisms
mediating cross-talk between steroid hormone receptors coexpressed in the
hippocampus.

112

Materials and Methods

Animals
Three month old male Sprague-Dawley rats (Charles River, Inc., Portage, MI)
were housed in environmentally controlled quarters and maintained on a 12: 12 h light
dark schedule (lights on at 0700 h) with food and water available ad libitum.
Bilateral GDX and ADX, or sham ADX, were performed under ether anesthesia. At
the time of GDX, some rats received hormone replacement by the subcutaneous
implantation of two Silastic capsules (2.5 cm long, 0.07" i.d., 0.125" o.d.) filled with
the non-aromatizable androgen, DHTP, (Steraloids, Inc., Wilton, NH). Previous
studies in our laboratory have shown that these capsules provide a constant level of
circulating DHT that is 2-5 fold higher than DHT levels found in intact male rats
(Pouliot et al., 1995), but is similar to total circulating androgen levels (Bingamen et

al., 1994). Following ADX, rats maintained with 0.9% NaCl in their drinking water.
All rats were sacrificed by decapitation between 09:00 and 11:00 h.

Experimental Procedures
In the first series of experiments, we examined the effects of androgen
removal or replacement on the steady-state levels of hippocampal GR, MR and AR
mRNAs in ADX and sham ADX male rats. Androgen treatments (intact, GDX, and
GDX

+

DHTP) lasted for three weeks, and each rat was either ADX or sham

operated in the morning four days prior to sacrifice. At the time of sacrifice, trunk
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blood was collected and brains were rapidly removed from the skull, frozen in prechilled isopentane (-30°C), and stored at -70°C until sectioned and processed for in

situ hybridization. Brains were sectioned in the coronal plane and three series of
brain sections from the same animals were used for determining GR, MR and AR
mRNA. Serum CORT was measured using radioimmunoassay (RIA) as previously
described (Burgess and Handa, 1992). The completeness of the ADX procedure was
determined by the absence of CORT and any presumably ADX animal that showed
detectable levels of serum CORT were removed from the study.
To evaluate the levels of circulating androgen reaching the hippocampus in the
intact, GDX and GDX

+ DHTP groups, we determined the level of hippocampal AR

occupancy obtained following these androgen treatments. Animals were left intact,
GDX or GDX and implanted with two Silastic capsules of DHTP at the time of
surgery as described earlier. Rats were sacrificed three weeks after the onset of
treatment and their brains were rapidly removed and placed on ice. The hippocampus
was dissected out of each brain and homogenized for in vitro binding analysis with
3

H-DHT. Anterior pituitary glands from selected animals were also taken for binding

analysis because this tissue contains a very high concentration of AR and thus served
as an inter-assay control.
To assess the selectivity of binding in hippocampal cytosols, we examined the
ability of DHT, CORT, RU 28362 (a GR specific agonist), and dexamethasone to
compete for 3H-dexamethasone labelled MR and GR sites (Burgess and Handa, 1992)
in hippocampal cytosolic fractions using an in vitro binding assay. Rats were ADX'd
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24 h prior to sacrifice to allow for glucocorticoids to clear from the circulation and
leave MR and GR binding sites unoccupied. Following sacrifice, whole hippocampi
were dissected out of the brain, homogenized and cytosolic extracts were purified for

in vitro competition binding analysis.

Jn Situ Hybridization
For the in situ hybridization procedure, antisense 35 S-labelled riboprobes were
used to detect GR, MR and AR mRNA. The GR and MR riboprobes were reverse
transcribed as previously outlined by Burgess and Handa (1993b) using 35S-UTP as
the radioactive nucleotide (800 Ci/mmol, Amersham, Arlington Heights, IL).
Briefly, the original rat GR cDNA construct (Meisfield et al., 1986) was kindly
provided by Dr. K. Yamamoto, UC San Francisco. A 1072 basepair fragment,
corresponding to the ligand-binding domain and beginning of the 3' untranslated
region, was subcloned into a pGEM 3Z plasmid vector. Following linearization with
Dra I and reverse transcription with T7 RNA polymerase, a 262 basepair GR
riboprobe was generated. A rat MR cDNA pGEM 4Z construct corresponding to
nucleotides 2809-3321 (Arriza et al., 1987) was kindly provided by Dr. R Evans,
Salk Institute. This construct generated a 196 basepair riboprobe complementary to
the ligand-binding domain and beginning of the 3' untranslated region of the rat MR
mRNA following linearization (Stu I) and reverse transcription with SP6 RNA
polymerase. A 141 basepair long in vitro transcribed AR cRNA complementary to
the 5' translated region (nucleotides 963-1104) of the rat AR mRNA (Tan et al.,

115

1988) was generated as previously described (Kerr et al., 1995a). All cRNA probes
had specific activities averaging 109 cpm/ug. Aliquots of all probes were analyzed on
denaturing 5% acrylamide, 7.5 M urea gels to confirm their integrity. Only those
probes > 90% full length were used for in situ hybridization.
The in situ hybridization procedure used in the present study was based on the
method described by Handa et al. (1993) with slight modifications. Briefly, coronal
brain sections (16 µm) were made with a Leitz 1600 cyrostat, mounted onto
superfrost plus slides (Fisher Scientific, Pittsburgh, PA), and stored at -7CfC until
use. The sections were brought to room temperature, pretreated in 4 % buffered
formaldehyde, acetylated in acetic anhydride (0.25 % in triethylamine), dehydrated in
ethanols, and delipidated in chloroform. Slides were air dried. For hybridization, the
probe was heated to 65°C for 5 min and diluted in hybridization buffer containing
50% formamide, 20% dextran sulfate, 1.2 M NaCl, 20 mM Tris, 0.04% Denhart's, 2
mM ethylenediaminetetraacetic acid (EDTA), 0.02 % salmon sperm DNA, 0.1 % yeast
RNA, 0.01 % yeast tRNA, 0.1 % sodium thiosulfate, 100 mM dithiothreitol (DTT),
0.1 % sodium dodecyl sulfate (SDS) to a final concentration of 20 x Ht cpm/ml.
Approximately 85 µl of the hybridization buffer was applied to each slide and
coverslipped. Hybridization was carried out in a 65°C humidified incubator for 16-20
h. Following hybridization, the coverslips were removed and the sections were
repeatedly rinsed in 2 x SSC then subjected to RNase A treatment (20 µg/ml at 37°C
for 30 min) to digest any nonhybridized RNA. The sections were washed to a final
stringency of 0.1 x SSC at 65°C and dehydrated in increasing concentrations of
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ethanol. Autoradiographs were obtained by exposing slides to x-ray film (Hyperfilm
{3-max, Amersham, Arlington Heights, IL) for 9 days (MR mRNA and GR mRNA)

or 21 days (AR mRNA). After film exposure, slides were dipped in nuclear tract
emulsion (Kodak NTB-3, Eastman Kodak, Rochester, NY) and exposed for 21-35
days before development and cresyl violet staining. Sections were examined under
darkfield illumination using a Zeiss Axioplan microscope (Zeiss, New York, NY).

Image Analysis
Quantification of steady-state levels of mRNAs coding for GR, MR and AR
was accomplished by digitizing autoradiographic images with the Macintosh-based
software NIH IMAGE v.1.54. Optical densities were converted into dpm/mg protein
by a third order polynomial equation based on 35S standards co-expressed on each
film. This method has been described in more detail by Brady et al. (1992).
Hybridization density in cell body regions of the dorsal hippocampus were
obtained by individually tracing the upper blade of the DG granule cell layer, as well
as the entire CA 1, CA2 and CA3 pyramidal cell layers defined in accordance with the
stereotaxic atlas of Paxinos and Watson (1982). Both the left and right hemispheres
were measured. A background sample from the molecular layer of the hippocampus
was subtracted from each measurement. Measurements from four sections from each
animal were averaged to obtain a final density value for each hippocampal subfield.
The large scale of these experiments necessitated the use of multiple film
autoradiographs for the MR and GR probes. To minimize error between film
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autoradiographs, hybridization density values were transformed to the percent of the
mean obtained from the gonadally-intact, sham ADX rat sections included on each
film. Percent data were then grouped and subjected to statistical analysis. For AR
mRNA in situ hybridization, the sections were processed together using the same
probe and a single film. Therefore, these data were expressed as dpm/mg protein.

Jn vitro Androgen Receptor Binding Assay
Cytosolic (ARc) and nuclear (ARn) AR were measured using modifications of
previously described methods (Randa et al., 1986). All procedures were carried out
at 0-4°C. Hippocampi and pituitaries were placed into chilled Dounce tissue grinders
(Wheaton Scientific, Millville, NJ) and homogenized in 500 µl (hippocampus) or 200
µl (pituitary) TEGMD buffer (10 mM Tris, 1.5 mM EDTA, 10% glycerol, 25 mM

molybdate, 1 mM DTI, pH 7.4). The homogenates were transferred with an
additional 200 µl wash to ultracentrifuge tubes and centrifuged at 1500 x g for 15
min. The purified cytosols were prepared from the resultant supernatants by
recentrifugation at 100,000 x g for 30 min. The high speed supernatant was saved to
measure ARc levels and 10 µl was used to determine protein content by the method of
Lowry et al. (1951).
The crude nuclear pellets obtained from the first low speed spin were further
purified by resuspending the pellets in 400 µ1 of Low sucrose buffer (Buffer A, 1 mM
KH 2P04 , 0.32 M sucrose, 3 mM MgCli, I mM DTT, 10% glycerol) containing
0.25% triton x-100 and then were centrifuged at 1500 x g for 15 min to separate.
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The supernatant was discarded and the pellet was washed with 400 µ1 Buffer A
(without triton x-100) and centrifuged (1500 x g, 15 min). The supernatant was
discarded and 400 µl of high sucrose buffer (Buffer B, 1 mM KH2P04 , 2.1 M
sucrose, 3 mM MgC12 , 1 mM DTT, 10% glycerol) was added. The tubes were
vortexed and centrifuged at 50,000 x g for 30 min to obtain a purified nuclear pellet.
ARn complexes were salt extracted from each nuclear pellet by adding 250 µ1 TEBD
buffer (10 mM Tris, 1.5 mM EDTA, 0.5 mM bacitracin, 1 mM DTT, pH 7.4) and 5
min later adding an equal volume of TEBDK (TEBD containing 1.6 M KCl). Tubes
were vortexed repeatedly for an additional 25 min and the suspension was again
centrifuged (37 ,000 x g for 15 min) to separate the nuclear extract (supernatant) from
DNA material (pellet). DNA content in each pellet was measured using a modified
version of the method of Burton (1956). Single point receptor measurements were
made using 5a-( 1, 2,4,5, 6, 7-N-3H)androstan-17,B-ol-3-one (3H-DHT, 110-150
Ci/mmol; New England Nuclear Research Products, Boston, MA) as the specific AR
ligand. The 3H-DHT was stored in 100% ethanol and was purified by thin layer
chromatography to assure low levels of non-specific binding.
Total binding was measured using 100 µ.l aliquots of the cytosolic and nuclear
extracts that were incubated with 2 nM and 5 nM 1H-DHT, respectively. To
determine non-specific binding, 1 µM (200-500 fold excess) of radioinert Rl881 (an
AR specific agonist) was incubated in parallel tubes with 1H-DHT and cytosols.
Cytosolic and nuclear samples were incubated at 4°C for 24 h and 48 h, respectively.
To separate bound from free ligand, samples were passed through miniature Sephadex
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LH-20 columns using 600 µl of the appropriate buffer. Four ml of Ultima Gold
scintillation fluid (Packard Inc., Downers Grove, IL) was added to each eluate and
the radioactivity was counted for 5 min in a Packard 1900 LA liquid scintillation
counter (Packard Instruments, Downers Grove, IL) at approximately 37% efficiency.
Specific binding was determined by subtracting non-specific from total binding.
Receptor data were expressed as femtomoles (fmol) per mg protein (ARc) or per mg
DNA (ARn).

In vitro Competition Binding Assay
To determine whether DHT binds to MR or GR in the hippocampus, we
examined the binding of [l,2,4,6,7-3H]Dexamethasone (3H-Dex, 92 Ci/mmol,
Amersham, Arlington Heights, IL) to hippocampal cytosols in competition with
increasing concentrations of radioinert 5a-DHT (0.1 - 10,000 nM, Steraloids, Inc.,
Wilton, NH). Specificity of 3H-Dex binding was determined by competition of 3HDex with increasing concentrations (0. l - 10 nM) of radioinert CORT (Steraloids,
Inc.), RU 28362 (Roussel-UCLAF, Romainville, France), and dexamethasone
(Sigma, St. Louis, MO). Hippocampal cytosolic fractions from ADX male rats were
prepared as described above and were pooled together. Purified cytosol (100 µl) was
incubated with 2 nM 3H-Dex with or without competitor at 4<>c overnight. Bound and
free ligand were separated by Sephadex LH-20 column chromatography and
radioactivity counted as described for the ARc assay. Data were converted to percent
of total 3H-Dex binding.
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fil_atistics
Data from in situ hybridization histochemistry were analyzed using a two-way
analysis of variance (ANOV A) with androgen treatment (intact, GDX, GDX

+

DHTP) and corticosteroid treatment (ADX, sham ADX) as main factors. Subsequent
analyses used a one-way ANOVA across treatment groups followed by Student
Newman-Keuls' post-hoc tests. AP value less than 0.05 was considered significant.

Results

GR. MR and AR mRNA Regulation in the Hippocamgus
As shown in figure 16, in situ hybridization analysis demonstrated unique
patterns of MR, GR and AR mRNA expression in the hippocampus of control rats
(gonad and adrenal intact). Consistent with several earlier studies (Van Eekelen et

al., 1988; Herman et al., 1989; Seckl and Fink, 1991), high levels of GR mRNA
were found in the CAl and DG cell body regions of the hippocampus and expression
was somewhat lower in the CA2 and CA3 pyramidal cell regions. MR mRNA levels
were high in all regions with particularly dense hybridization in CA2 pyramidal cells.
AR mRNA was also uniquely distributed across hippocampal subfields with high
levels present in the CAl area, lower levels in CA2/CA3 cells and little to no
expression in DG granule cells.
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GR

MR

AR

Figure 16. In situ hybridization autoradiographic films demonstrating the
distribution of GR mRNA (A), MR mRNA (B) and AR mRNA (C) in the male
rat hippocampus. Overlapping expression of AR, GR and MR mRNA is evident in
the CA 1 pyramidal cell region. CA 1 = CA 1 pyramidal cell region, CA3 = CA3
pyramidal cell region, DG = dentate gyrus granule cell region.
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Quantitative densitometric analysis of film autoradiographs revealed region and
treatment specific regulation of hippocampal GR mRNA. The large scale of the MR
and GR mRNA experiments required the use of multiple film autoradiograms and
riboprobes which can generate variability between films and from study to study.
Therefore, it was necessary to transform the mean dpmfmg protein values from each
animal to percent of the intact

+ sham ADX mean from each film

autoradiogram.

As shown in figure 17A, ADX treatment upregulated GR mRNA levels in the CAI
region an average of 33% as compared to the sham operated control. In the CAl
region, DHTP treatment of castrates significantly decreased GR mRNA to 69 percent
of levels found in gonadally intact rats (P < 0.01) and prevented the ADX-induced
increases in GR mRNA observed in the gonadally intact and castrated animals (P <
0.01). In the CA2 and CA3 subfields where GR mRNA levels were considerably
lower, ADX increased GR mRNA expression as compared to sham operated controls
(P < 0.01), however androgen treatment had no effect (data not shown). In contrast,
GR mRNA levels in the DG were unaltered by androgen status or ADX (figure 17B).
MR mRNA levels in ADX animals were significantly increased above sham
operated control values in the CAI, CA2 and CA3 pyramidal cell regions, however,
androgen treatment or GDX failed to modulate MR mRNA expression (figure 18A,
CAl region data shown). Similar to GR mRNA, MR mRNA levels in the DG were
unchanged by ADX or androgen treatments (figure 188).
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Figure 17. Effects of three week castration (GDX) or dihydrotestosterone
propionate treatment of castrates (GDX + DHTP) on GR mRNA levels in the
hippocampal CAl and DG cell regions of sham operated (SHAM ADX) or
adrenalectomized (ADX) male rats. *, Significantly different from intact + sham

ADX value, @, significantly greater than DHT + sham ADX value, and#,
significantly different from intact + ADX value as determined by Newman-Keuls'
post-hoc analysis (P < 0.01). In situ hybridization densities are expressed as percent
of intact + sham ADX mean from individual film autoradiograms (100%, black line).
Each bar represents the mean ± SEM of 3-5 animals.
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Figure 18. Effects of three week castration (GDX) and dihydrotestosterone
propionate treatment of castrates (GDX + DHTP) on hippocampal MR mRNA
levels in sham operated (SHAM ADX) and male rats adrenalectomized four days
prior to sacrifice (ADX). (A) Hippocampal CAI pyramidal cell region. (B) Dentate
gyrus granule cell region (DG). Density values are expressed as percent of the intact
+ sham ADX control mean obtained from the corresponding in situ hybridization
autoradiogram. Each bar represents the mean ± SEM from 3-5 rats. *, Denotes
significantly different from corresponding sham ADX value (P < 0.05). Androgen
treatment had no effect on MR mRNA levels.

125

AR mRNA levels were also examined in hippocampal sections from the same
animals. These sections were all processed together using one AR ribopobe and were
developed on a single film autoradiogram. Therefore, the dpm/mg protein
hybridization density means from each hippocampal subfield in each animal could be
directly compared and statistically analyzed. In the CAl region which contains the
highest concentration of AR mRNA of all the hippocampal subfields, steady state AR
mRNA levels were not altered by 3 week androgen removal or replacement either
alone or in combination with ADX 4 days prior to sacrifice (Figure 19). AR mRNA
levels also remained constant in the CA2, CA3 and DG regions (data not shown).

Differential AR Occupancy by GDX and DHT Treatment
To confirm that the androgen treatments used in this study were sufficient to
occupy AR in the hippocampus, we examined ARc (cytosolic, unbound form) and
ARn (nuclear, bound form) concentrations in purified extracts from the hippocampus
and of intact, GDX and GDX

+

DHTP treated rats (figure 20). Three weeks after

GDX there were significantly higher ARc Levels as compared to intact controls.
Concomitant decreases in ARn following GDX did not reach statistical significance.
In contrast, the administration of DHTP to castrates resulted in the dramatic
accumulation of ARn (P < 0.05). The appearance of AR in the nuclear fraction of
DHTP treated animals was accompanied by decreased AR in the cytosolic fraction
(P < 0.05). As inter-assay controls, ARc and ARn concentrations were also
measured in the anterior pituitary gland of selected rats. Mean ARc and ARn
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concentrations in intact rat pituitary were 4- to 20-fold higher than found in the
hippocampus (ARc: 6.3
25. l vs. 10.54

±

±

0.7 vs. 1.5

± 0.2 fmol/mg protein

and ARn: 193.6

±

4.5 fmol/mg DNA). Regardless of the differences in overall AR

content in the pituitary and hippocampus, the relative changes in AR occupancy
following androgen treatment or castration were similar in both tissues.

3H-Dexamethasone Competition Binding
To test the possibility that DHT might be promiscuously binding MR or GR in
the hippocampus we incubated hippocampal cytosol with 3H-Dex and several
radioinert corticosteroids or DHT (figure 21). In the presence of 50-fold molar
excess of DHT, 3H-Dex binding was decreased only slightly. A 500-fold molar
excess of DHT (1000 nM) was necessary to achieve any appreciable competition for
3

H-Dex binding (Approximate Ki= 1500 nM). RU 28362, CORT and dexamethasone

were all excellent competitors of 3H-Dex for the corticosteroid receptor with
approximate Ki values in the 2-8 nM range.
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Figure 19. Effect of castration (GDX) and dihydrotestosterone propionate
treatment of castrates (GDX + DHTP) on the magnitude of AR mRNA
expression in the CAl region of the hippocampus from adrenalectomized (ADX)
and sham operated (SHAM ADX) male rats. Results from semi-quantitative
densitometry of in situ hybridization histochemistry are shown. Each bar represents
the mean + SEM from 3-5 animals. No changes in AR mRNA were observed.
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Figure 21. Competition of various radioinert steroids with the binding of 3Hdexamethasone (3H-Dex) in hippocampal cytosolic extracts from male rats
adrenalectomized one day prior to sacrifice. ,H-Dex was used at a concentration of
2 nM. Binding is expressed as percentage of that obtained in the presence and
absence of cold competitor. Each point represents the mean of two replications.
Approximate Ki values: 2 nM for RU 28362; 4 nM for dexamethasone (DEX); 8 nM
for corticosterone (CORT); and 1500 nM for dihydrotestosterone (DHT).
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Discussion

In the present study we have demonstrated a downregulation of GR mRNA by
androgen treatment which occurs selectively in the CAl pyramidal cell region of the
hippocampus. In contrast, androgen treatment did not change MR or AR mRNA
levels in any cell body region of hippocampus. Our results provide a plausible
mechanism to explain recent studies by Bohn et al. (1994) showing lower GR mRNA
content in the adult male hippocampus as compared to the female. These
observations of message abundance are interesting when considered in conjunction
with data from binding studies that show lower adrenocorticoid receptor binding
capacity in the male rat hippocampus (Turner and Weaver, 1985). Whether our
observed decline in CAl pyramidal cell GR mRNA content following androgen
treatment is translated into similar changes in GR protein has yet to be examined.
However, the fact that data from in vivo receptor autoradiography using GR-selective
ligands, and in situ hybridization with GR riboprobes have shown parallel distribution
patterns of GR binding and GR mRNA in the hippocampus implies a correlation
between GR mRNA expression and the level of expression of functional protein.
Our findings concerning downregulation of GR mRNA levels by androgen
treatment are interesting in light of earlier work by Ahima and Harlan (1992) showing
that the daily injection of high doses of anabolic-androgenic steroids increased the
nuclear localization of GR immunoreactivity in the CAI and DG regions of the male
hippocampus. These authors suggested that circulating androgen present at levels
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over and above that necessary to saturate hippocampal AR may bind non-specifically
to GR thereby causing increased nuclear GR occupancy. These increases in GR
occupancy could result in a downregulation of GR mRNA, as seen in our studies,
however, our competition binding studies do not point to any appreciable binding of
DHT to the hippocampal GR. The possibility of promiscuous binding of androgen to
GR following extremely high levels of androgen cannot be ruled out. Additional
studies examining the effects of various androgen concentrations on GR mRNA and
protein levels are necessary to further elucidate the mechanism of this interaction.
Although we have not directly assessed the mechanisms governing androgenmediated downregulation of GR mRNA observed in this study, we believe that DHT
altered GR mRNA levels via AR binding and not through non-specific interactions
with adrenocorticoid receptors. This is based on our results demonstrating that: 1)
the majority of hippocampal AR was located in the nuclear fraction following DHTP
treatment, 2) androgen treatment decreased GR mRNA levels selectively in the CAI
pyramidal cell region where AR mRNA expression predominates, and androgen
treatment had no effect in area CA3 where GR mRNA is high, but AR mRNA is low
and 3) there was little in vitro competition by DHT for hippocampal dexamethasone
binding. Furthermore, the treatment of castrates with the non-aromatizable androgen,
DHTP, eliminated the possibility of an estrogen receptor mediated effect that has been
observed by others (Ferrini and DeNicola, 1991; Burgess and Randa, 1993b).
Since AR is a ligand-activated transcription factor, it is plausible that ARmediated downregulation of GR expression is occurring at the level of gene
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transcription. Although methological difficulties have prevented the direct
colocalization of AR and GR expression in CAl pyramidal cells, earlier work in our
laboratory showing AR mRNA in most, if not all, CAI neurons (See Chapter III and
Kerr et al., 1995a), and the current finding of even higher expression of GR mRNA
in virtually every neuron in the CAI region render colocalization of these two
receptors in the majority of CAI cells highly likely. It is known that AR, MR and
GR regulate gene transcription by binding to an identical HRE (Beato, 1989;
Chandler et al., 1983). Since the GR gene contains this HRE sequence which likely
mediates its autologous regulation (Burnstein and Cidowski, 1992), then activated AR
complexes could act directly at this HRE to halt or repress transcription of the GR
gene. Not surprisingly, activated MRs have been shown to regulate normally GRresponsive genes through a similar mechanism (O'Donnell and Meaney, 1994). If AR
can act non-discriminately as an activated GR would at the same HRE, it is unclear
why MR expression was not similarly affected. However, a consensus HRE has not
been examined within or upstream of the rat MR gene.
Recently it has become apparent that MR mRNA autoregulation in the rodent
hippocampus may be much more complex than originally thought. Similar to the
finding of two distinct AR mRNA isoforms in the rat brain (McLachlan et al., 1992),
multiple MR mRNA forms that vary in their 5' untranslated regions have been found
to exist in rat neural tissues (Kwak et al., 1993). Interestingly, these three different
sized MR mRNA isoforms were found to be unequally expressed in each subfield of
the rodent hippocampus, and the expression of only one of these mRNA forms was
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upregulated following ADX (Kwak et al., 1993). As our MR riboprobe could not
distinguish these three mRNA variants, limited regulation of just one form by GDX
or DHTP treatment may not have been detected using our in situ hybridization
methodology.
It appears that glucocorticoid regulation of brain adrenocorticoid receptors is

complex. In these studies, ADX differentially affected hippocampal GR and MR
mRNA expression in a subfield-specific manner. The moderate increases (30-45%) in
GR and MR mRNA in each pyramidal cell field and no changes in MR mRNA levels
in the DG region of the hippocampus following ADX were consistent with previous
studies (Herman et al., 1989; Herman, 1993). In contrast to our findings, earlier
studies have demonstrated ADX-mediated increases in GR mRNA in the DG,
however, the variability in the length of ADX appears to play a crucial role in the
magnitude of the measured response. Taken together, the hippocampus shows diverse
responses to glucocorticoid removal across its functionally heterogeneous subfields.
These findings strengthen the hypothesis that multiple factors likely control
adrenocorticoid receptor balance in this region.
The lack of hippocampal AR mRNA regulation by castration, androgen
treatment for three weeks, or short-term ADX was intriguing, yet not unexpected.
Upregulation of AR expression following GDX and decreases in AR expression by
androgen treatment have been found in peripheral male reproductive tissues such as
the testes and ventral prostate (Blok el al., 1992a; Abdelgadir el al., 1993).
However, studies examining autologous regulation of AR mRNA in brain regions are
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more difficult to interpret. In particular, earlier studies have detected attenuated AR
mRNA levels in the whole male rat hippocampus following four day castration,
whereas in the aged rat, AR mRNA content was increased (See Chapter III and Kerr

et al., 1995a). In both cases, concomitant changes in AR binding levels were not
found. As the present studies suggest, AR expression can be maintained in the
hippocampus after three week androgen removal or treatment.
Previous studies have demonstrated many different effects of androgen on
hippocampal physiology (Roof and Havens, 1992; Banda et al., 1994a, Kerr et al.,
1995c, Pouliot et al., 1995, Hampson and Kimura, 1992). Some of these androgenic
effects are similar to reported glucocorticoid effects in the brain (Roof and Havens,
1992; Banda et al., 1994a), whereas others are very different (Kerr et al., 1995c,
Pouliot et al., 1995) from effects attributed to glucocorticoids (reviewed in De Kloet

et al., 1993b; Dubrovsky et al., 1993; McEwen et al., 1994). Based on my results,
the effects of androgen in the hippocampus may be, in one respect, to mimic that of
glucocorticoids, as evidenced by the reduction of GR mRNA in a fashion similar to
that seen after glucocorticoid administration. An example of this is demonstrated by
our recent studies showing that androgen treatment can inhibit stress-related
corticosterone secretion, presumably by acting at the level of the hippocampus or
hypothalamus (Banda et al., 1994a). Conversely, androgens may act to antagonize
glucocorticoid action by decreasing the synthesis of GR, and thus, sensitivity to
circulating glucocorticoids. This possibility has been evidenced by studies
demonstrating increased cell death in hippocampal pyramidal cells following chronic

135

stress of gonadectomized animals, but not intact or androgen treated animals
(Mitzoguchi et al., 1992).
In summary, it appears that AR, GR and MR are embedded in a complex
network of transcriptional regulatory factors and our studies indicate some level of
interaction of these networks in hip:pocampal CA 1 pyramidal cells. The process of
androgen-induced GR mRNA downregulation may prove to be an important influence
on the ability of hippocampal CAl pyramidal cells to adapt appropriately to hormonal
stimuli, especially at times of heightened stress or during the aging process when
hippocampal neurons are more susceptible to damage by glucocorticoids (McEwen,
1992). Further study of AR, GR and MR expression and regulation at the gene,
mRNA and protein level following various hormonal challenges is necessary to
determine the exact functional significance of the potential molecular interactions of
AR, GR and MR in defined neuronal circuits.

CHAPTER V
ANDROGENS SELECTIVELY MODULATE c-fos mRNA
INDUCTION IN THE RAT HIPPOCAMPUS FOLLOWING NOVELTY

Abstract

Earlier studies have shown that ARs are found in high concentrations in
hippocampal CA 1 pyramidal cells. To begin to explore the possible roles for AR in
this area of the brain, the effects of endogenous and exogenous androgen on the
behaviorally-induced expression of cIEG mRNAs were examined. Adult male Fischer
344 rats were either gonadectomized, gonadectomized and given two Silastic capsules
of DHTP at the time of surgery, or left intact. Three weeks later, animals were
placed into a novel open field for twenty minutes. This behavioral paradigm caused
region- and gene-specific increases of cfos, jun-B, c-jun and zif268 mRNA in the
hippocampus as determined by semi-quantitative in situ hybridization histochemistry.
The removal of circulating androgen by GDX potentiated, whereas DHTP treatment
of castrates attenuated, the behaviorally-induced expression of cfos mRNA in the
CAI region of the hippocampus. No changes in c-fos mRNA expression were
detected in the CA3 or DG regions where AR levels are low. Androgen status did
not affect either the basal or stimulated expression ofjun-B, c-jun or zif268 mRNA in
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any of the three cellular regions of the hippocampus examined.
These results implicate ARs in modulating the active response of hippocampal
neurons to a behaviorally relevant stimulus. Since the products of cIEGs can function
to alter an array of downstream genes, the modulation of these genes in the
hippocampus by gonadal hormones may have important ramifications for hippocampal
function.

Introduction

Androgens have a profound modulatory role in the mammalian CNS by not
only directing the formation of neuronal pathways during fetal development (for
reviews, see McEwen, 1983; Breedlove, 1992), but also through the maintenance and
modulation of existing neural circuitry in adults (Arnold and Breedlove, 1985; Randa

et al., 1994b). Androgens initiate many of these effects by specifically binding to AR
in the cytoplasm and nucleus of target cells (Barley et al. , 1975). These hormonereceptor complexes act as ligand-activated transcription factors at specific DNA
sequences, termed RREs, upstream of target genes (Beato, 1989; Roche et al., 1992).
Recent studies have found similar levels of AR mRNA and AR binding in the
hypothalamus and hippocampus of the male rat (Burgess and Randa, 1993a; Kerr et

al., 1995a). In the hippocampus, AR expression was found to be particularly
concentrated in the CAI pyramidal cells (Kerr

el

ar.,

1995a). These neurons form

the major efferents of the hippocampal formation to various cortical and limbic areas
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of the brain (Van Groen and Wyss, 1990). In the rat hypothalamus, androgen action
has been well characterized and is known to mediate some aspects of reproductive
behavior (Davidson, 1966) and hormonal feedback (Messi et al., 1988; Zeitler et al.,
1990; Randa et al., 1994b). Presently, the role of AR in the hippocampus is unclear,
however, androgens have been shown to modulate some hippocampal-mediated
behaviors including learning and memory (Flood et al. , 1992; Hampson and Kimura,
1992; Roof and Havens, 1992; Janowsky et al., 1994) and emotionality (Hubert,
1990; Lumina et al., 1994).
Despite accumulating molecular data on the interaction of steroid hormonereceptor complexes actions with HREs, the cellular machinery initiated by hormonal
signals which leads to neuronal plasticity remains poorly defined. The identification
of target genes in the brain whose expression is modulated by androgens would begin
to clarify the role this hormone plays in selected brain areas, such as the
hippocampus. Recent approaches to such questions have led to the observation that in

vivo and in vitro stimulation of neurons causes the production of second messengers
that rapidly activate the transcription of a family of genes termed cIEGs (for review,
see Morgan and Curran, 1989). The protein products of these genes function as
transcription factors that regulate the expression of additional genes over extended
periods of time (for review, see Morgan and Curran, 1991). Both the pattern and
magnitude of cIEG expression in the brain appears to be dependent on the stimulus
employed (Bartel et al., 1989; Wisden et al., 1990) and the relative concentrations of
cIEG protein products likely confers some level of specificity in the long-term cellular
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response (Rausher et al., 1988; Schutte et al., 1989; Lin et al., 1993b). In the rodent
hippocampus, several cIEGs including the fos and jun family members, and zij268
(also known as NGFI-A, krox-24 or egr-1) are of particular interest as they are readily
induced following stimulation paradigms relating to seizure (White and Gall, 1987;
Wisden et al., 1990; Gass et al., 1992), memory formation (Tischmeyer et al., 1990;
Wisden et al., 1990; Nikolaev et al., 1992; Richardson et al., 1992; Demmer et al.,
1993; Heurteaux et al., 1993) and stress (Randa et al., 1993; Imaki et al., 1993; also
see review, Robertson, 1992). Thus, the high levels of AR in neuronal populations
that express cIEGs following various behavioral stimuli strongly suggests the presence
of cross-talk between these two signal transduction pathways. Therefore, it was
hypothesized that androgen status may alter cIEG induction in the hippocampus.
In the following study in situ hybridization was used to examine the pattern

and magnitude of c-fos, jun-B, c-jun, and zij268 mRNA induction in the male rat
hippocampus following behavioral testing in the novel open field; a paradigm which
has previously been shown to activate hippocampal neurons (Handa et al., 1993).
The novel open field has been used to monitor changes in fear, emotionality, anxiety
and depression in rats (Denenberg, 1969). As a consequence of the exposure to a
novel environment, rats show mild stress responses as measured by increases in
ACTH and CORT secretion (Handa et al., 1994a). In addition, the influence of the
removal and subsequent addition of circulating androgens on the level of expression of
these clEGs was explored in discrete cellular regions of the hippocampus. Such
modulation would implicate androgen in the alteration of hippocampal function and
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would suggest that the hormonal status of the animal can affect the active response of
hippocampal cells to incoming information.

Materials and Methods

Animals
Three month old Fischer 344 rats (Harlan Inc., Indianapolis, IN) were used in
these studies. Animals were maintained in temperature (72 · C) and humidity
controlled rooms on a 12 h light/dark cycle (lights on at 0700 h) and were given free
access to food and water. Bilateral GDX was performed under ether anesthesia.
Some gonadectomized rats received hormone replacement by the subcutaneous
implantation of two, 2.5 cm long Silastic capsules (0.07" i.d., 0.125" o.d.) containing
the non-aromatizable androgen, DHTP (Steraloids Inc., Wilton, NH), immediately
following GDX (GDX

+

DHTP group). These capsules have previously shown to

provide a constant level of DHT 2-5 times that of circulating DHT found in intact
male rats (Pouliot et al., 1995). All androgen treatments lasted for three weeks. All
rats were handled daily (2-5 min) for at least 10 days prior to sacrifice to reduce any
stress responses associated with handling. Animals were killed by decapitation and
their brains were removed immediately, frozen in isopentane (-30'C), and stored at 70'C.
Behavior testing was performed by placing animals in the center of the novel
open field and allowing them to roam free for 20 min. The novel environment
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apparatus consists of a wooden box measuring 100 cm x 100 cm x 40 cm high. The
floor is painted white and divided into 25 squares with thin black lines. Four holes
(3.5 cm diameter) are located in the four corner squares of the central nine squares.
The open field was placed in a dark, quiet room next to the animal quarters and was
illuminated by a 40W bulb positioned over the center of the chamber. Behaviors in
the open field were monitored by a remote videocamera and videotaped for later
analysis. Scores for a) the number of squares entered in the first 5 min, b) the total
number of squares entered during the 20 min testing, c) the number of rears, and d)
the number of nose pokes (rat enters snout into one of the holes) were tabulated for
each animal.

Experiment 1. Time-course of cIEG mRNA Induction in the Hippocampus Following
Novel Open Field.
With the exception of c-fos mRNA (Randa ti al., 1993), no previous studies
have examined the time-course of cIEG expression in the hippocampus following
exposure to a novel environment. Therefore, a preliminary experiment was
performed to examine the levels of c{os, c-jun, jun-B, and zij268 mRNA induction in
the hippocampus of intact male rats using in situ hybridization and to determine the
time point where cIEG induction is maximal for later studies. Animals were
sacrificed either directly from their home cage (HC), immediately following 20 min in
the open field environment (20 min OF), or at 0.5 h (20 min OF
min OF

+ 2h),

or 8 h (20 min OF

+ 8h) following open

+ 0.5h),

2 h (20

field and return to the home
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cage. Hybridization density from film autoradiograms of the CAl, CA3 and DG
regions of the hippocampus were quantitated using an image analysis system. Each
treatment group contained two animals.

Experiment 2. Effect of Castration and Androgen Replacement on novelty induced
cIEG mRNA levels in the Hiwocampus and Behaviors in the Open Field.
To determine if androgen status modulated the pattern or magnitude of clEG
mRNA induction in the hippocampus, intact, castrated, and castrated + DHTP treated
rats (3 week treatment) were sacrificed either directly from their home cage or were
exposed to the novel open field and sacrificed immediately upon removal from the
apparatus (n = 6-13 rats per group). In situ hybridization to detect c-jun, c-fos, junB, and zif268 mRNAs was performed on separate series of brain sections from each

animal. The resulting film autoradiographs were analyzed using an image analysis
system to quantitate hybridization density in the CA1, CA3 and DG cell regions of
the hippocampus. To determine whether androgen status effects the behavioral
response to novelty (which in turn could effect the magnitude of cIEG induction);
intact, castrated or castrated

+ DHTP rats (3

week treatment, n = 6 per group) were

scored in the novel open field environment as described above.
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l!1 situ Hybridization
For the in situ hybridization experiments, oligonucleotide probes were used to
detect c-jun mRNA [48mer, probe sequence 5'-GGCGTTGAGGGCATCGTCGTAGA
AGGTCGTTTCCATCTTTGCAGTCAT-3'; complementary to bases 353-400 of the
rat c-jun mRNA (Sakai et al., 1989)], jun-B mRNA [45mer, probe sequence 5'GAAGGCGTGTCCC TTGACCCCTAGCAGCAACTGGCAGCCGTTGCT-3';
complementary to bases 1278-1322 of the ratjun-B mRNA (Ryder et al., 1988)], and

zij268 mRNA (40mer, Oncogene Science). Each probe was 3' end-labelled with

35

S-

dATP and terminal deoxynucleotidyltransferase (Promega, Madison, WI). A 35Slabelled cRNA probe to detect c-fos mRNA was reverse transcribed as previously
described by Randa et al. (1993). This probe was complementary to nucleotides
1838-2116 of the rat c-fos mRNA.
Coronal brain sections (16 µm) were made with a Leitz 1600 cryostat and
mounted onto superfrost plus slides (Fisher Scientific, Pittsburgh, PA) and stored at
-70°C. In situ hybridization using the oligonucleotide and cRNA probes were
performed as previously described by Hammer et al. (1993) and Handa et al. (1993),
respectively. Briefly, tissue was postfixed in 4% buffered formaldehyde, acetylated
with acetic anhydride (0.25 % in TEA), dehydrated in ethanols and delipidated in
chloroform. Approximately 85 µI of a 20 x IOr; cpm/mL hybridization solution (50%
formamide, 20% dextran sulfate, 1.2 M NaCl, 20 mM Tris, 0.04% Denhart's, 2 mM
EDTA, 0.02% salmon sperm DNA, 0.1% yeast RNA, 0.01% yeast tRNA, 0.1%
sodium thiosulfate, 100 mM DTT, 0 .1 % SDS) were placed on each slide,
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coverslipped and incubated for 16 hat 65°C (for cRNA probe) or at 45°C (for
oligonucleotide probes). cRNA-hybridized probes were rinsed in 2 x SSC, subjected
to RNase A treatment (20 µglml at 37°C for 30 min) to digest any nonhybridized
RNA, and washed to a final stringency of 0.1 x SSC at 65 'C. Oligonucleotide
probes did not undergo RNase A digestion and were washed to final stringency of 2 x
SSC/50% formamide at 40°C. Autoradiographs were obtained by exposing slides to
x-ray film (Hyperfilm /jmax, Amersham, Arlington Heights, IL) for 9-15 days.

Image Analysis
NIH Image software was used to analyze film autoradiography. Hybridization
density in the brain area of interest was expressed in terms of dpm/mg protein. To
obtain a standard curve, a brain mash standard was made using increasing amounts of
35

S/mg protein. Co-exposure of this curve alongside a C14 plastic standard curve and

subsequent exposure of the C14 standard in the cassette with hybridized tissue allowed
for quantitation of density. This method has been described by Brady et al. (1992).
Brains were analyzed at the level of the dorsal hippocampus. Hybridization
density within cell body regions of the hippocampus were obtained by separately
tracing the entire upper blade of the DG granule cell layer, as well as the entire CAl
and CA3 pyramidal cell layers as defined by the atlas of Paxinos and Watson (1982).
A background sample taken from the molecular layer of the hippocampus was
subtracted from every measurement from each brain section. For each section, both
the right and left hemispheres of the hippocampus were sampled. Values from four
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brain sections were averaged to obtain a final density for each hippocampal field in
every animal. To confirm our observations, experiment 2 was repeated three times
for cjos mRNA measurement. Thus, the use of multiple film autoradiographs for the
analysis of c-fos mRNA expression necessitated the transformation of hybridization
density values to the percent of the mean obtained from the gonadally intact rats on
each film. Percent of intact data from all films were then grouped and subjected to
statistical analysis.

Statistics
Statistical analysis was performed using a two-way analysis of variance
(ANOV A) with treatment (intact, GDX, GDX + DHTP) and testing (HC vs. OF) as
factors. Subsequent analyses used a one-way ANOVA across treatment groups and
Student Newman-Keuls post-hoc tests. AP value less than 0.05 was considered
significant for all tests.

Results

Experiment 1. cIEG mRNA Time-course.
As shown in figure 22, a preliminary time-course study indicated that open
field behavior induced the rapid and transient expression of cjos, jun-B, c-jun and
zij268 mRNAs in the CAl region of the rat hippocampus. cIEG mRNA levels were
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low to non-existent in the hippocampus of home cage (HC) rats except for c-jun and

zif268 mRNAs which had relatively high constitutive expression (figure 22). For all
four of the cIEGs studied, mRNA induction reached between 853 and 1003 of
maximum immediately following the removal of the animal from the open field
environment (20 min OF, figure 22, only CAl region shown). Subsequently, in all
later experiments, animals were sacrificed immediately following removal from the
open field when it was now known that cIEG mRNA was at or near its peak
expression in all areas of the hippocampus. All but zif268 mRNA returned to HC
levels within 8 h after open field exposure (20 min OF

+

8h, figure 22).
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Figure 22. The time-course of cIEG mRNA induction in the CAl pyramidal cell
region of the hippocampus following introduction to a novel open field. Rats were
sacrificed from their home cage (HC), after 20 min in the open field (20 min OF), or
0.5 h (20 min OF + .Sh), 2 h (20 min OF + 2h), or 8 h (20 min OF + 8h)
following open field and return to their home cage. Hybridization densities from film
autoradiographs were obtained using a computerized image analysis system. Each
point represents the mean of two animals. Due to enormous differences in basal
levels between cIEGs, the time point at which the highest mean hybridization density
value for each cIEG was obtained was considered 100% (maximal induction) and all
other densities were transformed to percent of this maximal level for each cIEG.
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Experiment 2. Effects of Castration and Androgen Treatment on cIEG mRNA Levels
in the Hippocampus Following Novelty and Behavior in the Open Field.
As depicted in figure 23, in situ hybridization analysis revealed unique
patterns of cIEG mRNA expression in response to novel open field testing in the
intact male rat. c-fos mRNA was undetectable in the hippocampus of home cage
animals, and was found in moderately high levels in the CAI and DG regions of the
hippocampus following novelty. The levels of both jun-B and zif268 mRNA were low
to moderate in the hippocampus of home cage animals and open field behavior
resulted in increases in all areas. zif268 mRNA levels were particularly high in the
CAl region. In contrast, c-jun mRNA was constitutively expressed in the CA3 and
DG regions in home cage rats and no observable increases occurred as a result of
behavioral testing. Neither castration nor androgen treatment altered the basal levels
or distribution patterns of cIEG mRNA expression in the hippocampus.
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Figure 23. cIEG mRNA expression in home cage animals (HC, left panel) and in
animals removed immediately following 20 min in the novel open field (OF, right
panel). In the control hippocampus, c{os mRNA was virtually absent. Novelty
induced c{os, jun-Band zifl,68 mRNA in distinct regions of the hippocampus and
cortex. c-jun mRNA is constitutively expressed at high levels in the CA3 and dentate
gyrus cell regions of the hippocampus. Autoradiographs were digitized.
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Quantitative densitometric analysis of jun-B and zif268 mRNA from film
autoradiographs demonstrated that the open field stimulus induced both jun-B (figure
24A) and zij268 (figure 248) mRNA above home cage levels regardless of androgen
treatment (P < 0.05). However, there were no effects of castration or DHTP
treatment in any region of the hippocampus in either home cage or open field rats
(CAl and DG shown). In contrast, c-jun mRNA levels were unchanged by open field
or androgen treatment in the CA3 and DG cell regions, where constitutive c-jun
mRNA expression was high (figure 24C). The very low levels of c-jun mRNA in the
CA 1 region of both home cage and open field rats made quantitation of hybridization
density in this area difficult. Since none of the density values obtained fell on the
linear part of the film standard curve, statistical analysis of these data was not
performed. In a single study of 6 rats per group, c-fos mRNA induction after novel
open field was dramatically increased above home cage levels in the CAI and DG
regions (figure 24D). Essentially, cfos mRNA hybridization was not above
background levels in the hippocampus of home cage animals. In addition, c-fos
mRNA levels in the CAl region were attenuated in castrates treated with DHTP as
compared to the castrate controls (figure 24D, P

< 0.05). There were no effects of

androgen treatment on any cIEG mRNA expression level in the CA3 or DG regions.
The finding that cfos mRNA induction was attenuated by DHTP treatment in
the CAI region were consistent in three separately run groups of animals, therefore,
combining the groups was warranted. However, due to variations in film
autoradiogram intensities and the use of a newly transcribed c-fos cRNA probe for
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each in situ hybridization run, it was not possible to compare dpm/mg protein
hybridization densities between films without introducing an enormous amount of
variability. To circumvent this problem, the results were expressed as percent of the
density of gonadally intact mean for each film autoradiograph then these data were
combined and statistically analyzed to generate the graph depicted in figure 25 (only
open field c-fos mRNA levels in the CA 1 and DG regions are shown). When the
studies were merged, thereby raising the number of animals per group to 11-13,
androgen treatment significantly affected c-fos mRNA induction in the CAl region
(ANOVA: F(2,33) = 12.32, P = 0.0002). GDX increased inducible c-fos mRNA
levels in the CAl region of the hippocampus by 32% as compared to intact controls
(P < 0.05) and DHTP treatment of castrated. males prevented the effect of GDX and
lowered c-fos mRNA expression to 69% of intact values (figure 25, P < 0.05). No
effect of androgen treatment were found in the DG (ANOVA: F(2,33) = 1.552,
p = 0.23).
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TABLE 1.
Effect of androgen treatment on open field activity measures
in the male F344 rat.

Total Squares Entered
Treatment

n

First 5 min

INTACT

6

GDX \If

6

GDX + DHTPcp 6

20 min

Rears

21 ±9.1

102±27.9

22 ±4.4

11 ±4.2

44±8.8 *

133±27.4

28±7.5

14±4.3

9±3.3

60±21.1

20±4.0

4±1.6

Nose Pokes

Data are presented as group mean± SEM.

* Significantly different (p < 0.05) from intact group (ANOVA followed by Newman-Keuls' test).
\jl Gonadectomized 3 weeks prior to testing.

<p Gonadectomized and given two 2.Scm Silastic capsules of dihydrotestosterone
propionate (DHTP) at time of surgery.

Castrated males showed significant increases in exploratory behavior during
the first 5 minutes of testing as compared to intact or hormone-replaced male rats

(Table 1). This effect of hormone treatment was not present when data were
examined over the entire 20 minute period. Androgen treatment did not significantly
affect any other measures of open field behavior.
Correlation analysis of total squares entered within the first 5 min of open
field exposure, as well as total squares entered within the entire 20 min, with the
corresponding CAl c-fos mRNA density in individual rats (n = 18) revealed R2 values
of only 0.19 and 0.52, respectively (nonsignificant, data not shown).
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Figure 24. Quantitation of cIEG mRNA expression in the rat hippocampus.
Effect of long-term castration (GDX) and DHTP treatment of castrates (GDX +
DHTP) on the magnitude of (A) jun-B, (B) zif268, (C) c-jun, and (D) c-fos mRNA
induction in the hippocampus of rats removed from their home cage (solid bars) or
immediately following 20 min in the open field (hatched bars). Results from
quantitative densitometry of in situ hybridization histochemistry in the CAI region
(left) and dentate gyrus (DG, right) are shown. Each bar represents the mean ± SEM
from 6 animals. *, Significantly greater than home cage value (P < 0.05) and#,
significantly different from each other (P < 0.05).
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DHTP) on the magnitude of hippocampal c-fos mRNA induction foil owing 20 min
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autoradiograms, densitometry values from each animal are expressed as percent of the
intact mean obtained from each film autoradiogram. Each bar represents the mean +
SEM from 11-13 rats. #, Significantly different from intact value (P < 0.05).
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Discussion

The purpose of this study was to determine if androgens modulate the in vivo
expression of cIEGs in the rat hippocampus following novelty. The hippocampus is a
likely target for androgens based on earlier studies showing that AR and AR mRNA
were expressed in this region with the greatest levels being found in the CA 1
pyramidal cell region, lower levels in the CA3 region, and no expression in the DG
granule cells. 27 Quantitative densitometry of in situ hybridization histochemical
labelling detected by film autoradiography provided a means of assessing c-fos, c-jun,

jun-B, and zij268 mRNA levels in the densely packed cell body layers of the
hippocampus. Since open field exploratory behavior had previously shown to
stimulate c-fos mRNA (Randa et al., 1993), as well as enhance the binding of
hippocampal transcription factors to their DNA recognition elements (Kinney and
Routtenberg, 1993), it was suspected that this behavior would be a simple, nonintrusive method of inducing cIEG expression in the hippocampus. In addition,
scores for general activity in the open field apparatus could be tabulated and later
related to gene induction.
Initially, novel open field exposure caused rapid increases of c-fos, jun-B, c-

jun and zij268 mRNA levels. However, there was also a region and gene specific
pattern of expression which would argue against the possibility that this behavioral
stimulus activates all hippocampal neurons leading to global, non-specific increases in
mRNA transcription. In general, hippocampal c1os andjun-B mRNA levels
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increased more after novelty than did zij268 or c-jun mRNA levels. The lower
stimulation of c-jun and zij268 mRNA levels appeared to be due to their relatively
high basal expression; a finding that has been noted by others (Worley et al., 1990;
Gass et al., 1992; Hughes et al., 1992). zif268, the cIEG best correlated with the
induction and maintenance of the hippocampal memory stimulus paradigm, LTP
(Worley et al., 1990; Richardson et al., 1992), showed the longest time-course of
expression of all the cIEGs studied. Hippocampal zij268 mRNA levels were still
higher than home cage levels 8 h after open field behavior and this protracted
expression may play a role in memory formation. Preliminary studies demonstrated
that novelty elicits specific cIEG signals in each hippocampal region. Since many of
the cIEG protein products work in concert with each other to control transcription
(Chiu et al., 1988), this transcriptional network likely leads to the fine tuning of
transcriptional activation of target genes.
To investigate the modulatory role of androgen on cIEG expression, GDX was
used to eliminate endogenous androgen and hormone replacement of castrates with the
non-aromatizable androgen, DHTP, was used to stimulate hippocampal ARs and
isolate AR-mediated effects. The intact rat, which has high circulating levels of the
aromatizable androgen, T, served as a physiological control. Castration of adult male
rats for three weeks potentiated the behaviorally-induced c-fos mRNA levels in the
CAl region of the hippocampus as compared to intact rats. Furthermore, DHTPtreatment attenuated c-fos mRNA induction to 70% of the level found in intact rats,
and to only 52 % of that found in castrated animals. Since no significant changes in c-
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fos mRNA occurred in the DG, where AR are not found (see Chapter III and Kerr et
al., 1995a), this finding strongly suggests that androgen acts through an AR-mediated

process to initiate these effects. The intermediate expression of c-fos mRNA in intact
rats may reflect the actions of the less potent androgen, T, on hippocampal AR
activation or the possible counteractive effects of estrogen through estrogen receptors
by the localized aromatization of T to estrogen in the hippocampus (Abdelgadir et al.,
1994). Unfortunately, RNase treatment of the tissue and the extreme density of cells
in the CA 1 cell body layer of the hippocampus makes examination of c-fos expression
at the single-cell level difficult. In order to elucidate possible mechanisms of
androgen action, it would be informative to know whether the decreases in
behaviorally-induced c-fos mRNA levels that we have observed were the result of
lower expression per cell, or if fewer CAI cells expressed c-fos mRNA.
The findings concerning c-fos mRNA in these studies were perhaps in contrast
to earlier work showing that seven days after castration or treatment with DHT,
mating-induced Fos immunoreactive cell numbers were not altered in several areas of
the rat brain (Baum and Wersinger, 1993). However, these researchers used a
shorter androgen treatment duration which may not have allowed for the necessary
AR-mediated changes in the cells to occur. Also, Fos was examined in hypothalamic
brain areas, not in the hippocampus, and Fos immunireactivity was measured
following a different stimulus (mating versus novelty). Finally, the androgenic effects
on c-fos mRNA concentration that were observed in this study may not directly
correlate with numbers of Fos-immunoreactive cells. To better understand this
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cascade of cellular events and make assumptions on the role of Fos in hippocampal
neuronal plasticity, as opposed to using cfos mRNA induction strictly as a marker for
neuronal activation, as was done in this study, it would be necessary to investigate
whether changes in c-fos mRNA led to subsequent changes in Fos protein levels. In
this regard, studies by Shultz et al. (1994) demonstrated that the induction of Fos
immunoreactivity closely followed the induction of cfos mRNA in the rat brain
following novelty. This observation suggests that Fos protein levels would likely
follow the same pattern of expression that was observed for c-fos mRNA.
The observation that castrated animals had increased activity in the novel open
field during the first 5 min was intriguing. These increases in activity paralleled c-fos
mRNA induction patterns in the CAI region of the hippocampus and raised the
possibility that main effects of c-fos were solely due to changes in activity. However,
analysis of activity and the magnitude of CAI cfos mRNA levels on an individual
animal basis revealed no significant correlations. Additionally, if treatment group
differences in activity were the sole determinants of c-fos expression, then one would
of expected to see significant changes in the CA3 and DG regions as well. The fact
that the levels of jun-B mRNA, which was highly inducible by this behavioral
stimulus, did not correlate with activity in individual animals, and did not change in
response to androgen removal or treatment, also argues against activity level being the
only factor regulating cIEG expression.
Earlier studies have revealed AR mRNA expression in virtually every
hippocampal CAI neuron (see chapter

rrr and Kerr et al.,

1995a). This finding
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enhances the probability that AR is present in the same CAl neurons expressing c-fos,

jun-Band zij268 mRNA following novelty. Co-localization of mating-induced Fos
and AR immunoreactivity has been described in the male hamster brain (Wood and
Newman, 1993) and provides further evidence that these two transcriptional pathways
are intertwined in several areas of the central nervous system. It is difficult to assess
from these data why androgen status only affected c-fos mRNA levels, and not c-jun,

jun-B, or zij268 mRNA levels. Clearly, since c-fos was the most highly inducible
mRNA following novelty, its expression had the greatest room for modulation by
androgens. Since c-jun mRNA was not induced in the CAl region, where AR
expression is highest, it was not suprising that androgen had no effect on the
expression of this cIEG. It can only be speculated that the cellular events triggering

zij268 and jun-B expression in CAl neurons differ from that of c-fos and are not
similarly altered by AR activation.
The consequences of altered cjos expression in CA l neurons are likely
diverse. Earlier work has shown that Fas proteins must dimerize with Jun family
member proteins to initiate its transcriptional regulation (Chiu et al., 1988), and shifts
in the relative concentrations of Fos and Jun can communicate very different messages
in the cell nucleus (Diamond et al., 1990). For example, differences in the amount of
Fos expressed in cells in vitro relative to Jun expression allows for discrimination of
transcriptional activation from transcriptional repression by GR acting at a composite
HRE (Pearce, 1994). These studies suggest that changes in c-fos expression, without
corresponding changes inc-jun, could alter Fos)Jun ratios, and thereby add another

160
level of transcriptional control within neurons.
Although the mechanisms accounting for the repression of c-fos mRNA levels
by androgens were not explored in the present experiments, it appears likely that the
long-term activation of AR in Fos-expressing CAl cells was involved. Unlike what
has been found for estrogen receptors (Weisz and Rosales, 1990), there is no evidence
for a direct effect of androgen on the c-fos gene through the binding to an upstream
HRE. Therefore, AR activation may lead to cellular changes which alter the ability
of CAl neurons to respond to in vivo stimuli and accounts for the observed changes
in c-fos mRNA induction. Recently, it has been shown that DHT treatment attenuates
the binding of MK-801, an NMDA receptor antagonist, in the CAl region of the rat
hippocampus (Kus et al., 1995), and may subsequently inhibit the electrophysiological
responses of CAl pyramidal cells to NMDA. This decrease in membrane-bound
excitatory receptor concentration is one possible mechanism by which androgens
could alter synaptically mediated CAI neuronal depolarization and/or lower the
production of second messengers, thereby decreasing cIEG induction. The present
findings concerning c-fos mRNA complement a recent study showing that removal of
glucocorticoid hormones by ADX potentiated kainate-induced cIEG mRNAs in the
hippocampus (Li et al., 1992). Thus, androgen modulation of glucocorticoid receptor
mediated events in the hippocampus are a possibility and are currently being
investigated. If these mechanisms are occurring in CAI hippocampal neurons, it is
not yet clear why c-fos expression was preferentially affected.
In summary, these data have demonstrated that androgen modulates the
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inducibility of certain cIEGs following a behaviorally relevant stimulus, most
probably by acting through the androgen receptor. This may have been the result of
changes in the excitability of existing neural circuits. Androgen modulation of
behaviorally-induced cIEG levels within hippocampal neurons may result in large
variations in transcription factor networks and may serve to fine tune androgenmediated processes at the molecular level. In the hippocampus, these functions may
include memory formation, cell maintenance, as well as cell survival.

CHAPTER VI
DISCUSSION

Growth, differentiation and plasticity of neurons involve the coordinated
expression of many genes in a precise temporal sequence. In these studies, the
expression of the receptor for androgens was characterized in the adult male rat
hippocampus and this area of the brain was found to be sensitive to this potent class
of steroids. This was emphasized by the fact that hormonal manipulations, in
particular, selective, high level stimulation of AR for relatively prolonged periods,
altered the expression of certain target genes within CAl pyramidal cells.
Briefly, to summarize the results of this dissertation, it was shown that the
male rat hippocampus contains a single, saturable, high-affinity binding site for
androgen, and that this receptor has the same size and affinity characteristics as the
AR found in other areas of the brain, and in peripheral tissues. AR and AR mRNA
was expressed in the hippocampus in amounts comparable to that found in the
hypothalamus -- an area where androgens act to control aspects of reproductive
function and hormonal feedback. In situ hybridization revealed that AR mRNA
expression is not uniformly distributed within the hippocampus. AR mRNA was
concentrated in CAl pyramidal neurons, and very little expression was found in the
DG. Short term GDX and AR antagonism downregulated AR mRNA in the whole
162
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hippocampus; however, AR levels (as determined by in vitro [3H]DHT binding) were
slightly elevated following similar treatment. These data suggest a unique AR
autoregulatory process in hippocampal neurons. Additionally, steady state AR mRNA
levels, but not AR binding levels, were higher in the hippocampus of old rats as
compared to their young counterparts suggesting, at least, a maintenance of androgen
sensitivity in this tissue throughout life. Sub-chronic treatment of young rats with the
AR-selective androgen, DHTP, significantly decreased steady state GR mRNA
expression, and prevented ADX-induced GR mRNA upregulation, selectively in the
CAl region of the hippocampus. Neither MR or AR mRNA levels were altered by
the same androgen treatments. Finally, inducible gene expression was characterized
in the hippocampus following exposure to novelty. Of the four cIEGs studied, c-fos
mRNA was the most highly induced in the hippocampus by this stimulus, and DHTP
treatment attenuated c-fos mRNA induction selectively in CAl pyramidal cells.
As with most scientific endeavors, many questions have arisen from these
studies. Certainly, two fundamental questions remain. 1) Through what cellular
mechanisms does the ligand-activated AR regulate the expression of GR, c-fos and,
possibly, other genes in hippocampal CAI pyramidal neurons? 2) How might
androgen-mediated regulation of GR and cjos expression lead to physiologically
relevant changes in hippocampal plasticity and, ultimately, affect hippocampal
regulated behaviors? Unfortunately, at the current level of understanding neither of
these questions can be answered definitively. Much of the following discussion is a
theoretical scheme of potential molecular mechanisms and ramifications of androgen
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action in the hippocampus. To support these theories, evidence from recent studies
examining interactions among the several classes of transcription factors and cIEG
protein products in neurons, cell culture and other molecular systems is discussed.

Mechanisms of Androgen Receptor Action

These dissertation studies have demonstrated that AR activation for subchronic periods attenuates steady state levels of constitutively expressed GR mRNA
and behaviorally-induced c-fos mRNA selectively in hippocampal CAl pyramidal
cells. As neither c-jun, junB, zij268, MR or AR mRNA levels were similarly altered
by this treatment, it is doubtful that generalized decreases in transcriptional efficiency
would account for these results. More likely, other mechanisms account for the effect
of androgens on the transcription of selective target genes in CAl neurons. Potential
mechanisms to explain AR-mediated decreases in GR mRNA levels include: direct or
indirect androgen-induced alterations in the ability of GR to mediate its own
transcriptional regulation, changes in GR mRNA processing or stability, and/or by
direct AR inhibition of GR gene transcription through a simple HRE. Androgenic
effects on inducible c-fos mRNA expression following a behavioral stimulus may be
occurring through androgen modulation of membrane receptor levels, changes in other
second messenger systems that have known effects on cIEG transcription, multisynaptic changes in neuronal excitability, and! or direct modulation of cIEG
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transcription or mRNA stability. A more detailed discussion of some of these
theoretical mechanisms, and any available evidence for them, follows below.

Cellular Interactions Between

Andro~en

and Glucocorticoid Receptors

AR and GR may be interacting in CAI pyramidal cells at several levels of
their transcriptional pathways to regulate GR gene expression. Three plausible
mechanisms to account for androgen modulation of GR mRNA levels are depicted in

figure 26. Activated AR may act non-discriminately at a simple HRE within or
upstream of the GR gene and block its transcription (figure 26A). In this scenario,
AR mimics the normal GR effect and, at high enough levels, AR may displace GR
dimers at this site. Both AR and GR have been shown to activate transcription in
vitro from the simple HRE contained in the mouse mammary tumor virus promoter
(Shemshedini et al., 1991) which lends some support to this theory. However, most
AR-regulated genes thus far (including probasin and mouse sex-limited protein)
contain complex response elements that were specific for AR as a result of selective
protein-protein interactions and response element spacing within the promoter region
(Adler et al., 1993). Further characterization of the HRE controlling steroid
regulation of GR transcription would help to determine whether this mechanism could
also occur in CAl neurons.
Alternatively, as depicted in figure 26B, high levels of activated AR may use
transcription factors and/or accessory proteins also necessary for normal GR gene
transcription. One such protein, designated receptor accessory factor (RAF; later
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found to have complete amino acid identity with insulin degrading enzyme), has been
shown to directly interact with and enhance DNA binding of both AR and GR peptide
fragments (Kupfer et al., 1993). This finding suggests that RAF may play a role in
the transcriptional activity of these receptors. Along these lines, overexpression of
ER significantly inhibited AR transcriptional activity in cell culture (Kumar et al.,
1994) prompting the authors to suggest that these two receptors must compete for
some unknown factor necessary for their transcriptional activity. Several studies have
demonstrated that GR interacts with many other transcriptional activators in vitro,
including Fos, Jun, and octamer transcription factor I (Yang-Yen et al., 1990; Jonat
et al., 1990; Schille et al., 1990; Kutoh et al., 1992). Although AR protein-protein
interactions have yet to be studied in depth, the overlapping use of transcription
factors by AR and GR may serve an important regulatory function in hippocampal
pyramidal cells.
Due to the long-term nature of the androgen treatments used in these
dissertation studies, it is also possible that AR activation could have altered GR
expression through more indirect means than discussed above. As mentioned earlier,
there is mounting evidence that the transcriptional activity of GR is modulated by its
interaction with other transcription factors traditionally thought to be stimulated by
cell surface receptor signal transduction (Diamond et al., 1990; Hoeck et al., 1990;
Jonat et al., 1990; Lucibello et al., 1990; Yang-Yen et al., 1990; Schiile et al., 1990;
Shemshedini et al., 1991; Shiile and Evans, 1991; Unlap and Jope, 1994). In
Particular, the protein-protein interaction of GR with the AP 1 transcription factor may
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repress or activate the transcriptional activity of GR depending on the relative
concentrations of clEG family members, Fos and Jun, in the complex (Diamond et

al. , 1990). Since the studies present in this dissertation have revealed decreased
levels of behaviorally-induced c-fos mRNA in the CA 1 region of the hippocampus of
DHT-treated castrates, this potential modulation of the Fos:Jun ratio within CAl
pyramidal cells following three week androgen treatment may in tum alter how GR
acts at its HRE within or upstream of its own or other target genes (figure 26C).
Along these lines, expression of Ha-ras and v-mos oncogenes in GR-expressing NIH
3T3 cells enhanced ligand-induced down-regulation of GR (Hoeck et al., 1990).
Taken together, androgen modulation of such intermolecular interactions between GR
and other transcription factors may be another mechanism mediating GR
transcriptional activity, conferring steroid hormone specificity, or fine-tuning gene
expression at the HRE resulting in our observed decreases in GR mRNA levels. It is
also possible that AR-mediated downregulation of GR expression enhances androgen
sensitivity within cells that express both GR and AR, as this mechanism would
enhance the probability of AR action at HRE sites used by both AR and GR. Many
additional studies examining the cross-talk between these signal transduction pathways
are necessary to ascertain which, if any, of the previously mentioned mechanisms are
occurring in CAl neurons.
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Figure 26. Schematic representation of three possible mechanisms by which
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receptor(GR)-mediated autoregulation. Bent arrow thickness indicates strength of
gene transcription.
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Mechanisms of Androgen Modulation of Cellular Immediate Early Genes
Few studies have examined specific AR interactions with cIEG protein
products, however, as mentioned above, there is increasing evidence that nuclear
hormone receptor pathways do cross-talk with the cIEG pathways, thereby modulating
each other's activity (see review by Hyder et al., 1994).
At our current level of understanding, the most plausible mechanism to explain
androgen mediated attenuation of cfos mRNA induction in the CA 1 region is through
the modulation of the function of a stimulating receptor in these neurons. In the CAl
region, the best example of a stimulatory receptor is the NMDA receptor. The
expression of these receptors is highly concentrated in CAl neurons (Mackler and
Eberwine, 1993; Kus et al., 1995) and glutamate is thought to be the principle
excitatory neurotransmitter in the hippocampal formation (Jahr and Stevens, 1987).
In addition, rapid cfos expression has been observed in the hippocampus following
NMDA receptor activation (Sonnenberg et al., 1989). Similarly, studies have
demonstrated that the administration of the NMDA receptor antagonist, MK801,
strongly attenuates the rise in cfos mRNA and protein in the DG following a kindling
stimulus, but has a lesser effect on jun-B and c-jun mRNA and protein and does not
markedly attenuate zij268 mRNA and protein levels (see review by Hughes and
Dragunow, 1995). This selectivity of the NMDA receptor for c-fos expression
strongly suggests that NMDA sensitivity may play a key role in androgen modulation
of c-fos expression. Studies are currently underway to investigate androgen regulation
of NMDA receptor expression and action in the hippocampus. In support of this
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hypothesis, initial studies by Kus et al. (1995) have found that androgen
administration decreases MK801 binding in CAl pyramidal cells. In accordance with
these findings, Pouliot et al. (1995) have demonstrated that androgen treatment
attenuates NMDA's excitotoxic electrophysiologic responses in CAl neurons. In
contrast, estrogen has been shown to increase NMDA agonist sites in the CAl
pyramidal cell region (Weiland, 1992). Such polarized effects of androgen and
estrogen may underlie sex differences in hippocampus-mediated behaviors.
It can not be ruled out that other pyramidal cell membrane receptors could also

be regulated by androgens thereby affecting neuronal excitability and cIEG induction.
Interestingly, the induction of c-jos by administration of the nonselective muscarinic
agonist, pilocarpine, was localized to the CAI and CA2 cell body regions of the
hippocampus (Hughes and Dragunow, 1993, 1994). Unfortunately, no studies have
yet explored androgen regulation of muscarinic receptors to determine if such
mechanisms could account for our results.
Alternatively, androgens may regulate the levels of second messenger
molecules or transcription factors known to activate or control the rapid induction of
cIEGs. Such possibilities include the protein kinase C-dependent serum response
factor (SRF) and the Ca2 +/cAMP-activated CREB protein; both of which bind to
upstream response elements in the Fos gene and stimulate its expression (Treisman,
1985; Sheng et al., 1990). Although androgen withdrawal has been shown to
decrease CREB transcript in the adult rat testis (West et al., 1994), no such studies
have been performed in brain tissue. Thus, it is still too early to predict if androgen
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acts through this mechanism in CAI pyramidal neurons.
Androgen may also be acting at a site distant from the hippocampus, but
through multi-synaptic connections alters CAI cell excitability and, in tum, modulates

c-fos expression following a behavioral stimulus. Certainly when one considers the
widespread connectivity to and from the hippocampus, such a complex process can
not be ruled out. Future studies using more localized administration of androgen into
the hippocampus, cultured pyramidal cells, or the hippocampal slice preparation will
help to elucidate if androgen's actions are multi-synaptic.

Functional Implications of Androgen Sensitivity in the Hippocampus

Due to the fact that only subtle changes in gene expression following relative
extreme alterations in circulating androgen levels were observed, it appears that
androgens act in the adult hippocampus to fine-tune selective transcriptional
responses. Interestingly, the presence of functional AR in the body is not necessary
for life or normal intelligence. This information has been attained from genetic XY
individuals who are born with mutations in the AR gene, and thus, are insensitive to
androgen's developmental and activational effects despite having high levels of
circulating T. In most cases, these individuals have severely malformed sexual
organs and are typically raised as females, but, otherwise have normal IQs (lmperatoMcGinley et al., 1991) and life spans (McPhaul et al., 1991). These findings
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suggest that androgen's actions in the brain are delicate, or, it is possible that other
mechanisms may compensate for a lack of direct androgen action in the brain. In
light of these data, androgen insensitive individuals have been found to perform worse
on hippocampally-mediated visuospatial tests as compared to both normal males and
their own unafflicted sisters (Imperato-McGinley et al., 1991); and curiously, T
supplementation to female-to-male transsexuals was associated with an increase in
their spatial ability, and had a deteriorating effect on their verbal fluency (Van
Goozen et al., 1994). These findings further support the studies in this dissertation
suggesting subtle activational effects of androgens in the hippocampus.

Functional Implications of Androgen Regulation of GR and c-tos Expression

Although the studies in this dissertation did not explore the functional or
behavioral significance of androgen-mediated changes in GR and c-fos mRNA
expression in hippocampal pyramidal cells, it is still possible to speculate how
changes in the expression of these genes may affect hippocampal function using
evidence from studies that have investigated GR- and Fos-mediated functions within
the hippocampal formation.
Activation of GRs in the hippocampus has been associated with decreased
excitability within CAl neurons (Joel and De Kloet, 1992), and in the process of
information storage (Oitzl and De Kloet, 1992). Jn addition, the activation of
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hippocampal GRs at high levels of circulating CORT contributes to the HPA axis
hormonal feedback inhibition process, resulting in the termination of the stress
response (Ratka et al., 1989). Potentially, all of these physiologic outcomes could be
indirectly modulated by fluctuations in androgen levels. It has also been well
documented that prolonged exposure to high levels of glucocorticoids, especially in
older rats, is neurotoxic; with preferential injury to the hippocampus (Landfield et al.,
1978; Sapolsky et al., 1985; Meaney et al., 1988; Woolley et al., 1990). In addition,
exposure to physiological levels of glucocorticoid:s can "endanger" the hippocampus,
making its neurons less likely to survive coincident challenges such as hypoxiaischemia (Sapolsky and Pulsinelli, 1985; Morse and Davis, 1990), seizures (Sapolsky,
1985), and NMDA receptor-mediated excitotoxicity (Supko and Johnston, 1994). If
androgen treatment proves to be effective in decreasing GR protein levels in CAl
pyramidal cells, such a mechanism may, in turn, be protective to these neurons.
The use of androgens to control the magnitude of c-fos induction in the
hippocampus following a stimulus or stres:sor may also prove to be a useful tool to
prevent cell loss or injury. The debate continues a:s to whether the induction of c-fos
after stress, seizure or neurotoxin exposure is involved with the neuroprotective
regeneration process, or if it sets into motion the genetic program for cell death.
When this process is better understood, androgen :sensitivity may play out to be an
important modulator of this process.
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Conclusion

These studies have demonstrated relatively high levels of functional AR in
hippocampal CAI pyramidal cells of the adult male rat. In addition, it was found that
these receptors are sensitive to changes in circulating androgen levels by altering AR
occupancy and the modification of selective transcriptional responses within these
neurons. Although, it is still difficult at this time to pinpoint the functional
significance of AR expression in the hippocampus, the preceding observations unveil
a solid foundation for further investigation of the activational roles of androgen in
hippocampal pyramidal cells and the cellular interactions between steroid hormone
receptors and other transcription factor responses within neurons. Undoubtedly, AR
action is complex and involves multiple signal transduction pathways. Future studies
clarifying the molecular cascade of events following AR activation, as well as the
precise behavioral outcomes of androgen manipulation, will provide crucial
information in the aim of understanding androgen action in the brain.
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